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ABSTRACT
Isolates of bovine herpesvirus-1 subtype 1 (BHV-1.1) and bovine 
herpesvirus-1 subtype 2 (BHV-1.2), the cause of infectious bovine 
rhinotracheitis-infectious pustular vulvovaginitis were compared with three 
other distinct ruminant alphaherpesviruses isolated from a goat (CapHV-2), a 
red deer (CerHV-1) and a reindeer (RanHV-1). Restriction endonuclease 
profiles produced by Bgin differentiated the five ruminant alphaherpesviruses. 
Amplification of a 468 bp fragment of each of the five alphaherpesviruses by 
the polymerase chain reaction (PCR) was achieved using 22 bp primers 
selected from the BHV-1 glycoprotein gl DNA sequence. All the amplified 
products contained Bgll and Hinfl cleavage sites. Only RanHV-1 did not 
contain Smal or Aval sites. Serological comparison by ELISA and serum 
neutralisation (SN) tests using rabbit hyperimmune sera, and cattle, goat, red 
deer and reindeer convalescent sera revealed a close serological 
cross-reactivity between all 5 viruses. Analysis of their relationships 
confirmed that: 1) the two BHV-1 viruses were most closely related, 2) 
CerHV-1 and CapHV-2 were more closely related to BHV-1 than they were to 
each other, and 3) RanHV-1 was more related to CerHV-1 than to BHV-1 and 
CapHV-2. Western blotting using polyclonal sera identified at least seven 
major proteins common to all the viruses with molecular weights of 130kDa, 
108 kDa, 90 kDa, 87 kDa, 74 kDa, 64 kDa and 45 kDa. With a view to 
identifying epitopes which would allow the differentiation of these viruses, a 
panel of 14 monoclonal antibodies (Mabs) against CerHV-1 were derived 
from BALB/c mice previously immunised with gradient purified CerHV-1. 
Four Mabs which had neutralising activity against CerHV-1 reacted in
i i i
Western blots with polypeptides of Mr 68-70 kDa and 74 kDa. The other 10 
Mabs reacted in Western blots with polypeptides of Mr 68-70 kDa and/or 64 
kDa. Radioimmunoprecipitation (RIP) results indicated that the 74 kDa 
protein detected in CerHV-1 was analogous to the 74 kDa cleavage product of 
the gl glycoprotein of BHV-1. The reactivity of each Mab against the five 
ruminant alphaherpesviruses was tested by ELISA. Two Mabs cross-reacted 
with all the five ruminant alphaherpesviruses while 10 others showed variable 
reactivity with the 5 viruses. Two Mabs reacted exclusively with CerHV-1 
antigens and these may be suitable for developing a diagnostic test to 
distinguish antibodies between BHV-1 and CerHV-1 in their natural hosts.
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1INTRODUCTION
Bovine herpesvirus type 1 (BHV-1) also known as infectious bovine 
rhinotracheitis-infectious pustular vulvovaginitis (IBR-IPV) virus is a member 
of the alphaherpesvirinae subfamily (Roizman et al, 1992). It is associated 
with a wide variety of clinical conditions including respiratory infection, 
conjunctivitis, vulvovaginitis, abortion and less comonly encephalitis and 
generalised systemic infection (reviewed by Gibbs and Rweyemamu, 1977a). 
It is one of the most important agents of bovine respiratory disease either 
directly or as a predisposing factor for bacterial infection, most commonly 
Pasteurella haemolytica (Yates, 1982).
The species specificity of ruminant alphaherpesviruses has not always 
been recognised. Antibodies against BHV-1 were widely demonstrated in 
both domestic and certain wild ruminants (reviewed by Gibbs and 
Rweyemamu, 1977a; Pastoret et al, 1988). It was assumed that ruminants 
which were seropositive to BHV-1 were either infected or had been in contact 
with the virus. However, it has been found recently that ruminants other than 
cattle can become infected with viruses antigenically related to, but distinct 
from BHV-1 (reviewed by Pastoret et al, 1988). At present, four such 
herpesviruses serologically related to BHV-1 have been isolated from 
ruminants. Three of these viruses, caprine herpesvirus-2 (CapHV-2) from 
domestic goats (Mettler et al, 1979); cervine herpesvirus-1 (CerHV-1) from 
red deer (Inglis et al, 1983; Ronsholt et al, 1987) and rangiferine
2herpesvirus-1 (RanHV-1) from reindeer vaginal swabs after dexamethasone 
treatment (Ek-Kommonen et al, 1986) have been isolated in Europe (Figure 
1.1). The fourth, a herpesvirus from water buffalo (Bubalus arnee) initially 
typed by serum neutralisation as BHV-1 (St. George and Philpott, 1972; 
Brake and Studdert, 1985; Bulach and Studdert, 1990) was isolated in 
Australia. A ruminant species seropositive for BHV-1 may therefore be 
infected by BHV-1 or one of these or other related herpesviruses. The 
existence of this close antigenic relationship among ruminant 
alphaherpesviruses could lead to misinterpretation of both diagnostic tests and 
epidemiological data. For this reason there is a growing requirement to have 
more reliable diagnostic tests which can distinguish these viruses both for 
disease control and animal certification in international trade. It is therefore 
important to identify the basis of genetic and serological relatedness among 
the ruminant alphaherpesviruses and particularly to identify the major 
common and virus-specific glycoproteins and their neutralising antigenic 
epitopes. Furthermore, the development of monoclonal antibodies capable of 
discriminating between the different ruminant alphaherpesviruses could lead 
to reliable immunodiagnostic assays for the comparison of antibodies to 
alphaherpesviruses in the serum of a wide range of potential hosts.
3Figure 1.1. Natural hosts of the five ruminant alpha­
herpesviruses studied in this thesis. 
Cow (top), goats (middle), red deer and 
reindeer (below, left and right 
respectively).
/
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CHAPTER 1 
REVIEW OF THE LITERATURE
This review of the literature is divided into three parts; firstly a brief 
review and update of the classification and nomenclature of the family 
herpesviridae, secondly a review of some of the comparative aspects of the 
biology of alphaherpesviruses with particular reference to BHV-1 and thirdly 
a review of alphaherpesvirus glycoproteins.
1.1. CLASSIFICATION AND NOMENCLATURE OF THE 
HERPESVIRIDAE
The classification and nomenclature of viruses within the family 
herpesviridae is complex and not yet fully resolved despite the wealth of data 
on their biology and molecular biology (Porterfield, 1989).
However, in its first report, the International Committee for the Taxonomy of 
Viruses (ICTV) Herpesvirus Study Group designated Herpesviridae as the name 
of the herpesvirus family comprising three subfamilies on the basis of their 
biological properties; the Alphaherpesvirinae, Betaherpesvirinae and 
Gammaherpesvirinae and provided guidelines for the classification of 
herpesviruses into three subfamilies (Roizman et al, 1981). The criteria for this 
classification include host range, reproductive cycle, cytopathology and the 
characteristics of their latent infection as reviewed in detail by Honess (1984). 
Recently, the ICTV approved the recommendation of its Herpesvirus Study 
Group that the members of the family Herpesviridae be classified into the three 
subfamilies on the basis of biologic properties (Roizman et al, 1992). 
Furthermore, the ICTV also approved the Herpesvirus Study Group proposals to
5assign several genera based on DNA sequence homology, similarities in gene and 
sequence arrangements, and relatedness of important viral proteins demonstrable 
by immunologic methods (see Table 1.1).
The general properties of the subfamilies are as follows:
Alphaherpesvirinae are characterised by a relatively short replication cycle 
(hours or days rather than weeks) and a rapid spread in tissue culture with 
accompanying cytolysis. They are permissive in fibroblasts, and experimental 
infection of cells from sources other than the natural host can be achieved with 
most viruses of this subfamily. In their natural hosts they cause mild 
infections of short duration notably involving the epithelium of the skin or 
mucosal surfaces, and establish latent infection in their natural hosts, 
primarily, but not exclusively, in nervous tissue - sensory and autonomic 
nerve ganglia and the central nervous system (CNS). Herpes simplex virus 
(HSV) is the type member.
Betaherpesvirinae (the cytomegaloviruses) are characterised by a long 
replication cycle and slow spread of infection in culture. Development of 
cytopathic effect (cpe) may take several weeks following low multiplicity of 
infection (moi) and is typified by giant cell formation. The viruses are notably 
species-specific both in vitro and in vivo; fibroblasts of the natural host are 
usually optimal for virus culture, and infection of cells from other than the 
natural host can rarely be achieved. In vivo infection is systemic and of 
considerable duration; virus can be isolated from multiple secretions over a 
period of months or even years. The genomes of betaherpesviruses (180-240
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6kbp) are larger than those of alpha- (125-165 kbp) or gammaherpesviruses 
(135-172 kbp). Human cytomegalovirus is the type member.
Gammaherpesvirinae are generally termed lymphotropic herpesviruses 
and are perceived as such because they are associated with 
lymphoproliferative disease in their natural or experimental hosts. Lymphoid 
cell lines containing multiple copies of viral DNA can frequently be 
established from peripheral blood. Lymphocytes in the acute or convalescent 
phase of infection and in some cases cell lines with similar characteristics can 
be generated by virus-induced immortalisation of lymphocytes in vitro. The 
viruses are conveniently divided into B-cell tropic (e.g. Epstein Barr Virus 
(EBV)) or T-cell tropic (e.g. Herpes saimiri) groups but there is no good 
reason to suppose that these tropisms are mutually exclusive. The term 
lymphotropic as applied to gammaherpesviruses is somewhat misleading since 
lymphocytes are generally non-permissive or at best semi-permissive for virus 
replication and many viruses in the subfamily will productively infect 
fibroblasts.
The classification of herpesviruses into three subfamilies is based on 
somewhat subjective and arbitrary criteria, and as a result many herpesviruses 
are ungrouped and some may have been wrongly classified (Porterfield,
1989). Nevertheless, the grouping has proved useful and its validity has been 
reinforced by nucleic acid hybridisation and by analysis of nucleotide 
sequence data both of which have shown that the genetic content and genome 
organisation of a number of different herpesviruses is generally comparable
7with the pre-existing classification, which was primarily based on biological 
properties (McGeoch et al, 1993). There are however some exceptions: 
Marek’s disease virus (Gallid herpesvirus-1 (GHV-1)) and herpesvirus of 
turkeys (Gallid herpesvirus-2 (GHV-2)), which had been regarded as 
belonging with the lymphoproliferative Gammaherpesvirinae. These two 
viruses can now be grouped with the Alphaherpesvirinae on the basis of 
limited sequence analyses (Buckmaster et al, 1988). The human herpesvirus 
6 (HHV-6) was initially thought to be a gammaherpesvirus. However, 
analysis of its genome structure and studies of nucleotide sequence homology 
show that it is more closely related to the human cytomegalovirus which is a 
type member of the Betaherpesvirinae than to the primate 
gammaherpesviruses (Efstathiou et al, 1988). The fish herpesvirus channel 
catfish virus (CCV), had been considered to be a member of the 
Alphaherpesvirinae. However, the complete genome sequence of this virus 
has now been determined and shows no clear relationship whatever with 
viruses belonging to the three subfamilies already discussed (Davison, 1992). 
Thus as proposed by Davison (1992) CCV would probably now be assigned to 
a separate taxonomic group.
The nomenclature for herpesviruses recommended by the ICTV (Roizman 
et al, 1981) is based on the use of the taxonomic unit to which the natural host 
belongs followed by the term ’herpesvirus’ and a number based on order of 
discovery. The first two bovine herpesviruses to be described, namely 
infectious bovine rhinotracheitis-infectious pustular vulvovaginitis 
(IBR-IPVV) and bovine herpes mammilitis are consistently named bovine
8herpesvirus type 1 (BHV-1) and bovine herpesvirus type 2 (BHV-2) 
respectively.
Comparisons of BHV-1 isolates by restriction endonuclease (RE) profiles 
of their viral genomes have shown significant differences (Engels et al, 1981; 
Mayfield et al, 1983; Misra et al, 1983). Four subtypes have been defined 
from these RE profiles, infectious bovine rhinotracheitis virus (EBRV) as 
BHV-1 subtype 1.1, infectious pustular vulvovaginitis (IPW ) as BHV-1 
subtype 1.2a and 1.2b (Engels et al, 1981; Misra, et al, 1983; Ludwig, 1984; 
Metzler et al, 1985; Miller et al, 1988; Edwards et al, 1990; Hamelin et al, 
1990) and BHV-1 subtype 1.3 (Studdert et al, 1981a; Brake and Studdert,
1985). However, the nomenclature of ruminant herpesviruses is still confused 
as the numerical system of nomenclature recommended by the ICTV is used 
widely but inconsistently with more recently discovered viruses. Several 
different names are used to describe herpesviruses of sheep and goats. The 
domestic goat herpesvirus is named caprine herpesvirus type 2 by Roizman et 
al (1981), BHV-6 by Ludwig (1983) and caprine herpesvirus type 1 by Engels 
et al (1987a) and Roizman et al (1992). The sheep herpesvirus associated 
with sheep pulmonary adenomatosis (Jaagsiekte) is named bovine 
herpesvirus-5 (Ludwig, 1983), caprine herpesvirus type 1 (Roizman et al, 
1981) and ovine herpesvirus 1 (Roizman et al, 1992).
Lately, since the red deer virus was the first alphaherpesvirus to be 
identified as a unique cervid herpesvirus, the designation cervid herpesvirus 
type 1 (CHV-1) was proposed (Ronsholt et al, 1987). However, anticipating
9that this acronym would further confuse that already used for canine 
herpesvirus type 1 and caprine herpesvirus type 1; Reid et al (1986) proposed 
herpesvirus of cervidae type 1 (HVC-1). Nettleton et al (1987) proposed the 
acronym CerHV-1 as another alternative for the red deer virus.
Since the publication of the first ICTV Herpesvirus Study Group report in 
1981, the ICTV have approved the recommendation of previous Herpesvirus 
Study Groups to assign several genera which have been updated quite recently 
(Roizman et al, 1992). However, the Herpesvirus Study Group recognised 
that common names in use prior to the establishment of new rules will 
continue to be used. It is likely that each of the more than 128 ruminant 
species in the family bovidae and 42 species in the family cervidae will have 
at least one alphaherpesvirus (Brake and Studdert, 1985). The nomenclature 
of the ruminant alphaherpesviruses referred to in this thesis is based on the 
subfamily from which the natural host belongs followed by the term 
’herpesvirus’ and a number in accordance with the recommendations by the 
ICTV (Roizman et al, 1981; Roizman et al, 1992) (see Figure 1.2 and Table
1.1 and 1.2). The bovine herpesviruses used in this study are referred to as 
bovine herpesvirus type 1.1 and 1.2 (BHV-1.1 and BHV-1.2). The caprine 
virus as caprine herpesvirus type 2 (CapHV-2), cervine herpesvirus type 1 
(CerHV-1) and rangiferine herpesvirus type 1 (RanHV-1) for the red deer and 
reindeer herpesviruses respectively. In this thesis the old nomenclature is used 
for the caprine virus, as since up until the recent ICTV report by Roizman et 
al (1992), caprine herpesvirus type 1 referred to the sheep pulmonary 
adenomatosis virus which is now called ovine herpesvirus type 1.
9a
Figure 1.2. Classification of the order Artiodactyla showing the 
relationship between the subfamilies from which 
ruminant alphaherpesviruses studied in this thesis 
have been isolated.
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1.2 COMPARATIVE ASPECTS OF THE BIOLOGY OF 
ALPHAHERPESVIRUSES.
The alphaherpesvirinae is one of the three subfamilies within the family 
Herpesviridae. Amongst the members of this subfamily are; Bovine 
herpesvirus-1 (BHV-1), Bovine mammilitis virus (BHV-2), Suid 
herpesvirus-1 (SHV-1, Pseudorabies virus, Aujeszky’s disease virus), Herpes 
simplex virus-1 (HSV-1), Herpes simplex virus-2 (HSV-2), Varicella-zoster 
virus (VZV), Equine herpesvirus-1 (EHV-1), and Caprine herpesvirus-2 
(CapHV-2) (Roizman et al, 1981).
Other herpesviruses serologically related to BHV-1 have recently been 
isolated from farmed red deer (Cervus elaphus) (Inglis et al, 1983; Nettleton 
et al, 1986, Ronsholt et al, 1987) and reindeer (Rangifer tarandus) 
(Ek-Kommonen et al, 1986; Rockbom et al, 1990). They were provisionally 
included in the subfamily alphaherpesvirinae pending further characterisation 
(Nettleton et al, 1986, Ek-Kommonen et al, 1986). Evidence from their 
biological characteristics (Reid et al, 1986; Rockbom et al, 1990) and 
genome organisation as shown by restriction endonculease analysis 
(Vanderplasschen et al, 1992) confirms them to be alphaherpesviruses. Both 
viruses have now been classified as alphaherpesviruses (Roizman et al, 1992).
1.2.1 Morphology
All herpesviruses consist of four structural elements; an electron opaque
11
core containing the double stranded DNA genome, an icosahedral capsid that 
encloses the core; an electron-dense asymmetrically distributed material 
abutting the capsid designated the tegument; and an outer membrane or 
envelope which surrounds the capsid and tegument. Electron microscopy of 
negatively stained preparations shows that extracellular enveloped virions 
measure from 120 nm to nearly 300 nm in diameter (Roizman and Furlong, 
1974). One possible explanation for this variability is the thickness of the 
tegument. The major source of variability, however, is the integrity of the 
envelope. Virions with intact envelopes are impermeable to negative stain and 
generally retain a quasi-spherical shape while virions with damaged envelopes 
are permeable to negative stain and have a sunny-side-up egg appearance with 
an irregular shape and a diameter generally larger than that of an intact virion 
(Roizman et al, 1992).
The icosahedral nucleocapsid within the envelope is about 100 nm to 110 
nm in diameter and is composed of 162 hollow capsomeres of which 12 are 
pentameric and 150 hexameric the latter with a hole running down the long 
axis (McCombs et al, 1971; Fong et al, 1973). The envelope contains 
protrusions or spikes which are more numerous and shorter than those 
appearing on the surface of many other enveloped viruses (Morgan et al 
1959; 1968; Spear and Roizman, 1972; Stannard et al, 1987). It was thought 
for many years that the DNA in the core was spooled around a protein plug, 
since in many electron micrographs it appeared to be a toroid (Furlong et al, 
1972). However, recently Booy et al (1991) have shown using cryoelectron 
microscopy and image reconstruction, that the DNA forms a uniform dense
1 2
ball. The condensed toroidal shapes seen previously may have resulted from 
the fixation procedures used for preparing specimens (Puvion-Dutilleul et al, 
1987). The morphology and morphogenesis of herpesviruses has been 
reviewed by Dargan (1986), Roizman and Sears (1990) and Rixon (1993).
1.2.2. Genome characteristics and organisation
Three mammalian alphaherpesvirus genomes have been sequenced to date: 
VZV (Davison and Scott, 1986), HSV-1 (McGeoch et al, 1985, 1988; Perry 
and McGeoch, 1988) and EHV-1 (Telford et al, 1992). The determination of 
the total nucleotide sequence of BHV-1 has just been started (Schwyzer and 
Ackermann, 1992). The linear, double stranded (ds) DNA genomes of the 
majority of herpesviruses that have been studied in detail have a 3’ single 
nucleotide extension (Roizman, 1990; Roizman and Sears, 1990). Table 1.3 
summarises some of the genome characteristics of some of the 
alphaherpesviruses. The gross arrangement of large scale sequence elements 
in these genomes is similar, with all possessing a long unique region (UL) and 
a short unique region (Us) bounded by inverted repeats (D^, IRS, TRL and 
TRS). The precise sizes of these elements differ for each virus. The genomes 
of alphaherpesviruses studied to date belong to either type D or E genome 
group (Figure 1.3) (Farley et al, 1980). Group D genomes are exemplified by 
those of VZV, SHV-1, BHV-1, EHV-1 and EHV-4 where the sequence at one 
terminus is repeated in an inverted orientation internally. In these genomes 
the domain consisting of the stretch of unique sequences flanked by inverted 
repeats (short or S component) can invert relative to the remaining sequences 
(long or L component) such that the DNA extracted from virions or infected
12a
Table 1.3. Genome characteristics of some alphaherpesviruses
Virus Genome Size Mol.Wt G+C Reference
type kbp kDa content
%
HSV-1 E 152 96 68 Sheldrick and Berthalot (1975)
HSV-2 E 152 96 69 Gentry and Randall (1973) 
Graham etal (1972)
BHV-2 E 133 88 64 Buchman and Roizman (1978a,b) 
Martin etal (1966)
VZV D 125 100 46 Dumas et al (1980); 
Davison & Scott (1986)
BHV-1.1 D 137 95 72 Mayfield etal (1983); 
Misra etal (1981)
BHV-1.2 D 138 94 72 Misra etal (1981)
BHV-1.3 D 140 7 72 Engels etal (1986)
CapHV-2 D 137 90 72 Engels etal (1987b)
SHV-1 D 140 91 74 Ben-Porat and Kaplan (1985)
EHV-1 D 142 94 57 Soehner etal (1965) 
Whalley etal (1981); 
Cullinane etal (1988)
EHV-4 D 148 ? 56 Sabine et al (1981); 
Studdert etal (1981b); 
Cullinane et al (1988)
FHV-1 D 134 7 46 Rota etal (1986)
GHV-1 D 165 ? 46 Cebrianetal (1982); 
Fukuchietal (1984); 
Sugaya etal (1990)
CerHV-1 D 141 ? ? Vanderplasschen etal (1992)
RanHV-1 D 132 87 ? Vanderplasschen etal (1992)
12b
Figure 1.3. Schematic diagram of two alpha- herpesvirus 
genome types. The basis of their difference is the 
content and arrangement of unique and redundant 
nucleotide sequences in populations of mature 
virus DNA. For each virus L and S indicate Tong’ 
and ’short’ unique sequences; a, b, indicate 
repeated sequences with aVaV being their 
complements. Arrows indicate the possible 
relative orientations of unique sequences 
represented in the population of mature DNA 
molecules (two for type D and four for type E)
UL - unique long, Us- unique short, - long 
terminal repeat, IRL - long internal repeat, IRs - short 
internal repeat, TRS - short terminal repeat
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cells consists of two equimolar populations differing solely in the orientation 
of the S compoment relative to the fixed orientation of the L component. 
Group E viral genomes, exemplified by HSV-1, HSV-2 and BHV-2 have 
sequences from both termini repeated in an inverted orientation and 
juxtaposed internally dividing the genomes into two components, L and S 
each of which consists of unique sequences flanked by inverted repeats. 
Unlike type D genomes, both components can invert relative to each other and 
DNA extracted from virions or infected cells consists of four equimolar 
populations differing in the relative orientation of the two components (see 
Figure 1.3). The characteristics of the other genome types defined as A, B, C 
and F are not described here but have been reviewed in detail by Roizman et 
al, 1992.
A direct comparable measure of diversity or unity can be achieved by 
cross-hybridisation to reveal the degree of nucleotide sequence homology in 
viruses which appear to be closely related by other criteria (see Table 1.4.). 
Overall, comparisons of genome organisation between the alphaherpesviruses, 
HSV-1, HSV-2, VZV, SHV-1 and EHV-1 (Davison and Wilkie, 1983) and 
between VZV, HSV-1 and BHV-1 (Davison and Scott, 1986; McGeoch et al, 
1988; Wirth et al, 1989) have shown extensive colinearity between genomes of 
these viruses.
1.2.3. Antigenic relationships
There are numerous reports in the literature indicating the presence of 
shared or group antigens amongst the herpesviruses. A great variety of
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techniques has been used in these studies. However, cross-neutralisation has 
been suggested by ICTV as the prime serological relationship for qualification 
of a virus as a member of the herpesvirus genus. Other immunological 
methods used include immunoelectrophoresis (IEP) (Evans et al, 1973) which 
demonstrated an antigen common to 10 herpesviruses from diverse primary 
hosts; agar gel immunodiffusion test (AGID) (Killington et al, 1977) which 
identified a common antigen to five viruses, later identified to be the major 
DNA binding protein by Littler et al (1981); immunofluorescence (Ross et 
al, 1972; Blue and Plummer, 1973) and particle agglutination test (Ross et al, 
1972). Recently, the virus neutralisation test (Nixon et al. 1988; Martin et al
1990) and ELISA (Nixon et al, 1988) have been used to study the antigenic 
relationship of some ruminant alphaherpesviruses.
Among ruminant alphaherpesviruses. An antigenic relationship exists 
between BHV-1 and CapHV-2, which is detected as a one-way reactivity i.e. 
anti CapHV-2 serum reacts weakly with BHV-1 antigen, but anti BHV-1 
serum reacts stongly with CapHV-2 antigen (Berrios et al, 1975; Mettler et al, 
1979; Engels et al, 1983; Kao et al, 1985; Ackermann et al, 1986; Nixon et 
al., 1988; Buddie et al, 1990; Martin et al, 1990). The main capsid protein 
(VP4) and the viral glycoprotein gl have been shown to be responsible for this 
reactivity (Ackermann et al, 1986; Friedli and Metzler, 1987; Engels et al, 
1992). However Ludwig (1983) and Ludwig and Gregersen (1986) found two 
glycoproteins common to CapHV-2 and BHV-1, with molecular weights of 
74kDa and 91kDa to be responsible for the cross-neutralisation between 
CapHV-2 and BHV-1. Recently Collins et al (1993) using a set of Mabs
15
raised against BHV-1.1 showed that glycoproteins gl and gIV were 
responsible for the cross-reactivity between BHV-1.1 and BHV-1.3.
CerHV-1 and RanHV-1 have been shown to be antigenically related to 
BHV-1 (Inglis et al, 1983; Ek-Kommonen et al, 1986). However, results 
from Nixon and others (1988) suggested that CerHV-1 and CapHV-2 are more 
closely related to BHV-1 than they are to each other. The only other virus of 
widespread importance which may cross-react with BHV-1 is suid 
herpesvirus-1 (SHV-1). Cross reactivity between suid herpesvirus-1 (SHV-1) 
and BHV-1 has been reported (Aguilar Setien et al, 1980; Bush and Pritchett, 
1986; Banks, 1989), but Nelson et al, (1972), Hasler and Engels (1986) and 
Afshar et al (1987) failed to demonstrate this cross reactivity by neutralisation 
and ELISA (Table 1.5).
Within ruminant alphaherpesvirus isolates. There is a wide range of 
reports often with conflicting results on the serological comparisons of BHV-1 
isolates (Gillespie et al, 1959; McKercher and Wada, 1964; Buenig and 
Gratzek, 1967; Bowling et al, 1969; House, 1972; Gregersen, 1983; Levings 
et al, 1984; Gregersen et al, 1985; Metzler et al, 1986; Friedli and Metzler, 
1987; Trepanier et al, 1988). The weight of evidence is that BHV-1 isolates 
can not be discriminated by conventional serological methods (Gillespie et al, 
1959; Gregersen et al, 1985; Metzler et al, 1986).
Two CapHV-2 strains, one from California (McK/US) (Saito et al 1974; 
Berrios and McKercher, 1975) and one from Switzerland (E/CH) (Engels et
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al, 1983) have been characterised in some detail. Several other isolates from 
goats in Norway (Hyllseth et al, 1985), Australia (Grewal and Wells, 1986), 
and New Zealand (Homer et al, 1982) are not well characterised. There is no 
information yet on the serological relatedness among these viruses. However, 
the clinical and pathological symptoms caused by the Swiss isolate were 
observed to be similar to those reported for the American strain, although the 
Swiss isolate did not cause abortion (Waldvogel et al, 1981). Goat 
alphaherpesviruses seem to be widely spread since antibodies have been 
detected in goat sera in various countries (Kao et al, 1985; Koptopoulos, 
1992).
Since the first isolations of CerHV-1 (Inglis et al 1983; Ronsholt et al, 
1987) and RanHV-1 (Ek-Kommonen et al, 1986) there has been described a 
new RanHV-1 isolate which is serologically related to BHV-1 (Rockbom et 
al, 1990).
1.2.4. Biology in vitro
Alphaherpesviruses are capable of productive cytocidal infections in a 
wide range of cell tissue types (Honess, 1984).
Host cell range. The host cell range of both BHV-1 and CapHV-2 has 
been studied extensively (Gibbs & Rweyemamu, 1977a; Kahrs, 1977; Jasty 
and Chang, 1972; Berrios and McKercher, 1975). BHV-1 multiplies in a wide 
variety of cell cultures including bovine embryonic kidney, skin and lung, 
bovine testis, lymph node, thyroid, thymus and kidney, ovine kidney, caprine
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kidney, equine and porcine kidney, MDBK and rabbit spleen cell lines. 
Caprine herpesvirus-2 replicates in cells of ruminant origin including bovine 
bone marrow, bovine embryonic kidney and lamb embryonic kidney. Bovine 
embryonic lung cells support replication of virus to high titres (Berrios and 
McKercher, 1975). Both CerHV-1 and RanHV-1 have been successfully 
grown in embryonic bovine trachea and turbinate cells (Nettleton et al, 1987).
Cytopathology. The cytopathic effect (cpe) of BHV-1 and CapHV-2 in 
bovine cells is characterised by rounding of the cells (McKercher, 1964; 
Berrios and McKercher, 1975; Mettler et al, 1979). In contrast to BHV-1; 
CapHV-2 induces a more diffuse cpe with prominent swelling of cells and 
vacuole formation followed by detachment and clump formation. The two 
viruses have an eclipse period of 5h followed by an exponential growth phase 
from 6 to 12 h after infection. CapHV-2 is one of the most rapidly growing 
herpesviruses known reaching maximum titres 12 h post infection. BHV-1 
reaches maximum titres 20h post infection (Engels et al, 1983).
The two cervid viruses, CerHV-1 and RanHV-1 show a common cpe, 
distinct from BHV-1 and CapHV-2. Syncitia formation for CerHV-1 and 
RanHV-1 is uncommon, and there is a prominent stranding of the infected 
cells (Ronsholt et al, 1987). Plaque formation by BHV-1 isolates is similar, 
ranging from 3.6-3.9 mm in diameter (Bagust, 1972). The plaques induced by 
CapHV-2 closely resemble those of BHV-1 by being circular with regular 
edges, but they are smaller at 1-2 mm in diameter (Stephens and Groman, 
1963; Berrios and McKercher, 1975).
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Temporal regulation of herpesvirus proteins. Most insight into the 
temporal regulation of herpesvirus proteins has been gained from studies on 
HSV. The herpesvirus proteins can be broadly designated as immediate-early 
(IE), early (E) or late (L) depending on the temporal order of their synthesis 
and whether their synthesis is dependent upon the successful progression of 
certain physiological processes in infected cells (Rakusanova et al, 1971; 
Roizman et al, 1974). In general the transcription, translation and expression 
of the herpesvirus polypeptides occur in a temporal cascade (Honess and 
Roizman, 1974,1975; Clements et al, 1977; Jones and Roizman, 1979), with 
expression of IE polypeptides being essential for the induction of early genes 
and functional E proteins subsequently being required for expression of late 
proteins. Briefly, the role of the different genes in polypeptide synthesis from 
HSV studies can be described as follows;
Immediate-early genes
IE proteins are first detected about lh after absorption. Early studies 
(Honess and Roizman, 1975) suggested that gene expression peaked at about 
2-3 hours. However these observations were usually made in the absence of 
viral protein synthesis or functional Vmw 175 and without using specific 
antibodies. Where studies have been carried out in the course of a normal 
infection, high levels of IE polypeptide accumulation have been detected in 
the middle and late stages of infection. Indeed recent experiments have shown 
that Vmw 110 steadily accumulates throughout infection with no evidence for 
repression (Everett and Orr, 1991).
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The promoter region of the IE genes, consists of two components, a 
"TATA" box sequence necessary for basal and induced levels of transcription, 
and upstream regulatory sequences containing multiple cis-acting elements 
conferring enhancer function and responsivity to IE regulation (Mackem and 
Roizman, 1982a, b; Cordingley et al, 1983; Preston et al, 1984; Kristie and 
Roizman, 1984; Bzik and Preston, 1986).
All the IE promoters contain GC-rich regions (Spl binding sites) and one 
to three copies in either orientation of the element TAATGARAT (where R is 
a purine), a cis-acting motif (Mackem and Roizman, 1982c; Whitton et al, 
1983; Whitton and Clements, 1984; Preston et al, 1984; Galloway et al, 
1984), which has been shown to mediate the stimulation of IE transcription by 
the major virion tegument protein Vmw 65 (VP 16), the product of gene UL48, 
upstream of the mRNA initiation sites (Post et al, 1981; Mackem and 
Roizman, 1982a; Campbell et al, 1984; Preston et al, 1984). Vmw65 
enhances expression of the immediate-early viral genes (Batterson and 
Roizman, 1983; Ace et al 1988) and also serves an important role in virion 
morphogenesis (Ace et al, 1988; Weinheimer et al, 1992).
Vmw65 does not form a direct interaction with DNA (Marsden et al, 
1987) but instead interacts with one or more cellular factors to form a tertiary 
complex (IEC) that binds to TAATGARAT (McKnight et al, 1987; Preston et 
al, 1988; O’Hare et al, 1988; O’Hare, 1993). A cellular component of this 
complex appears to be an ubiquitous protein with a variety of names NFLU
2 0
(Pruijn et al, 1986), OBPIOO (Baumruker et al, 1988; Strum et al, 1987), 
OTF-1 (Gerster and Roeder, 1988), TRF (O’Hare and Goding, 1988) and 
alpha-Hl (Kristie and Roizman, 1987). This factor was subsequently 
identified as Oct-1 (O’Hare and Goding, 1988; Stem et al, 1989) a 
transcription factor already implicated in the regulation of a number of cellular 
genes.
Oct-1 recognizes the TAATGARAT element and also an octomer 
consensus sequence ATGCAAAT. Although Oct-1 (NFIH) is capable of 
binding to a range of sequences, there is only efficient formation of the TRF-C 
(TAATGARAT recognition factor complex) when the TAATGARAT element 
is present (O’Hare et al, 1988; Gerster and Roeder, 1988; ApRhys et al, 
1989). IEC complex formation facilitates an acidic activating domain, which 
is located within the carboxy-terminus of Vmw65 to interact with a 
transcription complex and so amplify gene expression (Dalrymple et al, 1985; 
Triezenberg et al, 1988; Sadowski, et al, 1988; Cousens et al, 1989). Details 
of the functional role of Vmw65 in viral transcription and expression of IE 
genes have been reviewed by O’Hare (1993).
Early genes
Synthesis of early genes is initiated after the appearance of 
immediate-early polypeptides (Honess and Roizman, 1974; Wagner, 1985; 
Weinheimer and McKnight, 1987; Zhang and Wagner, 1987), since early 
genes require prior synthesis of IE gene products for their expression (Honess 
and Roizman, 1974; Clements et al, 1977). Different early genes are
2 1
expressed with different kinetics, gD although expressed as an early gene, is 
not maximally produced until the onset of viral DNA replication (Gibson and 
Spear, 1983; Johnson et al, 1986) and as such has been described as a 
beta-gamma or early-late (EL) gene (Roizman and Batterson, 1985; Wagner, 
1985; Harris-Hamilton and Bachenheimer, 1985). This increase in 
transcription of EL genes does not necessarily show a direct requirement for 
viral DNA synthesis, as increased expression may be due solely to an 
increased template copy number (Johnson and Everett, 1986a). As an 
example, the synthesis of the 65 kilodalton DNA-binding protein of HSV-1, 
encoded by gene UL42 has been shown to begin prior to viral DNA synthesis 
and continues to accumulate even late after infection (Goodrich et al 1989; 
Schenk and Ludwig, 1988). It has also further been demonstrated by 
Goodrich et al (1989) that the control of UL42 gene expression is at the level 
of transcription initiation.
The promoter regions of HSV early genes have been well studied and no 
viral specific sequences involved in transactivation have been detected. A 
typical HSV early promoter has been found to contain a "TATA" box element 
upstream of the transcriptional start site in combination with other elements, 
including "CCAAT" boxes, GC-rich regions (for Spl binding) and G-rich 
elements (McKnight et al, 1985; Everett, 1983; Eisenberg et al, 1985; El 
Kareh et al, 1985). Binding of various cellular transcription factors such as 
the "CCAATT" box binding factor and Spl to the promoter of the HSV TK 
gene has been demonstrated (Jones et al, 1985; Graves et al, 1986). Although 
many HSV promoters contain sequences homologous to TATA, CCAAT and
2 2
GC-rich elements, there is a great diversity between promoters of the same 
class (Mackem and Roizman, 1982c; Wagner, 1985). These differences may 
cause the differential rates of expression described previously for genes of the 
same class (Honess and Roizman, 1974; O’Hare and Hayward, 1985, Harris- 
Hamilton and Bachenheimer, 1985).
Late gene product accumulation can initially be detected at about 3 hours 
post absorption, reaching a peak at around 10-16 hours. This is approximately 
2 hours after the peak of viral DNA synthesis at 8 hours post absorption 
(Munk and Sauer, 1964; Roizman, 1969; Wilkie, 1973). The expression of 
late genes is dependent on the presence of a functional Vmwl75 protein 
(Watson and Clements, 1980) and is also dependent upon the replication of 
the viral DNA. As demonstrated by experiments with ts DNA-mutants and 
inhibitors of DNA synthesis (Swanstrom and Wagner, 1974; Honess and 
Roizman, 1974; Powell et al, 1975; Marsden et al, 1978; Jones and Roizman, 
1979; Holland et al, 1980; Conely et al, 1981; Pederson et al, 1981).
Late genes can be split into two classes; either gammaj or gamma2, 
otherwise termed "leaky-late" and "true-late" respectively. "Leaky-lates" are 
those genes whose expression is detectable in the absence of viral DNA 
replication, although they require DNA synthesis for maximal expression, 
whereas "true-late" genes have an absolute requirement for DNA synthesis for 
expression (Wagner, 1985; Roizman and Batterson, 1985; Johnson et al, 
1986). There is no operational distinction between "early-late" and
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"leaky-late" genes. Examples of "leaky-late" genes are the products of gene 
UL19, Vmwl55 - the major capsid protein and US6(gD). A protein which 
exhibits "true-late" characteristics is the product of gene US 11 (Johnson et al,
1986).
Experiments in which an HSV origin of replication was linked to the US 11 
promoter demonstrated that only the "TATA" box and replication of the host 
plasmid in cis were required for full expression (Johnson and Everett, 1986a, 
b). It is unclear what connection exists between the replication of viral DNA 
and late gene expression, although an increase in template copy number is 
unlikely to be responsible, as some effect would be detectable on early genes 
also.
A possible role has been indicated for IE protein Vmw63, where in 
transfection experiments it has been shown to have very little effect on its 
own, but can repress the transactivation of IE and E genes by VmwllO and 
Vmwl75 and augment their transactivation of L genes (Everett, 1986). There 
is growing evidence that it acts post-transcriptionally (Smith et al, 1992) 
probably by selectively stimulating mRNA 3’ processing of late gene poly A 
sites (McLauchlan et al, 1992).
1.2.5. Biology in vivo
Epidemiology. The geographical distribution of some of the ruminant 
alphaherpesvirus infections is shown in Table 1.6. Serological surveys show a
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high prevalence of ruminant alphaherpesvirus infections in host populations. 
Numerous species of ruminants, both wild and domesticated were shown to 
possess specific antibodies which neutralise bovine herpesvirus 1 (Table 1.7). 
Although viruses antigenically related but distinct from BHV-1 have been 
isolated from goats (Saito et al, 1974; Mettler et al, 1979), red deer (Cervus 
elaphus) (Inglis et al, 1983) and reindeer (Rangifer tarandus) 
(Ek-Kommonen et al., 1986) cross-neutralisation tests have suggested that 
each species is in fact infected with a similar but distinct virus which is 
specific for that species (Pastoret et al., 1988). Thus goats were stated to be 
susceptible to BHV-1 virus as a result of serological tests. In fact, this species 
is most often infected by its own herpesvirus namely CapHV-2 (Ackermann et 
al, 1986; Hasler and Engels, 1986). Experimental infection of goats with 
BHV-1 produces no more than a mild infection (Wafula et al, 1985) and the 
bovine virus fails to establish a latent infection, indicating a lack of true 
adaptation (Pirak et al, 1983). A similar situation probably exists in the wild 
ruminants which react serologically to BHV-1. The sensitivity of sheep and 
cattle to CapHV-2 has been investigated. Berrios et al (1975) reported that 
lambs and calves are not sensitive to infection with the McK/US strain. 
However, recently Papanastosopoulou et al (1991) showed that the virus can 
cause a mild infection in lambs following an intravenous experimental 
infection.
Species-specificity has also been demonstrated for cervid viruses in that 
red deer could be infected with their own virus which remained latent after a 
primary infection, while experimental infection of deer with BHV-1 failed to
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provide any evidence of replication (Reid et al, 1986; Ronsholt et al., 1987). 
This situation is similar to that in goats, and it is probable that every case of 
serological conversion in red deer (Cervus elpahus) is attributable to the 
cervid virus. Red deer, therefore, are never likely to be a reservoir of BHV-1 
for infecting cattle. In reindeer (Rangifer tarandus) early serological surveys 
indicated serological conversion to BHV-1, suggesting that a situation similar 
to that in red deer may also exist in reindeer (Rangifer tarandus) 
(Ek-Kommonen et al, 1982). However, although the reindeer virus caused 
mild clinical signs in experimentally-infected cattle, there was no report of the 
virus causing any symptoms in free-living reindeer (Nettleton et al, 1987). 
RanHV-1 was recently demonstrated by Rockbom and others (1990) to be 
associated with lesions of the alimentary tract and nose in reindeer. As stated 
earlier it is evident that ruminant species seropositive for BHV-1 are most 
likely to be infected with their own alphaherpesvirus which cross react 
serologically with BHV-1.
The epidemiological features of ruminant alphaherpesvirus infections are 
probably very similar in Europe and America (Chow and Davis, 1964; Kinyili 
et al, 1979; Kingscote et al, 1987), whereas in Africa they are rather more 
complex judging from the very high prevalence of antibodies to BHV-1 
observed in African buffalo (Syncerus coffer), eland (Taurotragus oryx) and 
wildebeest (Connochaetes spp.) (Table 1.8). The experimental infection of 
Wildebeest with BHV-1 showed them to be susceptible (Gibbs and 
Rweyemamu, 1977a). The infection remained confined to the genital tract, 
and it seems improbable that the infection would spread to other species. In
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general, herpesviruses can persist latently in small populations of animals 
without infection from outside (Pastoret et al, 1984; Pastoret et al., 1986; 
Thiry et al, 1986). It therefore seems reasonable to assume that other African 
species of wild ruminants, serologically positive for BHV-1 are infected with 
their own alphaherpesviruses.
Clinical syndromes. Ruminant alphaherpesviruses cause infections of 
veterinary importance in a wide range of animals (Table 1.9). The most 
common and economically important of ruminant alphaherpesvirus associated 
diseases is infectious bovine rhinotracheitis (IBR). The disease varies from a 
mild respiratory disease to a severe infection of the entire respiratory tract. 
The genital form of the disease, infectious pustular vulvovaginitis (IPV) is 
also relatively common and the virus is more rarely associated with 
conjunctivitis, abortion and encephalitis (Porterfield, 1989). Gastroenteritis 
may occur in adult cattle infected with BHV-1 and is a prominent feature in 
the generalised disease of neonatal calves, which is often fatal. Genital and 
respiratory disease are rarely diagnosed in the same herd at the same time. 
While IBR is uncommon in range cattle it is of major significance in feedlots 
where primary infection often coincides with transport and introduction to a 
feedlot of young fully susceptible cattle from diverse sources. BHV-1.3 
causes clinical encephalitis, usually without other clinical signs of BHV-1 
disease. This isolate has been shown to have different restriction enzyme 
profiles from BHV-1 and other ruminant herpesviruses (Brake and Studdert, 
1985). It was also shown earlier to be antigenically related to but 
distinguishable from BHV-1 isolates from the respiratory and reproductive
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tracts (Bagust, 1972). In domestic goats CapHV-2 causes rare disease 
epidemics in kids, in which a frequently fatal disease occurs characterized by 
severe mucosal lesions of the alimentary and respiratory tracts (Saito et al, 
1974; Berrios et al, 1975). The virus also causes vulvovaginitis (Homer et 
al, 1982; Hyllseth et al, 1985; Grewal and Wells, 1986).
In red deer an ocular disease has been associated with cervine herpesvirus 
type 1 infection (Inglis et al, 1983; Nettleton et al, 1986). Although the 
alphaherpesvirus which was isolated originally from the vagina of a reindeer 
experimentally treated with dexamethasone, was not associated with disease 
(Ek-Kommonen et al, 1986), Rockbom and others (1990) recently 
demonstrated the vims to be associated with ulcerative and necrotising lesions 
of the upper alimentary tract and nose.
The evidence to date suggests that alphaherpesvirus infections in both wild 
and domestic ruminants occur only in their natural hosts and do not cross 
stably into other species (Nettleton et al, 1987).
Pathogenesis. The aspects which have attracted most attention in the 
pathogenesis of ruminant alphaherpesvirus infection are latency and 
interaction with the immune system. In BHV-1, following infection by the 
respiratory or venereal route and vims replication in the mucosa at the portal 
of entry, a cell-associated viraemia is established and the vims progresses via 
sensory nerves to sacral or cervical ganglia eventually becoming latent in the 
trigeminal ganglia (Homan and Easterday, 1980, 1983; Narita et al, 1981;
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Ackermann et al 1982; Ackermann and Wyler, 1984; Rodriguez et al, 1984). 
Restricted latency-associated transcription has been described in cells latently 
infected with HSV-1, HSV-2, VZV, SHV-1 and BHV-1 (reviewed by Rock, 
1993). BHV-1 latency-associated transcripts (LAT’s) have been detected in 
neurons of trigeminal ganglia from latently infected rabbits and cattle (Kutish 
et al, 1990). Earlier Cheung (1989) demonstrated LATs in the trigeminal 
ganglia of latently infected swine. Other possible sites of latency are in the 
medulla and cervical spinal cord (Lawrence 1983). Latently infected animals 
exhibit sporadic shedding of virus and reactivation and shedding can be 
predictably induced by natural or corticosteroid-induced stress (Sheffy and 
Davis, 1972; Sheffy and Rodman, 1973; Babiuk and Rouse, 1979; Straub, 
1979; Pastoret et al, 1978, 1979a,b, 1980b; Thiry et al, 1985a,b; Whetstone 
and Miller, 1989). These features of latent infection have been reproduced in 
the rabbit (Rock and Reed, 1982) and used to demonstrate that the virus is 
transcriptionally active in latently infected neurones (Rock et al, 1986). 
Recently Whetstone and Miller (1989) showed that the two BHV-1 virus 
subtypes can be reactivated proving that two different strains of an 
alphaherpesvirus can establish latency in the same tissue in the host animal. 
Live vaccines can also establish latent infections in recipients (Pastoret et al, 
1980b).
Persistence, reactivation and re-excretion of BHV-1 under natural 
conditions are well recorded (Studdert et al, 1964; Saxegaard, 1966; Bitsch, 
1973; Hyland et al, 1975; Gregersen and Wagner, 1985). Frequent recurrence 
of clinical BHV-1 has been reported in closed herds (Hyland et al, 1975).
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Biological differences have been described in re-excreted virus strains 
(Pastoret et al 1979a,b, 1980a; Homan and Easterday, 1981). However, 
Castrucci and others (1980) showed that BHV-1 does not undergo significant 
modifications in its pathogenicity when reactivated from latently infected 
animals for the first time. Progress has been made in the last few years in 
describing molecular aspects of viral latency and reactivation. Restricted 
transcription of the viral genome is seen in latently infected neurones, with 
latency-associated transcription being antisense and overlapping that from 
viral immediate early genes (Rock, 1993). Restricted viral transcription in 
latently infected ganglionic and CNS neurons has been observed with several 
alphaherpesviruses including HSV-1, HSV-2, VZV, BHV-1 and SHV-1 (Rock 
1993). The LATs from BHV-1 localise predominantly to the nucleus, are 
approximately 0.77 to 1.16 kb in size and map to a region of the genome that 
overlaps an uncharacterised IE gene present on the complementary strand 
(Kutish et al, 1990). Transcription from the SHV-1 genome in latently 
infected neurons also appears to be restricted to a single region overlapping an 
IE gene region (Cheung 1989, Lokensgard et al, 1990, Priola et al, 1990). In 
VZV infection unlike the other alphaherpesviruses, satellite cells and perhaps 
other supporting cells, rather than neurons harbour latent virus. In addition, a 
much broader pattern of latency associated transcription is observed in latently 
infected cells; at least five distinct regions of the genome are transcriptionally 
active during latent infection. The function of latency-associated gene 
transcription in viral latency has not fully been defined. This question has 
been approached by examining the behaviour of HSV-1 LAT deletion mutants 
(viruses with defined deletions in regions encoding LATs or in
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promoter/regulatory regions controlling its expression) in animal latency 
models. Results from a number of laboratories indicate that LAT is not an 
absolute requirement for establishment or maintenance of latent infection in 
rabbit or mouse latency models (Javier et al, 1988; Ho and Mocarski, 1989; 
Steiner et al, 1989, Leib et al, 1989; Block et al, 1990; Hill et al, 1990; 
Sedarati et al, 1990). However evidence is emerging that LAT may play 
some role in establishment of latency and viral reactivation in vivo and in 
vitro. Sawtell and Thompson (1992) demonstrated that HSV-1 LAT promotes 
establishment of latent infection in mouse trigeminal ganglia. Although the 
functional significance of BHV-1 LATs remains largely unknown, the 
ganglionic events that occur during dexamethasone-induced viral reactivation 
suggests a role for them in some aspect of viral latency and reactivation. The 
number of LAT-containing neurons decreased significantly (by 60%) 24 to 48 
hours after dexamethasone treatment and returned to normal control values by 
72 hours after treatment (Rock et al, 1992). Thus, available data suggest that 
LAT function is not an absolute requirement for viral latency and reactivation 
under experimental conditions, but rather appears to enhance quantitatively 
the efficiency of the latency and reactivation cycle, (reviewed by Hill, 1985; 
Roizman and Sears, 1987; Stevens, 1989 and Rock, 1993).
The mechanisms by which animals recover from alphaherpesvirus 
infections include cell-mediated as well as humoral immune responses (Rouse 
and Babiuk, 1978). Virus infected cells may be destroyed by 
antibody-dependent cellular cytotoxicity (ADCC) (Rouse et al, 1975; 1976; 
Grewal et al, 1980; Misra et al, 1982) and T cell-mediated cytotoxicity
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antibody-dependent complement-mediated (Abe) cytolysis (Babiuk et al, 
1975). Outside the cells, virions can be neutralised by antibody or lysed by 
antibody and complement (Babiuk, et al, 1975).
13. ALPHAHERPESVIRUS GLYCOPROTEINS
The virion envelope of all alphaherpesviruses (and all herpesviruses) 
contains a number of virus-encoded glycoproteins some of which have been 
extensively studied (reviewed by Spear 1985, 1993a; Marsden, 1987; Wyler, 
et al 1989; Roizman and Sears, 1990; Mettenleiter, 1991). Many have now 
been identified and mapped on their respective genomes: 11 in HSV-1 
(Marsden, 1987; Roizman and Sears, 1990; Hutchinson et al, 1991; Baines 
and Roizman, 1993; MacLean et al, 1993; Spear, 1993a), 5 in VZV (Davison 
et al, 1986; Kinchington et al, 1986, 1990; Ling et al 1991), 5 in BHV-1 
(Marshall et al, 1986; van Drunen Littel-van den Hurk and Babiuk, 1986a; 
Meyer et al; 1991), 7 in SHV-1 (Hampl et al, 1984; Lukacs et al, 1985; Rea 
et al, 1985; Klupp and Mettenleiter, 1991; Klupp et al, 1992), 9 in EHV-1 
(Allen and Yeargan, 1987; Audonnet et al, 1990; Elton et al, 1991; Crabb et 
al, 1992; Telford et al, 1992; Whittaker, et al, 1992) and 9 in EHV-4 
(Cullinane et al, 1988; Riggio et al, 1989; Nicolson and Onions, 1990; 
Nicolson et al, 1990; Crabb et al, 1992; Cullinane et al, 1993) There is at 
present very little or no information on the glycoproteins of the caprine and 
the two cervid alphaherpesviruses. The role of herpesvirus glycoproteins in 
their primary interaction with the host continues to be a subject of intense 
interest as some of them are continuously being shown to play important roles 
in the pathogenicity of these viruses. At present 6 complete herpesvirus
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genome DNA sequences including the 3 mammalian alphaherpesviruses 
described in section 1.2.2 have been published. The other three herpesviruses 
are Epstein-Barr virus (EBV) (Baer et al, 1984) HCMV (Chee et al, 1990) 
and Channel catfish virus (CCV) (Davison, 1992). At least four other 
herpesvirus sequences are nearing completion (e.g. HSV-2 (McGeoch; 
personal communication, 1993); EHV-2 (Telford and Davison; personal 
communication, 1993); human herpesvirus 6 (Martin et al 1991); herpesvirus 
saimiri-2 (Albrecht et al, 1992)). Following the publication of the genome 
sequences of the above named viruses, there has been an accumulation of 
numerous reports of sequence and functional homologies among genes and 
proteins of different members of the herpesvirus family. As the complete 
nucleotide sequences of the many herpesviruses become available, these 
homologies will be confirmed and extended.
1.3.1. Nomenclature
Until very recently there has been no common nomenclature of individual 
herpesvirus glycoproteins. Over the last few years, workers studying the 
glycoproteins of herpesviruses have used different nomenclatures for each 
individual virus. This plethora of names has been confusing, particularly to those 
outside the field. However, the availability of increasing numbers of 
monospecific antisera, monoclonal antibodies, rapidly accumulating DNA 
sequence data and development of predictive methods to identify possible 
glycoproteins from analysis of DNA sequences (Perlman and Halvorson, 1983; 
McGeoch 1985, 1990; Hull and McGeoch, 1989; Griffin, 1991) has led to the 
adoption of common nomenclatures for the glycoproteins of individual
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herpesviruses including HSV (Spear, 1976), BHV-1 (Misra et al, 1981; van 
Drunen Littel van den Hurk and Babiuk, 1986a), SHV-1 (Hampl et al 1984), 
VZV (Davison et al, 1986) and EHV-1 (Whittaker et al, 1992). Considerable 
progress is being made in identifying analogous and or homologous glycoproteins 
in different herpesviruses (Marsden, 1987; Owen and Mittal, 1988; Mittal and 
field, 1980; Sheppard and May, 1989; Audonnet et al, 1990; Zhang and Leader, 
1990; Nicolson et al, 1990; Flowers et al, 1991; Whittaker et al; 1991, 1992; 
Carpenter and Misra, 1991; Ross and Binns, 1991; Mettenleiter 1991; Litwin et 
al, 1992; La Boissiere et al, 1992; Telford et al 1992; Scott et al, 1993). Despite 
the increasing wealth of information on the homologies of the herpesvirus 
glycoproteins there is very little evidence of efforts being made to adopt a 
commmon nomenclature. To date only gH is used to denote the homologous 
glycoproteins in the family Herpesviridae. Since the bulk of the knowledge about 
alphaherpesvirus glycoproteins is derived from the extensive studies on the 
prototype herpesvirus, HSV-1, a common nomenclature of alphaherpesvirus 
glycoproteins could be adopted on the basis of their respective homologies with 
HSV-1 glycoproteins as recently proposed by Whittaker and Coworkers (1992).
The nomenclature of BHV-1 glycoproteins was initially introduced by Misra 
et al (1981) and modified by van Drunen-Littel van den Hurk et al (1984) and 
van Drunen Littel van den Hurk and Babiuk (1985). However, van Drunen Littel 
van den Hurk and Babiuk (1986a) proposed a new nomenclature based on roman 
numerals which is now being adopted by many other workers (see Table 1.10). 
The major BHV-1 glycoproteins under this new nomenclature are: gl a complex 
of three glycoproteins with apparent molecular weights of 130 kDa/74 kDa/55
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kDa; gll (108 kDa), gDI (97 kDa) which also occurs as a dimer with an apparent 
molecular weight of 180 kDa; and gIV (71 kDa) also occurring as a dimer of 140 
kDa. The amino acid sequences of BHV-1 gl, gll, gDI and gIV are homologous 
to those of HSV gB, gE, gC and gD respectively (Babiuk et al, 1987; Wyler et 
al, 1989; Fitzpatrick et al, 1989; Misra et al, 1988; Tikoo et al, 1990; Whitbeck 
et al, 1988).
1.3.2. Homologous alphaherpesvirus glycoproteins
The adoption of common nomenclatures for glycoproteins of individual 
herpesviruses has increasingly made possible comparative identification of 
homologous or analogous glycoproteins in different alphaherpesviruses (see 
Table 1.11). The 11 HSV-1 glycoproteins identified and characterised in 
detail are designated gB, gC, gD, gE, gG, gH, gl, gJ, gK, gL (reviewed by 
Marsden, 1987 and Roizman and Sears, 1990; Hutchinson, et al 1992; Spear, 
1993a) and gM (Baines and Roizman, 1993; MacLean et al, 1993). 
Glycoproteins H and L are considered as a complex gH/gL since each, in the 
absence of the other is incorrectly processed (Fuller and Lee, 1992; 
Hutchinson et al, 1992). Homologous glycoproteins are found in other 
alphaherpesviruses; the corresponding homologues in some of the other 
alphaherpesviruses are listed in Table 1.11. In HSV, glycoproteins gB, gD, 
gH, gK and gL appear to be essential for virus replication since virus mutants 
deficient in any one of these glycoproteins are unable to replicate (Cai et al, 
1988; Ligas and Johnson, 1988; Fuller et al 1989; Hutchinson et al, 1992; 
Fuller and Lee, 1992; reviewed by Spear, 1993a). Essential glycoproteins 
homologous to gB, gD and gH have been characterized in BHV-1 (gl, gIV and
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gH) (Lawrence et al, 1986; Misra et al, 1988; Whitbeck et al, 1988; Chase et 
al, 1990; Blewett and Misra, 1991; Liang, et al, 1991; Meyer et al, 1991; 
Misra and Blewett, 1991; Fehler et al, 1992), SHV-1 (gH, gp50 and gH) 
(Hampl et al, 1984; Lukacs et al, 1985; Mettenleiter et al, 1986; Petrovskis 
et al, 1986a; Robbins, et al, 1987; Klupp and Mettenleiter, 1991; Peeters et 
al, 1992; Pensaert et al, 1992; Karger and Mettenleiter, 1993). Glycoproteins 
gC, gE, gG, gl, gJ and gM of HSV are dispensable for viral growth in tissue 
culture (Longnecker and Roizman, 1987; Baines and Roizman, 1991; Spear, 
1993b) as are glycoproteins gin, gl, gX and gp63 for SHV-1 (Robbins et al, 
1986; Petrovskis et al, 1986b; Zuckermann et al, 1989; Mettenleiter, 1991; 
Kimman et al, 1992b), glycoprotein gin for BHV-1 (Liang et al, 1991,1992) 
and probably VZV gpV (Kichington er al, 1990; Ling et al, 1991).
Although glycoproteins homologous to the essential HSV gB, gD and gH 
have been identified in VZV, EHV-1 and EHV-4 no similar functional studies 
have been reported in these viruses except for EHV-1 in which gD has been 
recently shown to play a major role in penetration of cells (Whittaker et al,
1992). However, although HSV gD homologues have been identified in the 
other alphaherpesviruses as listed in Table 1.11, VZV is the only 
alphaherpesvirus at this time to have been shown not to encode a glycoprotein 
gD homologue (Davison and Wilkie, 1983; Davison and Scott, 1986).
1.3.3. Genetic locations of homologous glycoproteins
A tremendous increase in the wealth of information is being derived from 
DNA sequence data highlighting the genomic organisation of most of the
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members of the alphaherpesvirus group. Comparisons of genome 
organisations between five alphaherpesviruses, HSV-1, HSV-2, VZV, SHV-1 
and EHV-1 has shown extensive genome colinearity between the viruses 
(Davison and Wilkie, 1983). Varicella-zoster virus (VZV) has also been 
shown to have a gene arrangement collinear to those of BHV-1 and HSV-1 
(Wirth et al, 1989; McGeoch, et al, 1988; Davison and Scott, 1986). The 
colinear arrangement within related regions indicates that the viruses share a 
common gene arrangement especially within those regions encoding a stretch 
of homologous proteins. However, because colinear arrangements are not 
maintained throughout entire genomes, homologous glycoproteins of several 
alphaherpesviruses including HSV, BHV-1, SHV-1, VZV, EHV-1 and EHV-4 
show both similarities and differences in their map locations (Roizman et al, 
1984; Rea et al, 1985; Ackermann et al, 1986; Gompels and Minson, 1986; 
Keller et al, 1986; Lawrence et al, 1986; Petrovskis et al, 1986b; Wathen and 
Wathen, 1986; Allen and Yeargan, 1987; Marsden, 1987; Misra et al, 1988; 
Whitbeck et al, 1988; Wirth et al, 1989; Zamb, 1987; McGeoch et al, 1988; 
Davison and Scott, 1986; McGeoch, 1990; Yalamanchili and O’Challaghan, 
1990; Yalamanchili et al, 1990; Simmard et al, 1990; Zhang and Leader, 
1990; Nicolson et al, 1990; Ling et al, 1991; Mettenleiter, 1991; Flowers and 
O’Callaghan, 1992; Telford et al, 1992; Whittaker et al, 1992; Spear, 1993a). 
Map locations of the genes encoding some of the homologous glycoproteins in 
these alphaherpesviruses are shown in Figure 1.4.
1.3.4. The structure of essential glycoproteins
Alphaherpesvirus glycoproteins have characteristics typical of a
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transmembrane glycoprotein (Pellet et al, 1985). These characteristics 
include an N-terminal hydrophobic signal sequence, a hydrophobic region 
close to the carboxy terminus which may function as a transmembrane anchor 
sequence (membrane-spanning domain) and a hydrophilic external surface 
region with potential N-linked glycosylation sites. By comparing the amino 
acid sequences of HSV gB homologues from 13 different herpesviruses, 
Borchers and her coworkers (1991) were able to show several regions of 
domains conserved in the closely related sequences, including a four amino 
acid motif, 10 cysteine residues, several proline residues and some potential 
N-glycosylation sites suggesting that the secondary and tertiary structures of 
these gBs were similar. Like HSV-1 gB, the predicted BHV-1 gl amino acid 
sequence exhibits two broad hydrophobic regions likely to represent an 
amino-terminal signal sequence and a transmembrane anchor domain 
(Whitbeck et al, 1988). Additional features shared with HSV-1 gB include 6 
potential N-linked glycosylation sites, four of which are colinear. One 
additional feature of BHV-1 gl extracellular domain is the presence of a 
22-amino acid region for which there is no counterpart in HSV gB. A similar 
situation has been noted for the gB homologues of VZV (Keller et al, 1986), 
SHV-1 (Robbins et al, 1987), EHV-1 (Whalley et al, 1989) and EHV-4 
(Riggio et al, 1989). This region of nonsimilarity represents a 
post-translational protease cleavage site (Borchers et al, 1991; Blewett and 
Misra, 1991). All the above gB homologues with the exception of HSV gB, 
exist in their mature form largely as cleaved, disulfide-linked heterodimers 
(van Drunen Littel-van den Hurk and Babiuk, 1986a; Grose et al, 1984; 
Lukacs et al, 1985; Meredith et al, 1988; Sullivan, et al, 1989). HSV gB
37a
Figure 1.4. Locations of the genes encoding 
alphaherpesvirus glycoproteins and, where 
known, DNA pol, TK, PK and the 
homologues for a major HSV tegument 
protein VP 13/14 The six alphaherpesvirus 
genomes are represented in their prototype 
orientations. The genes encoding 
glycoproteins are shown with a solid 
arrowhead whilst those encoding the enzymes 
are shown with an open arrowhead. The HSV 
tegument protein and its homologues are 
shown by ©  where the protein product has 
been identified and where it has not.
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exists as an uncleaved dimer (Eberle and Courtney, 1982; Classon-Welsh and 
Spear, 1987; Chapsal and Pereira, 1988). Recently Blewett and Misra (1991) 
demonstrated that cleavage of BHV-1 gl is not essential for its function and 
that the uncleaved BHV-1 gl could complement the function of HSV-gB, 
whereas Rauh and her coworkers (1991) showed that SHV-1 mutants lacking 
the essential glycoprotein gH could be complemented by BVH-1 gl. 
However, whether these structural differences are related to differences in 
their biological functions, remains to be determined.
Many HSV gD homologues including BHV-1 gIV (Whitbeck et al, 1988; 
Tikoo et al, 1990); SHV-1 gp50 (Petrovskis et al, 1986a), EHV-1 gD 
(gpl8/gp60) (Audonnet et al, 1990) and EHV-4 gD (gp 17/18) (Cullinane et 
al, 1993) share regions of significant amino acid sequence similarities which 
are confined to the central regions. These regions of sequence similarities 
contain conserved cysteine residues located within the central portion of the 
surface-exposed domain (Flowers and O’Callaghan, 1992).
EHV-1 gD contains 12 cysteine residues, while SHV-1 gp50 and HSV-1 
and -2 gD each contain 7 residues (Watson et al, 1982; Watson, 1983; 
McGeoch et al, 1985; Petrovskis et al, 1986a). Studies of HSV-1 gD have 
indicated that 6 cysteines form intramolecular disfulfide bonds that are 
essential for the structural integrity of the protein (Wilcox et al, 1985; Long et 
al, 1990). Despite these similarities differences do exist: for example, whilst 
HSV-1 gD (Cohen et al, 1983; Serafini-Cessi et al, 1988) and BHV-1 gIV 
(van Drunen Littel-van den Hurk and Babiuk, 1985) are both N- and
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O-glycosylated, SHV-1 gp50 is glycosylated by O-linked carbohydrate only 
(Petrovskis et al, 1986a), whereas EHV-1 and EHV-4 gD are glycosylated by 
mainly N-linked oligosaccharides (Whittaker et al, 1992; Cullinane et al,
1993).
A comparison of identities of amino acid sequences between related 
glycoproteins are summarised in Table 1.12. In addition comparisons of 
amino acid sequences of other related glycoproteins revealed an overall 
homology of 21% between EHV-1 gD and SHV-1 gp50, and 18% between 
EHV-1 gD and HSV-1 gD (Rowers et al, 1991). EHV-4 gD shares 83% 
sequence homology with EHV-1 gD, 38% with BHV-1 gIV, 34% with SHV-1 
gp50, 25% with HSV-1 gD and 24% with HSV-2 gD (Cullinane et al, 1993). 
The sizes of these gD homologues are very similar: 394 residues in HSV-1 
gD, 393 in HSV-2 gD, 402 in SHV-1 gp50 (McGeoch, 1990), 402 in EHV-1 
gD (Audonnet et al, 1990), 402 in EHV-4 gD (Cullinane et al, 1993) and 417 
residues in BHV-1 gIV (Tikoo et al, 1990).
Although HSV-1 gH appears to be only a relatively minor component of 
the virion envelope, it is essential to the viral replicative cycle (Desai et al, 
1988). Glycoprotein gH homologous proteins have been described in all 
herpesviruses examined so far including alpha, beta and gammaherpesvirinae 
(Gompels and Minson, 1986; Keller et al, 1987; Cranage et al, 1988; 
Gompels et al, 1988a; Heineman et al, 1988; Josephs et al, 1991; Klupp and 
Mettenleiter, 1991; Meyer et al, 1991; Nicolson et al, 1990; Pachl et al, 
1989; Klupp et al, 1992) and they constitute the second most highly
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Table 1.12. Identity of amino acid sequences between related 
alphaherpesvirus glycoproteins*
Gene
family
HSV-1 HSV-2 SHV-1
gB HSV-2 85.6
SHV-1 50.4 50.7
BHV-1 49.4 48.1 60.8
gc HSV-2 69.0
SHV-1 22.1 17.5
BHV-1 18.0 21.0 24.6
gD HSV-2 82.2
SHV-1 10.9 10.9
BHV-1 11.4 14.8 32.8
gH SHV-1 27.4
identities were determined after alignment of sequences from PALIGN 
programme of PCGENE. Adapted from Spear (1993b).
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conserved group of herpesvirus glycoproteins, surpassed only by the gB 
homologues (Fuller et al, 1989). The gH homologues and the gB homologues 
have been shown to possess all the characteristics of membrane glycoproteins 
including an N-terminal hydrophobic region which contains a signal sequence, 
a C-terminal region which serves as a transmembrane anchor domain and 
potential sites for N-linked glycosylation (Gompels et al, 1988a). With the 
exception of SHV-1 gH which is only 686 amino acids in length (Klupp et al, 
1992) the gH’s of alphaherpesviruses tend to be larger than their beta- and 
gamma herpesvirus counterparts, ranging from 838 (HSV-1) to 882 (BHV-1) 
as compared to 706 to 743 for the EBV, HVS and HCMV gH’s (Nicolson et 
al, 1990). It has also been shown by Nicolson and coworkers (1990) that the 
C-terminal region of the protein is clearly conserved to a greater degree than 
the N-terminal.
Several features emerged from a comparison of the amino acid sequences 
of gH proteins of alpha-, beta- and gammaherpesviruses by Gompels et al 
(1988a,b) and Cranage et al (1988). First, there was great diversity of 
sequences in the N-terminal region of the protein. Second, they possessed an 
unusually short cytoplasmic domain: 14 to 15 amino acids in
alphaherpesviruses and seven or eight amino acids in beta- and 
gammaherpesviruses. Third, four conserved cysteine residues lying within 
conserved local sequences were found at similar positions relative to the 
putative transmembrane domain. Out of the 10 cysteine residues in SHV-1 
gH, 7 are found at colinear positions in BHV-1 gH, VZV gpV, EHV-4 gH, 
and HCMV gH, 6 in EBV gH and HVS gH; but only 4 in HSV-1 gH. Fourth,
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a single C-terminal N-glycosylation site is conserved throughout herpesvirus 
gH proteins (Klupp and Mettenleiter, 1991). Fifth, considerable variation 
exists in potential N-linked glycosylation sites among the herpesviruses; 
eleven have been shown in the VZV, EHV-1 and EHV-4 gHs, eight in HVS, 
seven in HSV-1, six in HCMV, five in EBV, three in SHV-1 and six in 
BHV-1 (Keller et al, 1987; Robertson et al, 1991; Nicolson et al, 1990; 
Gompels et al, 1988a; Gompels and Minson, 1986; Cranage et al, 1988; Baer 
et al, 1984; Klupp and Mettenleiter, 1991; Meyer et al, 1991). All the 
conserved features imply some degree of similarity of both the secondary and 
tertiary structure of gH from different herpesviruses.
1.3.5. Functions and Activities
Herpesvirus glycoproteins that are present in the virus envelope are known 
to mediate several important steps in virus-host cell interactions (reviewed by 
Spear, 1985, 1993a; Mettenleiter, 1991). They are involved in virus 
adsorption to target cells (Schreurs et al, 1988; Mettenleiter et al, 1990; 
Sawitzky et al, 1990; Herold et al, 1991; Okazaki et al, 1991; Liang et al, 
1991,1992,1993; Karger and Mettenleiter, 1993), are essential for penetration 
(De Luca et al, 1982; Highlander et al, 1987; Cai et al, 1988; Ligas and 
Johnson, 1988; Fuller et al, 1989; Rauh and Mettenleiter, 1991; Peeters et al, 
1992; Fehler et al, 1992; Whittaker et al, 1992; Hutchinson et al, 1993) and 
also influence virus release from infected cells (Schreurs et al, 1988; Whealy 
et al, 1988; Mettenleiter et al, 1987; Zsak et al, 1989; van Drunen-Littel van 
Den Hurk et al, 1989). Most notably, all essential herpesvirus glycoproteins 
analysed so far are involved in fusion events between either virus envelope
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and cellular cytoplasmic membrane or between cytoplasmic membranes of 
infected and adjacent uninfected cells (Manservigi et al, 1977; Chase et al, 
1989; Fitzpatrick et al, 1990a; Tikoo et al, 1990; Peeters et al, 1992). By 
virtue of their involvement in the first steps of virus infection, glycoproteins 
are important in determining whether virions are able to enter target cells and 
initiate a productive infection. Glycoproteins of herpesviruses are also major 
targets of the host’s immune response both at the humoral and cellular level 
(Glorioso et al, 1984; Spear, 1985,1993a,b; Bishop et al, 1986; Zarling et al, 
1986; Blacklaws et al, 1987; Johnson and Feenstra, 1987; Rosenthal et al, 
1987; Van Oirschot et al, 1990; Zuckermann et al, 1990; Kimman et al, 
1992a). Among the 11 HSV glycoproteins identified to date; gB, gD, gH and 
probably gK and gL appear essential for virus replication, since virus mutants 
deficient in any of these glycoproteins are unable to replicate (Cai et al, 1988; 
Ligas and Johnson, 1988; Fuller et al, 1989; Hutchinson et al, 1991; Spear, 
1993b). Table 1.13 summarises the various viral activities affected by 
deletions of genes encoding homologous glycoproteins in selected 
alphaherpesviruses.
Essential glycoproteins of other alphaherpesviruses homologous to HSV 
gB, gD and gH have also been characterised (see Table 1.11). Whereas a 
functional analysis of HSV and SHV-1 glycoproteins is well advanced, studies 
aimed at elucidating the functions those of the other alphaherpesviruses 
including BHV-1, EHV-1, EHV-4 and VZV glycoproteins have only recently 
been started. The functions of the essential glycoproteins gB, gD and gH of 
HSV-1 and of their homologues in SHV-1 (gH, gp50 and gH) have been
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studied extensively in the past few years (Little et al, 1981; Noble et al, 1983; 
Fuller and Spear, 1987; Highlander er al, 1987; Cai et al, 1988; Cohen et al, 
1988; Desai et al, 1988; Ligas and Johnson, 1988; Johnson and Ligas, 1988; 
Fuller and Spear, 1989; Foa-Tomasi et al, 1991; DeLuca et al, 1982; Hampl 
et al, 1984; Robbins ef al, 1987; Klupp and Mettenleiter, 1991; Liang er al, 
1991; Rauh er al, 1991; Kimman er a/, 1992a, b; Kopp and Mettenleiter, 
1992; Peeters et al, 1992). Several of these studies showed that virus particles 
that were treated with neutralising monoclonal antibodies, or virus mutants 
that lacked one of these glycoproteins were unable to enter target cells despite 
their ability to adsorb to these cells. Furthermore, overexpression in 
mammalian cells of gB, gD and gH of HSV-1 and their homologues indicated 
that these proteins were also involved in cell fusion by acting as viral 
attachment proteins (VAPs) mediating specific interactions with receptors on 
the surfaces of permissive cells (Campadelli-Fiume et al, 1988a, b, 1990; 
Johnson et al, 1988; Manservigi et al, 1988; Petrovskis et al, 1988; Johnson 
and Spear, 1989; Fitzpatrick et al, 1990a; Tikoo et al, 1990; Liang et al, 
1991; Fehler et al, 1992; Forrester et al, 1992; Klupp et al, 1992; Peeters et 
al, 1992). There is also evidence which indicates that these glycoproteins are 
essential for the penetration of the virus particle into the target cell and that 
they are involved in the spread of the virus by fusion of infected cells with 
non-infected cells (Tikoo et al, 1990; Liang et al, 1991; Peeters et al, 1992, 
reviewed by Spear 1993b). Of the non-essential glycoproteins, the HSV-1 gC 
homologous glycoproteins, gUI (BHV-1), gUl (SHV-1) all bind to a cellular 
heparin-like receptor, thereby mediating adsorption of the virus to target cells 
(Mettenleiter, et al, 1990; Herold et al, 1991; Okazaki et al, 1991; Sawitzky
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et al, 1990). Recently, Liang and his coworkers (1993) identified a cluster of 
5 heparin-binding sites located between amino acids 129 and 310 in BHV-1 
gin and between amino acids 90 and 275 in SHV-1 gin as the sites involved 
in the virus attachment process. In initial studies aimed at analysing whether 
homologous glycoproteins also function in a heterologous viral background, 
the non-essential SHV-1 gin gene was replaced by the gene encoding its 
HSV-1 homologue, gC. Although expression in infected cells of gC from the 
recombinant SHV-1 genome could be shown, expression levels were low and 
mature gC could not be found in recombinant SHV-1 virions. In addition, 
complementation of defects associated with the lack of gHI was not observed 
(Whealy et al, 1989). However soon afterwards, Chase and co workers (1990) 
showed that gD-1 homologues shared a common function by demonstrating 
the ability of bovine cells expressing BHV-1 gIV to partially resist infection 
by BHV-1, HSV-1 and SHV-1. Previously, cell lines constitutively 
expressing SHV-1 gp50 had been shown to be able to interfere not only with 
SHV-1 replication but also, and even more efficiently, with HSV-1 replication 
(Petrovskis et al, 1988) suggesting that both proteins were at least in part 
functionally similar. Recently Rauh et al (1991) showed that gl (BHV-1) is 
able to complement functionally the defect in an SHV-1 mutant lacking the 
homologous essential glycoprotein gH Kopp and Mettenleiter (1992) 
demonstrated a stable rescue of a glycoprotein gH deletion mutant of SHV-1 
by the homologous gl glycoprotein of BHV-1. Their results conclusively 
demonstrated that gl (BHV-1) in an SHV-1 background can execute all 
essential functions normally provided by glycoprotein gH of SHV-1. Overall, 
such findings indicate that essential homologous glycoproteins can function in
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a heterologous herpesvirus background and that substitution of glycoproteins 
by their homologues from a different herpesvirus can influence viral growth 
characteristics in vitro and probably in vivo. Thus, there is growing evidence 
that herpesviral glycoproteins exhibiting sequence homology also share 
functional properties.
1.3.6. Involvement of glycoproteins in the host immune response
The immune response to HSV infection involves several host mechanisms. 
These include natural resistance (natural killer cells and interferon) (reviewed 
by Lopez, 1985; Nash and Cambouropoulos, 1993) and adaptive humoral and 
cell-mediated responses (Norrild, 1985; Nash et al, 1985, Nash and 
Cambouropoulos, 1993). The immune response to other alphaherpesvirus 
infections involve similar host immune mechanisms (Rouse and Babiuk, 
1978; Gerber et al, 1978; Ben-Porat et al, 1986). Viral glycoproteins are 
major targets for these host immune mechanisms (Vestergaard and Norrild, 
1979; Glorioso et al, 1984; Marshall et al, 1986, Ben-Porat et al, 1986; Israel 
et al, 1988). However, other viral components including immediate early and 
nucleocapsid proteins have been identified as targets for the host’s immune 
response (Van Oirschot et al, 1988; Eloitet al, 1991; Banks et al, 1991).
Although the nature and role of natural resistance is still a poorly defined 
area, there is evidence implicating natural killer (NK) cells in resistance to 
HSV (reviewed by Lopez, 1985; Nash and Cambouropoulos, 1993). 
Experiments by Bishop et al (1986) suggested that human cells with NK 
activity possess clonal specificity for HSV-1 infected targets involving
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determinants on HSV-1 gB and gC.
The humoral immune response against herpesviral infections involves two 
major mechanisms. These include antibody-dependent cell cytotoxicity 
(ADCC), which is effective against target cells in vitro early in the infectious 
cycle, and neutralising antibodies which are active against cell-free virions 
preventing spread to the nervous system and in the blood stream (reviewed by 
Kohl, 1991). Earlier studies with HSV-1 demonstrated that monospecific 
antibodies against each of the glycoproteins gB, gC, gD and gE were able to 
neutralise virus (Powell et al, 1974; Spear, 1975; Vestergaard and Norrild, 
1979; Dix et al, 1981) and mediate complement dependent cytolysLs of virus 
infected cells (Norrild et al, 1979). BHV-1 glycoproteins gl, gEH and gIV 
have all been shown to stimulate production of neutralising antibodies in mice, 
rabbits and cattle, and they all serve as targets for antibody-dependent 
complement-mediated lysis of virus-infected cells (Collins et al, 1984; van 
Drunen Littel-van den Hurk et al, 1984; van Drunen Littel-van den Hurk and 
Babiuk, 1985; van Drunen Littel-van Den Hurk and Babiuk, 1986b; Marshall 
et al, 1986; Okazaki et al, 1986; Trepanier et al, 1986; Israel et al, 1988; van 
Drunen Littel-van den Hurk et al, 1991). Antibody binding assays indicate 
that pigs infected with SHV-1 produce antibodies against gl, gH, gX, gp50, 
immediate early and nucleocapsid proteins (McGinley and Platt, 1988, 1989; 
Van Oirschot et al, 1988; Cheung, 1990; Eloit et al, 1988, 1991; Kimman et 
al, 1992a).
Cell-mediated immunity is an important part of the host’s reponse to HSV
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infection and is required for the clearance of virus from the sites of infection 
(reviewed by Nash and Wildy, 1983; Nash et al, 1985; Nash and 
Cambouropoulos, 1993). As pointed out by Nash and Cambouropoulos 
(1993) whereas CD4 T cells can initiate rapid clearance of infectious virus 
from epidermal surfaces probably by recruiting and arming macrophages; 
CD8 T cells from HSV-infected mice or humans have the ability to recognise 
proteins produced at different stages of the infectious cycle, particularly, the 
immediate early (IE) gene products which are major antigens recognised in 
association with MHC class I. Similarly it was previously demonstrated by 
Fitzpatrick et al (1988) that cytotoxic T lymphocytes induced by BHV-1 were 
directed against murine cells expressing gl or gDI. Recently Denis et al 
(1993) identified both gin and gIV as target antigens for the BHV-1-specific 
cytotoxic T lymphocytes CD4 and CD8. In SHV-1 infections, gDI has also 
been identified as a target antigen for cytotoxic T cells in pigs and mice 
(Zuckermann et al, 1990). Furthermore, it has been observed that 
non-neutralising antibodies to glycoproteins gB, gC, gD, gE and gG passively 
confer protection against a lethal HSV challenge showing that these 
glycoproteins function as targets for antibody-dependent cell-mediated 
cytotoxicity (Balachandran et al, 1982; Schrier et al, 1983). A similar 
observation has also been reported for SHV-1, where Mabs directed against 
gH, glU and gp50 passively protected mice and pigs against a lethal SHV-1 
infection (Eloit et al, 1988; Van Oirschot et al, 1990).
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1.3.7. Antigenic structure of the major glycoproteins of ruminant 
alphaherpesviruses
Knowledge of both the physical and antigenic structure of ruminant 
alphaherpesvirus glycoproteins is limited. However some progress has been 
made on the three major BHV-1 glycoproteins i.e. gl, gin and gIV. The 
putative functions of each of glycoproteins gl, gHI and gIV have been 
correlated to corresponding epitopic structures by mapping antigenic domains 
recognised by virus-neutralising Mabs (Marshall et al, 1988). Seven different 
epitopes on gl defined as I, H, m , IVa, IVb, IVc and V as well as eight 
epitopes on gIV defined as la, lb, H, Hla, mb, me, Did and IV have been 
mapped using two panels of monoclonal antibodies in competition binding 
assays (van Drunen Littel-van den Hurk et al, 1985; Hughes et al, 1988). 
Nine epitopes defined as la, lb, n, m, IV, V, VI, VH, Vffl have also been 
mapped on gm  (van Drunen Littel-van den Hurk et al, 1985). Further 
analysis suggests that both the antigenic and immunogenic structure of the 
eight epitopes on gIV, seven of which are neutralising, are carbohydrate 
independent (van Drunen Littel-van den Hurk et al, 1990). In contrast, three 
of the carbohydrate-dependent epitopes on gl were shown to correspond to 
neutralising epitopes IVa, IVb, and IVc (van Drunen Littel van den Hurk et 
al, 1985). Two of these epitopes IVa and IVb are also involved in 
infected-cell lysis. Monoclonal antibodies to these epitopes exhibit reduced 
binding to gl after carbohydrate removal, indicating that both antigenicity and 
immunogenicity of epitopes IVa, IVb and IVc are carbohydrate-dependent in 
contrast with the carbohydrate independence of epitopes I, n, m  and V. 
Epitope IV have been mapped to the amino terminus of gl between residues
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68 and 119 (Fitzpatrick et al 1990b). This region contains a potential 
N-linked glycosylation site at position 105 of the gl sequence, further 
suggesting carbohydrate dependence of this epitope. It has also been shown 
that domains gl-IV and glV-IH have attachment functions, while domains 
gl-m, gl-V and gIV-I are involved in penetration (Hughes et al, 1988; 
Fitzpatrick et al, 1990b). Recently Tikoo et al (1993) demonstrated that gIV 
protein mutants lacking N-glycans at residue 102 (gN2) or residues 41 and 102 
(gNlN2) showed altered reactivity with conformation-dependent glV-specific 
monoclonal antibodies. This change affects the formation of the 
discontinuous epitopes and reduces the ability to induce a potent neutralising 
antibody response in mice. Okazaki et al (1991) previously showed that an 
anti-BHV-1 monoclonal antibody which recognises an antigenic epitope 
between amino acid residue 114 and 144 could block the binding of BHV-1 
gin to heparin. Recently, Liang et al (1993) demonstrated that a cellular 
heparin-like moiety with five heparin-binding sites clustered between amino 
acids 129 and 310 in BHV-1 gin plays an essential role for BHV-1 
gffl-mediated virus attachment.
Differences in the antigenic structure of the major glycoproteins gl, gin 
and gIV of BHV-1.1 and the neurovirulent BHV-1.3 were demonstrated 
recently by Collins et al (1993) using a panel of Mabs prepared against the 
BHV-1.1 glycoproteins. The antigenic differences could, for some epitopes 
be correlated with biological function. One Mab which neutralised BHV-1.1 
but not BHV-1.3 was shown to react with a gl epitope, IVb, present on 
BHV-1.1 but not BHV-1.3.
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1.4 AIM OF THE STUDY
The major aim of this work was to compare the serological relationships 
among five ruminant alphaherpesviruses. By raising a panel of monoclonal 
antibodies against one of them i.e. the cervine herpesvirus-1 (CerHV-1) and 
using polyclonal serum against bovine herpesvirus type 1 (BHV-1), cervine 
herpesvirus type 1 (CerHV-1), rangiferine herpesvirus type 1 (RanHV-1) and 
caprine herpesvirus type 2 (CapHV-2) it was intended to distinguish and 
differentiate by western blotting and radioimmunoprecipitation infections by 
these viruses. The monoclonal antibodies were then used to identify common 
and virus specific antigenic determinants. The monoclonal antibodies which 
were able to differentiate the ruminant alphaherpesviruses were assessed for 
their suitability and potential in developing a sensitive and reliable diagnostic 
assay.
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CHAPTER 2 
GENERAL MATERIALS AND METHODS
This chapter describes the general techniques used in the study. All 
specific materials and methods are described in the appropriate chapters.
2.1. Cell Culture and Virus Stocks
2.1.1. Cells
Embryonic bovine trachea (EBTr) cells were established as a 
semicontinuous cell line at the Moredun Research Institute from explant 
cultures of tracheal rings from an abattoir foetus aged between 4-6 months. 
After establishment of sufficient cell outgrowth from the explant cultures, 
cells were trypsinised and expanded. A master stock was established free of 
contaminating viruses and mycoplasma at passage level 6 and cells were used 
between passage levels 6 and 14. The embryonic bovine trachea (EBTr) cells 
were used for the propagation of virus, and for the preparation of lysates of 
both infected and non-infected cells. The cells were grown in Eagle’s ’199’ 
medium (E’199’) (Northumbria Biologicals Ltd) containing 10% heat 
inactivated foetal bovine serum (FBS) (Advanced Protein Products Ltd), 100 
IU/ml penicillin, 100 ug/ml streptomycin, and ImM L-Glutamine (British 
Drug House, (BDH)).
2.1.2. Virus stocks
The ruminant alphaherpesviruses examined in this study and their histories
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are listed in Table 2.1. All viruses except Bovine herpesvirus 1.2 had already 
been plaque purified three times. BHV-1.2 was also plaque purified three 
times before being used as stock virus. Master stocks of all five viruses were 
established by growing them in EBTr cells. Working stocks for these viruses 
were prepared from the masterstocks and stored at -70°C until required.
2.1.3. Plaque purification of BHV-1.2 virus
Confluent monolayers of EBTr cells in twelve-well plastic plates 
(Linbro-Flow Labs) were washed three times with warm Hank’s balanced salt 
solution (HBSS). Ten parallel ten-fold serial dilutions of virus were made and 
each dilution (102 to 107 pfu) was inoculated on to two wells (200 ul/well). 
After 1 hour of absorption at 37°C, the virus inoculum was removed and 2 mis 
of overlay medium containing 1.5% carboxy methyl cellulose (CMC) was 
added to each well. The plates were incubated at 37°C in 5% C 02 for 2 to 3 
days. Plates were examined and wells containing a single plaque were 
chosen. Media and cells around the plaque were collected using a thin tipped 
capillary pipette. The virus was resuspended into 1 ml of Eagle’s medium 
(E’199’) containing 100 IU/ml penicillin, 100 ug/ml streptomycin, 50 IU/ml 
polymixin, 5 ug/ml fungizone and 50 IU/ml aerosporin. This procedure was 
repeated three times. Thereafter the virus was propagated in a 25 cm2 flask 
(Flow Labs) and then a 75 cm2 flask (Flow Labs). After harvesting and 
clarifying the media at lOOOg for 15 minutes at 4°C, the viral supernatant was 
aliquoted into 4 ml amounts and stored at -70°C as the masterstock virus.
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Table 2.1. Ruminant alphaherpesvirus stocks
Virus strain 
or isolate Species
Isolation 
Site Country Year
Reference
♦BHV-1.1 
(6660)
Bovine Respiratory
tract
Scotland 1978 Nettleton and 
Sharp (1980)
+BHV-1.2
(Aberdeen)
Bovine Ocular-
respiratory
tract
Scotland 1962 Dawson etal 
(1962)
♦CerHV-1 Red deer Ocular-
respiratory
tract
Scotland 1982 Inglis etal 
(1983)
++RanHV-l Reindeer Genital
tract
Finland 1985 Ek-Kommonen 
etal (1986)
♦♦CapHV-2
(E/CH)
Goat Respiratory
tract
Switzerland 1981 Engels etal 
(1983)
♦Viruses isolated at Moredun - BHV-1.1 masterstock passage level 7
- CerHV-1 masterstock passage level 7
+Virus supplied by Dr. Margaret Lucas, MAFF Central Veterinary 
Laboratory, Weybridge. Virus used at passage level 20
++Virus supplied by Dr. Ek-Kommonen, National Veterinary Institute, 
Helsinki, Finland. Virus passage level not known
♦♦Virus supplied by Dr. Steven Edwards, MAFF Central Veterinary 
Laboratory, Weybridge. Virus passage level not known
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2.1.4. Plaque assay
The stock viruses were all quantified by a plaque titration assay. Two mis 
of EBTr cell suspension containing approximately 2 x 105 cells/ml were added 
to all wells in twelve-well plastic plates (Linbro, Flow Labs Ltd) and 
incubated at 37°C in 5% C02 for 24-48 hrs until confluent monolayers were 
formed. Ten-fold serial dilutions from 10' 1 to 10' 10 were carried out for each 
virus stock to be titrated. All wells were washed three times with warm 
Hank’s balanced salt solution before two wells were each inoculated with 200 
ul of each virus dilution. The virus inoculum was removed after 1 hour of 
absorption at 37°C in 5% COr  Two mis of overlay medium containing 
E’199’ with 1.5% carboxy methyl cellulose (CMC) was added to each well. 
The plates were then incubated for 2 to 3 days at 37°C in 5% C02. The cells 
were fixed for 1 hour at room temperature with a 10% formol saline solution. 
The cells were stained for 10 minutes with 0.1% crystal violet in 20% ethanol. 
The plates were washed thoroughly with water and plaques were counted and 
quantified as plaque forming units per ml (pfu/ml).
2.1.5. Virus production
Monolayers of EBTr cells in 225 cm2 plastic-flasks (Coming, UK) were 
washed three times with Hanks balanced salt solution and then inoculated with 
virus at a multiplicity of infection (moi) between 0.1 and 10 pfu/cell 
depending on the experiment being undertaken. After absorption for 1 hour at 
37°C the inoculum was withdrawn and 100 ml maintenance medium (E’199’) 
supplemented with 2% heat inactivated foetal bovine serum (FBS) (Advanced
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Protein Products Ltd), 100 IU/ml penicillin, 100 ug/ml streptomycin, and 1 
mM L-glutamine was added and incubated at 37°C until infection was 
complete as judged by the development of maximum cytopathic effect (cpe). 
At this time, 2-4 days, more than 90% of the cells were round, enlarged and 
refractile under the microscope. The medium was harvested, clarified by 
centrifugation at 7800g for 15 minutes at 4°C in a JA21 Beckman centrifuge 
and the supernatant virus was stored in 10ml aliquots at -70°C. Control EBTr 
cells were mock-infected with Hanks balanced salt solution and treated 
similarly.
2.1.6. Purification of virus
Clarified supernatant containing virus was pelleted at 40,000g for 45 
minutes at 4°C in a JA21 Beckman centrifuge. The viral pellet was 
resuspended in 1 ml of phosphate buffered saline (PBS) (173 mM NaCl, 2.7 
mM KC1, 1.5 mM KH2P04, 8.1 mM Na2HP04, pH 7.4) and stored at -70°C 
until required. A 10% to 25% w/w ficoll 400 (Pharmacia) step gradient was 
prepared by weighing out 2g ficoll 400 and 18g 1 x TNE buffer (lMNaCl, 100 
mM Trisma, 10 mM EDTA, 200 ml distilled water, pH 7.5) for 10% and 5g 
ficoll 400 and 15g 1 x TNE buffer for 25%. The resuspended viral pellets 
were thawed, mixed thoroughly, loaded onto the step gradient and centrifuged 
at 95,000g for 1 hour at 4°C in an SW40 rotor on an LS2 or LS5 Beckman 
ultracentrifuge. The visible virus band at the 10-25% ficoll interface was 
removed by a pipette, resuspended in 1 ml of 1 x TNE buffer and mixed well 
by inversion. The virus was then pelleted at 95,000g for 40 minutes in an
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SW40 rotor at 4°C on an LS2 or LS5 Beckman ultracentrifuge. The virus was 
finally resuspended in 1 ml PBS and stored at -70°C until required.
2.1.7. Preparation of labelled cell extracts
Monolayers of EBTr cells were prepared by seeding 25 cm2 flasks (Flow 
Labs Ltd) with approximately 1 x 105 cells/ml (a total of 1 x 106 cells) in 10 
ml of E’199’ medium supplemented with 10% FBS, 100 IU/ml penicillin, 100 
ug/ml streptomycin and ImM L-glutamine. When confluent, the monolayers 
were mock-infected or infected with 20 pfu/cell. Virus was allowed to absorb 
at 37°C for 1 hr. The inoculum was removed and 10 mis of E’199’ medium 
containing 2% FBS, 100 IU/ml penicillin, lOOug/ml streptomycin, 1 mM 
glutamine and one tenth the normal concentration of methionine or one fifth 
the normal concentration of glucose was added to both mock infected and 
infected flasks and incubated at 37°C for 6 hrs. The medium was removed 
and replaced with 10 ml of the same medium immediately followed by 
addition of 15 uCi/ml of D-[6-3H]-glucosamine (Amersham) to all flasks and 
reincubated at 37°C for a further 10-14 hours.
2.1.8. Harvesting of labelled cell extracts
After 16-24 hrs of incubation, the medium was removed and 5 ml/flask of 
sample buffer containing 50 mM Tris.HCl, pH 6.8, 2% SDS, 10% glycerol, 
200 mM 2-mercaptoethanol, and 0.05 (w/v) bromophenol blue was added to 
both mock infected and infected cells and harvested. Samples were heated at 
95°C for 5 minutes aliquoted in 1 ml amounts and stored at -70°C until
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required.
2.2. Preparation of antisera
2.2.1. Rabbit antisera against each virus
Each of the gradient purified viruses was diluted in PBS and emulsified in 
an equal volume of Freund’s complete or incomplete adjuvant (Difco Labs, 
USA) as indicated in Table 2.2. Five rabbits, previously tested and found to 
be free from antibody to all five viruses, were each given one immunisation 
subcutaneously (s/c) with one of the five gradient purified viruses at different 
concentrations in Freund’s complete adjuvant (CFA) (Table 2.2), followed by 
a booster immunisation in Freund’s incomplete adjuvant (ICFA) 
subcutaneously 3 weeks later. After six weeks, they received another booster 
immunisation of the virus in PBS intravenously (i/v). They were then all bled 
twice, 10 and 17 days respectively after the final booster immunisation. All 
sera were heat inactivated at 56°C for 30 min, aliquoted in 0.5 ml amounts and 
stored at -20°C.
2.2.2. Red deer antisera against CerHV-1
Two adult female red deer aged between 2 and 3 years were bled before 
each was inoculated intranasally with 10 ml of CerHV-1 in PBS containing 5 
x 107 pfu/ml. The animals were bled twice, 3 and 6 weeks post-infection. All 
sera were heat inactivated at 56°C for 30 minutes and stored at -20°C.
Ta
bl
e 
2.2
. 
Sc
he
du
le 
for
 
im
m
un
isa
tio
n 
of 
ra
bb
its
 
for
 t
he 
pr
od
uc
tio
n 
of 
po
ly
cl
on
al
 h
yp
er
im
m
un
e 
ser
a 
ag
ai
ns
t 
the
 
fiv
e 
ru
m
in
an
t 
al
ph
ah
er
pe
s 
vi
ru
se
s
56a
C/3
. §
<v
b o
o
00
©
l - H
00
©
00
©
y—4
oo
©
00
©
oo
©
oo
©
oo 
©  
T—^
oo
©
H * © ' © i
t- -
© f H
ro t ©
> C3 X X X X X X X X X
O 2 in in in X X X in in in X X X in in m
O p ,2 CM CM CM in in m CM CM CM m in in r - ;
J3
M
C cx
CM CM* CM* co rn C O i > ^t* M" t j -
T3
<D
c3
I  * 
•s 1>  .s
e
*fc.2 
S) JsO 3 
§ 8 
2 .2 
P  N*-i .5 o
13 3  
.fca o  > 2
o
a>
«3
Q
co
c3
U  l-H
g S 6
« £  3  a : 2 Z
o  o  o
O
O  c/3 >
C/3 ►
<3 ^  GOrj CQ U «  CU 
c  c  c
>
X
«
2
o
> > 
X X 03 03
2 s
o  o
o  o  o
O n O n ON 
^  M  ^
M  o  in
H  H  M
t"-
00
00
o  o  o
:£
& a S
c  c  a
CM CM CM
> > 
X  X
03 03 03
2 2 © © 2o
o  © ©
ON ON ON
^  ^  ^  
n  o  in
t —i i—i CM
NO
CM
00
© o  o
< 2; oo^  n  03 u  «  £
.2 .2 .2
> > 
X X  a c
3  03
04 04
2 2 o  ©
>
Xa03
04
2o
©
©  ©  ON 
2  ^ ^  
oo oo h
©  ©  in  
*—i cn  i-H
CM
00
©  ©  ©
< <
:5
£  23
y £
.3 .s .3
CM CM CM
>
X
>  >
X X
& & & u  u  u
2 2 2 
©  ©  ©
©
©  ©  ON
5^ .Q\ O 
^  ^  CM
OO
00
©  ©  ©
<  £•; <« 
b u  £
c  c  c
>
X
<D
U
2
©
> >  
X Xl-H «-*<V <DCJ U
2 2 
©  ©
©
©  ©  ON 
ON ON ^
O n  ©  y—i
^  C  cJ
CM
00
00
30 <u c3•i—>
3
£
3
c/3
1
C/3 i/v 
- i
nt
ra
ve
no
us
CF
A 
- F
re
un
d’
s c
om
ple
te 
ad
ju
va
nt
 
ICF
A 
- F
re
un
d’
s i
nc
om
pl
ete
 
ad
ju
va
nt
57
2.2.3. Field sera against the five viruses
Field sera from host species of each virus were obtained from different 
sources. Cervine (red deer) (Nettleton et al 1986) anti-CerHV-1, bovine 
(cattle) anti-BHV-1.1 (Lyaku et al, 1990) and BHV-1.2 sera were obtained 
from the Moredun Research Institute. Goat anti-CapHV-2 (Waldvogel et al, 
1981) sera were gifts from Dr. M. Engels of the University of Zurich, 
Switzerland while reindeer anti-RanHV-1 (Ek-Kommonen et al, 1986) sera 
were kindly supplied by Professor B. Hyllseth of the Norwegian College of 
Veterinary Medicine, Oslo, Norway.
2.3. Serological techniques
2.3.1. Serum neutralisation test (SNT)
Microneutralisation tests using 100 TCID50 of virus/well were employed to 
test ascitic fluid or serum for evidence of antibody. The SNT was carried out 
as described elsewhere (Bitsch, 1978). Briefly two-fold serial dilutions of 
ascitic fluid or heat inactivated serum mixed with an equal volume of virus 
(25 ul) containing 100 TCID50 of virus/well were incubated for 24 hours at 
37°C in a C02 incubator. At the end of incubation, 50 ul of EBTr cells in 
E’199’ medium were added to the test wells, and the microtitre plates were 
further incubated for 3-4 days at 37°C in a C02 incubator after which wells 
were examined for the presence of viral cpe. Antibody titres were calculated 
by the Spearman-Karber method, and judged to be the highest dilution 
resulting in a 50% reduction of viral cpe relative to a virus control.
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2.3.2. Enzyme-linked immunosorbent assay (ELISA)
Preparation of the ELISA antigen
The ELISA antigen for each virus was prepared from EBTr infected or 
mock-infected cells. After 3 days infection, media was retrieved, clarified in a 
JA21 Beckman centrifuge at 7800g at 4°C for 15 minutes. The supernatant 
was removed and the cell pellets added back to the flasks. One ml of 0.5% 
Nonidet P40 (NP40) in PBS was pipetted into each flask, and the flasks placed 
at 4°C for 1 hour (tilting every 15 minutes to remove attached cells). The 
detergent-treated cells were recovered and clarified in a Micro Centaur 
microcentrifuge (MSE, UK) at 13,400 g for 5 minutes at room temperature. 
The pooled supernatant was aliquoted into 200 ul amounts and stored at -70°C 
(Lyaku et al, 1990).
The assay
To perform the assay, flat bottomed 96-well polyvinyl plates (Cooke 
M129A Dynatech Laboratories, Billinghurst, Sussex) were coated overnight at 
4°C with 100 ul/well of the viral antigen at an appropriate dilution (1/100 
predetermined by checkerboard titration) in 50 mM carbonate-bicarbonate 
buffer, pH 9.6. The wells were coated alternately in rows with positive and 
control antigens respectively. The wells in column one were not coated and 
were used as a blank in each plate. Fifty microlitres of each sample was tested 
undiluted (hybridoma supernatants) or at a single dilution as described in the 
text (polyclonal sera and ascitic fluid) and the plates incubated for 2 hours at 
room temperature in a humid box. After washing with PBS containing 0.05%
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Tween 20 (PBST-20), 50 ul of the appropriately diluted horseradish- 
peroxidase (HRP) conjugate (Scottish Antibody Production Unit (SAPU), 
Lanarkshire) was added to all wells except those in column one, and incubated 
for 1 hour at room temperature. After the final washing step with PBST-20, 
100 ul of 40 mg orthophenylene diamine (OPD) (Sigma) per 100 ml of citrate 
phosphate buffer pH 5 containing 10 ul of 30% hydrogen peroxide (H,02) was 
added to each well. The reaction was stopped after 30 minutes of incubation 
at 37°C in the dark by addition of 25 ul/well of 2.5M sulphuric acid (H2S04). 
The optical density (OD) was read at 492 nm wavelength (against substrate as 
blank) in a multichannel recorder (Titertek Multiskan Flow Laboratories) 
interfaced to a BBC computer and Epson FX-80 printer (Acorn Computer Ltd, 
Cambridge, UK) using a Titertek Multiskan interface (Flow Laboratories) and 
a 3187 serial interface type 312B (Flow Laboratories).
2.4 Other techniques
2.4.1. Total protein estimation by the Pierce Method.
Total protein estimation of the gradient purified stock virus and the ELISA 
antigen from infected and mock-infected EBTr cell lysates was determined by 
the Pierce method using a BSA protein assay reagent kit from Pierce and 
Warriner (UK) Ltd. Solutions containing a known concentration of bovine 
serum albumin (BSA) were used as standards. Results were read at 550 nm 
expressed as ug/ml and printed out from a computer interfaced to a Titertek 
Multiskan Plus.
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Figure 2.1. BHV-1.1 virus particles viewed under the electron
microscope. The virus particles were obtained from 
the supernatant of infected EBTr cells and purified 
through a ficoll gradient. They were stained with 
phosphotungstic acid and visualised by electron 
microscopy. Arrow indicates virion and capsid.
Total magnification x 75000
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Figure 2.2. CerHV-1 virus particles viewed under the electron 
microscope. The virus particles were obtained from 
the supernatants of infected EBTr cells, and purified 
through a ficoll gradient. They were stained with 
phosphotungstic acid and visualised by electron 
micrscopy. Arrow indicates virion and capsid.
Total magnification x 120000
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2.4.2. Electron Microscopy
The gradient purified viruses were resuspended in a drop of distilled water 
and applied to a formvar/carbon coated grid. Grids were negatively stained 
with 1% potassium phosphotungstic acid, pH 7.0 and examined in a Siemens 
Elmiskop 1A electron microscope. Electron micrographs for BHV-1.1 and 
CerHV-1 were prepared by Mrs. L. Inglis of the Electron Microscopy 
Department, Moredun Institute (see Figure 2.1 and 2.2).
2.4.3. SDS-Polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE was carried out in 10% discontinuous vertical slab gels (18 cm 
x 16 cm) (Laemmli, 1970) under reducing conditions as described by Herring 
and Sharp (1984). Briefly, stocks of 30% acrylamide (Bio-rad) were prepared 
in distilled water where the ratio of acrylamide to the cross-linking agent 
(N,N’-methylene bisacrylamide) (Bio-rad) was 28.5:1.5. After filtering 
through Whatman No. 1 filter paper, the solutions were used to prepare 
resolving gels containing 10% acrylamide in 250 mM Tris.HCl, pH 8.8 and 
0.1% SDS, and stacking gels consisting of 3% acrylamide in 122 mM 
Tris.HCl pH 6.8, 0.1% SDS. The gel solutions were polymerised chemically 
by the addition of 0.025 percent by volume of mM TEMED (Bio-Rad) and 
ammonium persulphate (Bio-Rad). Following polymerisation of the resolving 
gel (approximately 1 hr), a stacking gel was added on top with a teflon comb 
to form the sample wells. The stacking gel was allowed to set (approximately 
20 mins) and the comb removed gently. Before addition to the gel, protein 
samples were boiled at 95°C for 5 min in sample buffer containing 50 mM
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Tris.HCl, pH 6.8, 2% SDS, 10% glycerol, 200 mM 2-mercapto-ethanol 
(BDH) and 0.05% (w/v) bromophenol blue (Sigma). Electrophoresis was 
carried out in a buffer containing 250 mM Tris.HCl pH 8.8, 192 mM glycine 
(BDH) and 0.1% SDS at 40 mA overnight at room temperature. Following 
electrophoresis, gels with the resolved proteins were then transferred onto 
nitrocellulose (Schleicher and Schuell) or fixed in methanol:acetic acid:water 
(50:7:50) containing 0.2% Commassie brilliant blue R250 (Sigma) followed 
by destaining in 5% methanol and 7% acetic acid. For radiolabelled samples, 
gels were dried under vacuum onto Whatman 182 filter paper and 
autoradiographed with Kodak X-omat S film at -70°C.
2.4.4. Western blotting
The electrophoretically separated proteins were transferred to a 200 mm x 
200 mm 0.2um, nitrocellulose sheet (Schleicher and Schuell) in a buffer 
containing 250 mM Tris.HCl, pH 8.3, 192 mM glycine and 20% (v/v) 
methanol using electroblotting equipment (Bio-rad) as described by Herring 
and Sharp (1984). Following transfer the nitrocellulose was stained with 
Ponceau red (Sigma) for 10 minutes. The Ponceau red was poured off and the 
nitrocellulose membrane washed in distilled water until red-stained protein 
bands were observed. The positions of the standards and the area of protein 
transfer were marked and the strip with the molecular weight markers was 
cut-off.
The nitrocelluose strips were then incubated in blocking solution
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containing PBS, 0.05% Tween 20 and 10% horse serum. All washes using a 
buffer containing PBS and 0.05% Tween 20 were performed 3 times for 5 min 
at room temperature and all incubation periods were for 1 h at 37°C. Both 
steps were earned out with gentle mixing. After blocking, the nitrocellulose 
was cut into 5 mm wide strips and each strip was incubated in a predetermined 
dilution of 1:200 of each monoclonal antibody (Mab) (ascites) or 1:100 of 
polyclonal sera. The nitrocellulose-bound immune complexes were reacted 
with HRP-labelled sheep anti-mouse, goat anti-rabbit or rabbit anti-bovine 
IgG (SAPU). The strips were further washed and incubated for 20 min in the 
dark at room temperature with 4 mg of 3, 3’diaminobenzidine (DAB) (Sigma) 
in 100 ml 0.05M Tris.HCl containing lOul of 30% H202. The reaction was 
stopped by washing the strips in tap water, they were then blotted and air 
dried. The apparent molecular weights of nitrocellulose-bound proteins or 
immune-complexes detected were calculated from their mobility in the gels by 
extrapolation from a standard curve obtained by plotting mobilities of the 
marker proteins against their known molecular weights on a semi- logarithmic 
scale (Weber and Osborn, 1969).
2.4.5. Radioimmunoprecipitation (RIP)
Radioimmunoprecipitation (RIP) of 3H-glucosamine labelled virus was 
done by acid elution. Briefly, 50 ul of Mab (ascites diluted 1/10) was added to 
20 ul of 3H-glucosamine labelled virus infected cell homogenate, mixed with 
5 ul of sheep anti-mouse IgG and incubated at 4°C overnight. One hundred 
microlitres of a 10% Staphylococcus aureus suspension was added and mixed
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at 4°C for 30 minutes. The mixture was washed twice in 3 ml of STN buffer 
(0.15M NaCl, 0.01M Tris pH 7.4, 0.25% Nonidet P40) by spinning at lOOOg 
for 10 minutes at 10°C. After the last wash, as much fluid as possible was 
removed from the pellet. Two hundred microlitres of 0.2M glycine pH 2.5 
was added and mixed on ice for 30 minutes. The mixture was centrifuged at 
1300g for 15 minutes at 10°C from which lOOul of the supernatant was 
collected and mixed with 50 ul of sample buffer [30% stacking buffer 
(0.015M SDS, 0.5M Tris pH 6.8), 30% glycerol, 15% 2-mercaptoethanol and 
6% SDS]. The samples were heated at 95°C for 10 min and electrophoresis 
carried out on 10% acrylamide gels in a buffer containing 250 mM Tris.HCl, 
pH 8.8, 192 mM glycine and 0.1% SDS at 10 mA overnight at room 
temperature. The gels were fixed in methanol:acetic acid:water (50:7:50) for 
1 hour, destained in 5% methanol and 7% acetic acid, followed by soaking in 
EnHance (Dupont, UK) for 1 hour and washing twice in tap water each for 20 
minutes. The gels were dried under vacuum onto Whatman 182 filter paper in 
a Biorad gel dryer for 2 hours and exposed to Kodak X-omat S film for 
autoradiography at -70°C.
2.4.6. Restriction endonuclease profiles
Restriction endonuclease profiles for the five viruses including equine 
herpesvirus-1 (EHV-1) and herpes simplex virus-1 strain syn 17+ as controls 
were obtained as described by Lonsdale (1979) with some modifications. 
Twenty-four well plates (Coming) were seeded with 500ul per well containing 
approximately 1 x 106 cells per ml in E’199’ medium. The plates were
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incubated at 37°C overnight. Two wells with the monolayers were infected 
with each of the five viruses (Table 2.1) at a moi of 10. Two additional wells 
were infected with EHV-1 given by Dr. E. Telford and two further wells with 
HSV-1 strain 17+ given by Dr. J. Harland. These two viruses were included 
to provide control viral DNA known restriction endonuclease profiles for the 
two enzymes used. The plates were incubated at 37°C for lh. The medium 
was removed and the wells were washed twice each with 800ul of phosphate 
free Eagle’s medium (PIC). Four hundred and fifty microlitres of PIC were 
added to each well and the plate incubated at 37°C for 2h. Fifty microlitres of 
PIC containing 10 uCi 32P in orthophosphoric acid (Amersham UK) was 
added to each well and the plate incubated at 37°C for 2-3 days. The viruses 
were harvested after a complete cpe by adding 500 ul of 5% SDS solution per 
well followed by incubation at 37°C for 5 min. The cells and the medium 
were transferred into 15ml Sarsted tubes to which 1ml of saturated phenol 
(Phenol mixed at 2:1 v/v) with saturation buffer (75mM NaCl, 50mM EDTA, 
lOmM Tris, pH 7.5) was added. The tubes were inverted gently several times, 
left to stand for 10 min at room temperature. The top aqueous layer from each 
tube was removed using sawn-off blue tips and transferred into round 
bottomed glass test tubes. Two ml of ethanol (Analar, UK) was added to each 
tube, covered with Nescofilm and inverted gently several times to precipitate 
the DNA followed by centrifugation at 900g for 10 min at room temperature. 
The supernatants were poured-off, the tubes inverted and left to dry at 37°C 
for 15min. The viral DNAs were redissolved in 200ul of water containing 
50ug/ml of RNAse A (Sigma) (previously boiled for 10 min) for 2h at 37°C in
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a shaking water bath. Twenty microlitres of each viral DNA was digested for 
16h at 37°C with 5-10 units of restriction endonuclease Bgin using reaction 
conditions recommended by the manufacturer (Bethesda Research 
Laboratories (BRL), Gibco, Paisley, UK). The reaction was stopped by the 
addition of 5ul of RE stop solution (0.025M EDTA, 40% sucrose, 0.22% 
bromophenol blue) followed by electrophoresis through a 0.5% horizontal 
agarose gel (25 x 20 x 0.5 cm) in Tris-Borate (TBE) buffer (0.89 Tris/HCl,
0.89M Boric Acid, 0.02M EDTA, pH 8.3) at 60 volts. The gel was dried onto 
a glass plate in an oven at 95°C for 3h. The dry gel was exposed onto X-ray 
K-Oxomat S film for 16-20h at room temperature for autoradiography.
2.4.7. Polymerase Chain Reaction (PCR)
The BHV-1 gl gene (Whitbeck et al 1988) 468bp fragment was selected 
for amplification of the 5 viral DNAs by PCR. As primers the synthetic 
oligonucleotides Pj-S’-CACGGACCTGGTGGACAAGAAG-S’ (positions 
624-645 and P2-5 ’-CTACCGTCACGTGCTGTGTACG-3 ’ (positions 
1070-1091) were used (Vilcek, 1993). PCR was carried out according to the 
following protocol: Five lOOul eppendorf were used, where into each, 9ul of 
distilled water, 2.5ul of 50% glycerol (diluted with water at 1:1 vol/vol), 2.5ul 
lOx reaction buffer (Boehringer-Mannheim), 2ul (50pmol), 2ul P2 
(50pmol), 3ul of one of the 5 viral DNAs (phenol-chloroform extracted as in 
section 2.4.6) was added. The water phase in each eppendorf tube was 
covered with 40ul paraffin oil. The mixture was heated at 100°C for 6 min, 
then chilled in ice for 5 min. Two microlitres of 2.5mM dNTP (Pharamacia),
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and 2ul (1 unit) Taq polymerase (Boehringer-Mannheim) were added to each 
eppendorf. Thirty five amplification cycles were carried out in a 
Perkin-Elmer-Cetus DNA themal cycler at 95°C for 1 min, 56°C for 1 min, 
72°C for 1 min. Twenty ul of each of the five amplification products were 
analysed by electrophoresis in a 2% agarose gel (Tris-acetate-EDTA buffer, 
110V for 45 min) and detected by staining with ethidium bromide (Maniatis et 
al, 1982). Restriction endonuclease cleavage of each of the five amplification 
products was carried out using four enzymes; Bgll, Hinfl, Smal and Aval 
(Boehringer-Mannheim). Briefly, 18.5ul of distilled water, 3ul amplified 
DNA, 2.5ul lOx reaction buffer (Boehringer-Mannheim) and lul (10 units) 
enzyme were added into a 50ul eppendorf and incubated in a water bath at 
37°C for lh. The mixture was analysed by electrophoresis in 10% 
SDS-PAGE gels (see section 2.4.3) at 100V for 90 min and detected by silver 
staining as described by Herring and Sharp (1984).
2.5. Production of CerHV-1 monoclonal antibodies
Mouse monoclonal antibodies specific for cervine herpesvirus-1 
(CerHV-1) were raised using the following immunisation schedule and fusion 
protocol.
2.5.1. Immunisation schedule
A total of ten 5-6 weeks old Balb/c mice which were to become spleen cell 
donors were each immunised intra-peritoneally (IP) with 200 ul containing 2 x 
109 pfu/ml of gradient purified cervine herpesvirus-1 mixed with an equal
67
volume of Freund’s complete adjuvant (Difco Laboratories, Detroit, 
Michigan, USA). Three weeks later, the mice were each given a second i/p 
injection of 200 ul containing 2 x 109 pfu/ml of the same virus mixed with an 
equal volume of Freund’s incomplete adjuvant (Difco Laboratories, Detroit, 
Michigan, USA). Eight to fourteen months later, and three days before a 
fusion was performed, a final 200 ul containing 2 x 109 pfu/ml dose of the 
same virus in PBS was given to one mouse intravenously.
2.5.2. Fusion Protocol
Three days after the final "booster" dose the mouse was killed by 
anaesthetic overdose and blood collected from an incised axilla. At the same 
time, one non-immunised mouse was killed in the same way and blood 
collected similarly. The spleens were removed aseptically and each one 
placed into a universal bottle containing RPMI medium with 10% FBS. The 
two spleens from the different mice were treated similarly but separately in 
two sterile petri dishes. Using a 0.45mm-gauge needle, a total of 10 ml of 
medium was injected into several sites on each spleen forcing the cells out 
into the petri dishes until the whole capsule appeared almost transparent. 
Myeloma cells of line NSO/1 derived from NSI/l-Ag4.1 (Galfre and Milstein, 
1981) in continuous culture at the Moredun Institute with a viability above 
95% (checked by staining with Nigrosin) were harvested. Aliquots with 
viable counts less than 95% were discarded. The cells were centrifuged for 
seven minutes at 500g and both the spleen and myeloma cell pellets were 
washed once in RPMI medium containing 10% FBS and once in serum-free
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RPMI medium. The cell pellets were finally resuspended each in 10 ml of 
serum-free RPMI medium. Aliquots of both spleen cell suspensions (100 ul) 
were diluted with an equal volume of 0.2% Nigrosin stain, and the live 
unstained cells were counted in a cell counting chamber (Modified-Fuchs 
Rosenthal Counting Chamber).
Samples of at least 5 x 106 cells of both immunised spleen and myeloma 
cells were set aside as controls. Aliquots of immunised spleen cells were 
mixed with myeloma cells at a ratio of 10:1 and centrifuged at 500g for seven 
minutes. The supernatant was drained completely and all traces of fluid 
removed. Fusion was carried out by slowly adding one ml of 50% warm 
Polyethylene glycol (PEG) 1500 (BDH) over a period of one minute while 
gently mixing the cell pellets by rotation. Mixing of the cell pellets was 
continued for a further minute and one ml of serum free RPMI medium was 
added over one minute. Nine ml more of serum-free RPMI medium was 
added over a period of 3-5 minutes and the mixture was centrifuged at 500g 
for five minutes. The supernatant was discarded and the pellet was gently 
tapped to resuspend it before being added to 100 ml of RPMI medium 
containing 20% FBS, and double concentrate HAT. Non-immunised (normal) 
spleen cells to give a final concentration of 2 x 105 cells per ml were then 
added to the mixture. One hundred microlitres of the cell suspension was 
added to each of the central sixty wells of 96-well flat-bottom microtitre plates 
(Nunc, Denmark). Spleen cells from the immunised, non-immunised mice 
and unfused myeloma cells were also plated out separately as controls. The
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spleen cells were included to monitor the secretion of antibody and the 
unfused myeloma cells served to monitor the efficiency of the aminopterin at 
inhibiting their growth. Plates were maintained in a humidified incubator at 
37°C in 5% COr  One day following fusion, plates were inspected to ensure 
freedom from bacterial contamination. One week after fusion, plates were fed 
with 100 ul of fresh RPMI with 15% FBS containing 2% hypoxanthine 
thymidine (HT) and then re-incubated for a further seven days. Supernatants 
from growing hybridomas were tested for specific antibody and positive 
hybridomas which covered more than half of the bottom of the well were 
subcultured for cloning.
2.5.3. Growth stimulating factors.
Following the fusion, the density of cells plated in each well is so low that 
cells do not receive sufficient growth stimulating factors. In order to 
overcome this shortfall, normal mouse spleen or "feeder" cells or mixed 
thymocyte medium (MTM) were added to the culture medium to act as cell 
growth promoters as cells secrete growth stimulating factors into the culture 
medium when the cell density is high.
2.5.4. Screening of hybridomas for specific antibody.
Secretion of specific antibodies against CerHV-1 by hybridomas in the 
culture medium of each well was screened by ELISA as described earlier 
(section 2.3.2). Briefly 50 ul of the culture medium was added to each of two 
wells on a 96-well plate coated with either EBTr cells infected with CerHV-1
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or mock-infected EBTr cells. The plates were incubated for 2 hours at room 
temperature. After washing twice with PBST-20 50 ul of sheep anti-mouse 
IgG HRP conjugate (SAPU) at a predetermined dilution (1:1200) was added 
to each well. Subsequent procedures were as described in the ELISA. Mouse 
sera, reactive or non-reactive with CerHV-1 infected cells were used in each 
test as controls. The antibody level was estimated by the optical density 
(OD492) value after subtraction of the OD492 given by the same culture 
medium on the control antigen.
2.5.5. Subcloning of positive hybridomas.
Hybridoma cells from antibody positive wells were cloned three times by 
the limiting dilution method to establish their stability and to avoid antibody 
secreting hybridoma cells being overgrown by non-antibody secreting 
hybridoma cells. Subcloning was performed when the antibody secreting 
hybridoma cells covered more than half of the bottom of the well. Cells from 
one well, harvested in 200ul of medium were diluted in 1.8 ml RPMI with 
10% FBS. RPMI media containing 10% FBS (lOOul) was added to each well 
of 96-well flat-bottomed plates. A 100 ul aliquot of the diluted cells was 
added to each well of the top row and double diluted downwards discarding 
the last 100 ul. The remaining cell suspension was placed onto two wells of a 
four-well plate (Costar, Cambridge, England) containing 0.5ml of RPMI 
medium with 10% FBS. The plates were then covered and incubated at 37°C 
in an atmosphere of 5% C 02.
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2.5.6. Storage of hybridoma cells
Hybridoma cells which were secreting specific antibody were frozen down 
at every stage of the cloning procedure. By the the end of the third cloning 
when almost all wells became positive cell lines were expanded slowly by 
transfer to 4-well plates (Flow Labs Inc, USA) then to 25cm2 flasks (Gibco 
Ltd, Scotland). When the hybridoma cells had grown in the flask, the cells 
were removed and pelleted by centrifugation at 500g for 5 min and the culture 
medium collected and stored at 4°C. The cell pellet was resuspended in a 
small volume of supernatant before addition of 1 ml of ice cold freezing 
medium containing 10% dimethylsulphoxide (DMSO) (Sigma) in RPMI 
containing 50% FBS and dispensed in 1.8 ml screw-capped cell culture vials. 
The vials were wrapped in cotton wool, placed in a box covered with cotton 
wool and held at -70°C overnight. The vials were then transferred to storage 
in liquid nitrogen.
2.5.7. Recovery of frozen hybridoma cells from liquid nitrogen storage
Frozen vials were removed from liquid nitrogen storage, and their contents
thawed quickly in a waterbath at 37°C. When thawed, the cell suspension was 
taken out from the vial with a pasteur pipette and transferred to a centrifuge 
tube containing 20 ml of cold serum-free RPMI medium. The cells were 
pelleted by centrifugation at 500g for five minutes, the pellet resuspended in a 
flask with 10 ml RPMI medium containing 20% FBS and then incubated at 
37°C in an atmosphere of 5% C02.
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2.5.8. Determination of immunoglobulin isotype
The immunoglobulin isotype and light chain component of each of the 
CerHV-1 specific monoclonal antibody preparations was determined on cell 
culture supernatants by a commercial mouse monoclonal antibody isotyping 
kit (Amersham, UK) following the manufacturers instructions.
2.5.9. Production of ascitic fluid
A total of five male or female BALB/c mice aged between 10-18 weeks 
were injected intraperitoneally each with 0.5ml of 2, 6, 10, 14 
tetramethylpentadecane (pristane) (Sigma). Eight to fifteen days later, 2.5 x 
107 hybridoma cells which had been cloned three times were centrifuged at 
500g for seven minutes at room temperature. The supernatant was removed, 
the pellet resuspended in 1.5 ml of PBS and 0.3 ml containing 5 x 106 cells 
was injected intraperitoneally into each of the pristane-primed mice which 
developed ascites two to three weeks later. The mice were sacrificed when 
their abdomen exhibited visible signs of swelling. Ascitic fluid was then 
tapped from the peritoneal cavity with 1.25 mm gauge needles. The ascitic 
fluid was clarified by centrifugation at lOOOg at 4°C for 15 minutes to pellet 
any cells and the oily layer aspirated from the surface of the fluid. The ascitic 
fluid was aliquoted in small amounts and stored at -20°C.
2.5.10. Purification and isolation of IgG from ascitic fluid.
Ascitic fluid for each Mab was clarified by centrifugation in the MSE 
Micro Centaur at 1 l,600g for 10 min. The supernatant was carefully removed
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and immediately applied to a column of Protein G Sepharose (Pharmacia) 
(approximately 5 ml volume in 1 cm diameter column) pre-equilibrated with 1 
x PBS at approximately 18 ml/hr at 4°C. Bound IgG was recovered by eluting 
from the column with 0.1M glycine/HCl, pH 2.7. Fractions containing IgG 
were neutralised by addition of 0.6ml of 1M Tris.HCl to pH 7.0, pooled and 
then dialysed against PBS and concentrated in Sartorius collection bags 
(Sartorius Ltd). Protein concentration was measured at 280 nm and the 
purified IgG aliquoted in 0.5 ml amounts.
2.5.11. Conjugation of IgG with horseradish-peroxidase (HRP)
The conjugation of purified IgG of each Mab and rabbit anti-deer IgG was 
done by the periodate method as described by Wilson and Nakane (1978) 
using sodium meta-periodate (NaI04) (Sigma) and horseradish peroxidase 
(HRP) (Boehringer, Mannheim). Bovine serum albumin (Miles Laboratories) 
was added to a final concentration of 10 mg/ml, and aliquots were quickly 
frozen and stored at -20°C until required. Conjugations were kindly 
performed by Mr. A. Dawson.
2.6. Reagents and Solutions used
Unless stated otherwise all reagents were obtained from BDH Chemicals 
Ltd, Poole, Dorset or from Sigma (London) Ltd and were of analytical grade 
or better. Recipes of the solutions used in this study are given below:
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2.6.1. ELISA STOCK REAGENTS
1. SODIUM CARBONATE (0.2M)
Sodium carbonate(anhydrous) (N^COp 
21.198 g make up to 1 litre with deionised water.
Place on stirrer to dissolve. Store at 4°C.
2. SODIUM HYDROGEN CARBONATE (0.2M^
Sodium hydrogen carbonate (NaHCO>3)
16.80 g make up to 1 litre with deionised water.
Place on stirrer to dissolve. Store at 4°C.
3. PHOSPHATE BUFFER 0 SM
Potassium dihydrogen orthophosphate (K RP04) 
Di-potassium hydrogen orthophosphate(anhydrous) 
also known as potassium phosphate K2HP0 4
KH^PO 12.63 g (0.093M)
K2HP04 70.66 g (0.406M)
Deionised water to 1 litre.
Place on stirrer to dissolve. Store at 4*C.
4. EDTA Q-1M
Ethylenediaminetetraacetic acid (Disodium salt,Dihydrate). 
(NaJEDTA)
3.72 g make up to 100 mis with deionised water 
Place on a stirrer to dissolve. Store at ^C.
5. TWEEN 20 [l.Q%-SQLUTIQN]
Polyoxyethylene sorbitan monolaurate 
(Tween 20)
100 mis make up to 1 litre with deionised water 
Place on a stirrer to dissolve. Store at 4°C
2-hydroxypropane 1,2,3 -tricarboxylic acid-1-water 
(C3H4(OH)(COOH)3, H20)
21.01 g make up to 1 litre with deionised water. 
Place on a stirrer to dissolve. Store at 4*C
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7 DT-SODTT TM HYDROGEN ORTHOPHOSPHATE Q.2M
Di-sodium hydrogen orthophosphate (anhydrous)
(Na2HP04)
28.39 g make up to 1 litre with deionised water 
Place on a stirrer to dissolve. Store at 4°C
8. SULPHURIC ACID 2.5M
Sulphuric acid (concentrated) (f^S04)
133 ml make up to 1 litre with deionised water 
Store at room temperature
2.6.2. ELISA WORKING SOLUTIONS
1. COATING BUFFER - (CARBONATE/BICARBONATE 5Q mM)
(50 ml)
0.2 M NaXO 79 ml 3.95 ml
0.2 M NaHC03 171 ml 8.55 ml
Deionised water 750 ml 37.5 ml
pH to 9.6 (with 0.2M NaHC03)
2. WASH FLUID [PBST]
A) XlQPBSiz
Sodium Chloride (NaCl) 400g 800g
Potassium Chloride (KC1) 10g 20g
di-Sodium Hydrogen Orthophosphate 57.5g 115g
(N a^PO ^
20gPotassium diHydrogen Orthophosphate 10g
(KILPO) 
Dissolve in Distilled Water 5000ml 10000ml
Mix well.
Store in refrigerator. 
B)EBS3>
Dilute xlO PBS to xl with distilled water. 
Add TWEEN 20 at 0.05%.
76
3. SERUM & CONJUGATE DILUENT:-
Sodium Chloride (NaCl) 29 g 2.9g
0.5M Phosphate buffer 20 ml 2.0g
10% Tween 20 5 ml 0.5ml
0.1M EDTA 10 ml 1.0ml
Deionised water make up to 1 litre 100 ml
pH to 7.2 (with 0.2M NaOH)
* On day of test add
Ovalbumen (albumin, chicken egg) 5 g/litre
The ovalbumen is unstable in solution and has a deleterious effect on the solution 
if stored. The bulk diluent is therefore made up without albumen and stored at 
4°C. When adding the ovalbumen make a paste with a small amount of solution 
then gradually add the rest. This is then filtered through No.l Whatman (7.0cm) 
filter paper using a Buchner funnel (pre-wet filter paper with deionised water).
2.6.3. SDS-PAGE REAGENTS AND SOLUTIONS
1. 30% Acrvlamide stock solution
Acrylamide 30g
N,N, Methylene bisacrylamide 0.8g
add distilled water 100 ml
2. 2x Laemmli stacking gel buffer, pH 6.8 
Trisma base 6.06g
SDS 0.4g
add distilled water to 200ml
3. 4x Laemmli resolving gel buffer, pH 8.8
Trisma base 36.32g
SDS 0.8g
add distilled water to 200ml
4. Laemmli electrode buffer. pH 8.3
Tris 7-9 15.14g
Glycine 72.09g
SDS 5.0g
add distilled water to 5000ml
5. Sample buffer, pH 6.8
Glycerol 20g
SDS 4g
Bromophenol blue 2mg
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Mercaptoethanol 5 ml
Tris-HCl (1M) 25 ml
add distilled water to 100 ml
6. 3% polyacrylamide stacking gel
30% Acrylamide solution 2.4ml
2x Laemmli stacking gel buffer 12.0ml
Distilled water 9.6ml
10% Ammonium persulphate (APS) 150ul
Temed 20ul
7. 10% polyacrylamide resolving gel
30% Acrylamide solution 21.3ml
4x Laemmli resolving gel buffer 16.0ml
Distilled water 25.6ml
Sucrose 3.2g
10% Ammonium persulphate (APS) 150ul
Temed 20ul
Both the polyacrylamide stacking and resolving gels were degassed under 
vaccuum before polymerisation.
2.6.4. WESTERN BLOTTING REAGENTS AND SOLUTIONS
1. Electrnhlntting buffer, pHS.3 
Tris 7-9 
Glycine 
Methanol
add distilled water to
2. Phosphate buffered saline (PBS) 
Sodium chloride 
Potassium chloride 
di-sodium orthophosphate 
Potassium dihydrogen 
orthophosphate 
add distilled water to
3. Washing fluid, pH7.2 
1 x PBS 
Tween 20 
di-Sodium ethylene 
diamine tetra acetic acid (EDTA) 
Sodium chloride
120g
57.65g
1000ml
5000ml
(xlO)
400g
10g
57.5g
10g
5000ml
5000ml
25ml
1.85g
102.25g
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CHAPTER 3 
GENETIC DIFFERENCES AND SEROLOGICAL RELATIONSHIP 
AMONG THE FIVE RUMINANT ALPHAHERPESVIRUSES
3.1. Introduction
Since the introduction of restriction endonuclase (RE) analysis into herpes 
virology, the method has become widely used to differentiate between HSV-1 
and HSV-2 (Wilkie et al, 1974; Hayward, et al, 1975; Lonsdale, 1979; Ueno 
et al, 1982; Sakaoka et al, 1987), and to discriminate isolates of other 
alphaherepsviruses including VZV (Hondo et al, 1987), SHV-1 (Nishimori et 
al, 1987), BHV-1 (Engels et al, 1981; 1987a; Misra et al, 1983; Brake and 
Studdert, 1985; Metzler et al, 1985; Osorio et al, 1985; Seal et al, 1985; 
Honda et al, 1989; Bulach and Studdert, 1990; Edwards et al, 1990; Hamelin 
et al, 1990; Miller et al, 1991), EHV-1 (Allen et al, 1983), feline 
herpesvirus-1 (FHV-1) (Grail and Harbour, 1990) and canine herpesvirus-1 
(CHV-1) (Xuan et al, 1990). Comparison of common restriction sites 
between closely related viruses has been used to suggest evolutionary 
relationships between them (Brake and Studdert, 1985; Bulach and Studdert, 
1990; Rimstad et al, 1992).
More recently the polymerase chain reaction (PCR) has allowed 
amplification of specific tracts of DNA from chosen viruses for more exacting 
comparisons. Banks (1993) used the PCR to discriminate between very 
closely related strains of SHV-1. Vilcek (1993) also showed that it is possible
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to amplify a known BHV-1 DNA sequence by PCR. It was of interest to see 
if PCR using BHV-1 primers could be used to amplify DNA sequences of 
other alphaherpesviruses i.e. CapHV-2, RanHV-1 and CerHV-1 known to be 
antigenically related to BHV-1 (Nixon et al, 1988; Martin et al, 1990; 
Rimstad et al, 1992). Despite reports on the existence of antigenic 
relationships among the five ruminant alphaherpesviruses; only a few studies 
are available on the extent and identity of the proteins responsible for their 
relationships. The main capsid protein (VP4) and gl have been shown to be 
responsible for cross-reactivity between BHV-1 and CapHV-2 (Ackermann et 
al, 1986; Friedli and Metzler, 1987). Recently, Collins et al (1993) showed 
glycoproteins gl and glV to be responsible for the cross-reactivity between 
BHV-1.land BHV-1.3.
This chapter reports experiments to confirm that the five viruses were 
different from each other by: 1) a comparison of the DNA profiles by RE, 2) 
the use of PCR for the amplification of DNA sequences of the five 
alphaherpesviruses using 22 bp primers selected from the published sequence 
of the immunologically important BHV-1 gl glycoprotein gene (HSV-1 gB 
homologue) (Whitbeck et al, 1988) followed by RE digestion of the amplified 
fragments. The chapter also describes an investigation of the extent of the 
serological relationships among the five ruminant alphaherpesviruses using 
ELISA, SNT and Western blotting. Rabbit hyperimmune sera, cattle, goat, 
red deer and reindeer convalescent field sera were used to investigate the 
quantitative cross-reactivity among these viruses.
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3.2 Materials and Methods
3.2.1. Viruses and Cells
The plaque purified viruses examined in this study and their histories are 
listed in Table 2.1. A semicontinuous primary cell line of embryonic bovine 
trachea (EBTr) cells was used for virus growth as previously described 
(Section 2.1.1. and 2.1.5.). (Nettleton et al, 1983). The viruses were purified 
down a 10% to 25% Ficoll step gradient as described in Chapter 2.
3.2.2. Antibodies
Rabbit hyperimmune sera: Positive rabbit sera against each of the five 
viruses was prepared as previously described in Chapter 2. The negative sera 
were pre-inoculation sera from each rabbit.
Cattle and red deer field sera: the 40 cattle and 40 red deer field sera were 
samples submitted to the Moredun Research Institute for diagnostic analysis 
from different parts of Scotland. All sera were heat inactivated at 56°C for 30 
min and stored in 1 ml aliquots at -20°C.
Cattle, goat, red deer and reindeer convalescent field sera: Field 
convalescent sera against BHV-1, CapHV-2, CerHV-1 and RanHV-1 were 
from cattle, goat, red deer and reindeer respectively. These were used in 
Western blotting and had been obtained from different sources as described in 
Chapter 2 (section 2.2).
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3.2.3. Restriction endonuclease (RE) profiles and PCR
The materials and methods used for restriction endonuclease (RE) profiles 
and amplification of DNA sequences of the five ruminant alphaherpesviruses 
by PCR are described in detail in Chapter 2 (sections 2.4.6 and 2.4.7).
3.2.4. ELISA
Infected and non-infected cell lysates were used as the viral and control 
antigens respectively. The ELISA procedure is described in Chapter 2 
(section 2.3.2). The horseradish peroxidase (HRP)-conjugates used were; goat 
anti-rabbit IgG conjugate (Sigma), rabbit anti-deer IgG (a gift from Dr. 
Steven Edwards, Weybridge) purified by DEAE cellulose ion exchange 
chromatography and conjugated by the periodate method, rabbit anti-bovine 
IgG conjugate and donkey anti-sheep/goat IgG conjugate (SAPU, Scotland). 
All conjugates and antigens were used at optimal predetermined dilutions. 
The corrected optical densities (OD492) were obtained from the ELISA assays 
by taking the mean of duplicate wells containing infected cell lysate as antigen 
after subtracting the mean OD492 of duplicate wells containing a non-infected 
cell lysate control antigen.
Antigenic relationships were expressed by calculating the coefficient of 
antigenic similarity (R) (Archetti and Horsfall, 1950; Hubalek, 1982) 
according to the formula:
82
R = 100
titre of strain I with antiserum I x titre of strain II
with antiserum II
titre of strain I with antiserum II x titre of strain II
with antiserum I
An R value ^25 represents four-fold differences in titres between 
homologous and heterologous antisera indicating significant antigenic 
differences that are greater than would be expected from variations in the 
assay (Hubalek, 1982). An R value <5 has been used to assign viruses to 
different serotypes (Archetti and Horsfall, 1950).
3.2.5. Serum Neutralisation Test (SNT)
The serum neutralisation test was done as described in Chapter 2 (section 
2.3.1) to determine the neutralising activity of rabbit homologous and/or 
heterologous serum against each of the five ruminant alphaherpesviruses 
(Table 2.1).
3.2.6. SDS-PAGE and Western blotting
SDS-PAGE was carried out in 10% discontinuous slab gels (Laemmli, 
1970) under reducing conditions as described in detail in Chapter 2. Briefly, 
200 ul of each of the alphaherpesvirus antigens was loaded in a 15cm central 
well of a gel flanked on each side with control antigen (50 ul) containing 
proteins of mock-infected cells and molecular weight marker standards. 
Electrophoresis was carried out overnight followed by electroblotting using a 
technique described by Burnette (1981) with modifications described by
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Herring and Sharp (1984). The blot was cut into 5 mm wide strips and 
non-specific binding sites were blocked by PBS-containing Tween-20 for 60 
min at room temperature. The strips were then probed with a 1:100 dilution of 
each of the field antisera from cattle, goat, red deer and reindeer, and 1:100 
dilution of each of the homologous and heterologous rabbit hyperimmune sera 
prepared against each virus. After thorough washing, the nitrocellulose- 
bound immune complexes were reacted with a 1:1500 dilution of rabbit 
anti-bovine or goat anti-rabbit HRP conjugates for lh at room temperature. 
The strips were finally incubated for 20 minutes in the dark at room 
temperature with 4 mg of 3,3’diaminobenzidine (DAB) (Sigma) in 100 ml of 
0.05M Tris/HCl containing lOul of 30% H2Or  The reaction was stopped by 
washing the strips in tap water.
3.2.7 Statistical analysis
Regression, correlation coefficient analysis, student paired t-test, and 
analysis of variance (ANOVA) were used to measure the relationships in 
ELISA OD between the five viruses.492
3.3 Results
3.3.1. Restriction endonuclease (RE) profiles of viral DNA
Restriction endonuclease digestion of the five viral DNAs was carried out 
to confirm that the viruses which were being used were different from each 
other. The restriction endonuclease profiles of the five ruminant 
alphaherpesviruses and the two controls, EHV-1 and HSV-1 strain 17+ are
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shown in figure 3.1. Although the first two tracks appeared faint (especially 
track 2, which was amplified by photography) and HSV-1 DNA appears only 
partially digested (track 6) which could have been due to insufficient enzyme 
being used for digestion; there is a clear indication that the viruses used were 
different from each other.
3.3.2. Amplification of DNA sequences of five alphaherpesviruses by 
PCR
The polymerase chain reaction (PCR) was used to amplify a 468 bp 
fragment of each of the five alphaherpesviruses using 22 bp synthetic 
oligomers selected from the BHV-1 gl gene sequences as primers (Figure 3.2). 
All five amplified products were readily detectable on a 2.0% agarose gel 
following optimisation of the PCR reaction conditions. Successful 
amplification was achieved only with a combination of glycerol in the PCR 
buffer and an initial denaturation temperature of 96°C.
3.3.3. Specificity of amplification
Amplification with primers gl-Pj and gI-P2 produced the predicted 468 bp 
fragment of each of the five alphaherpesviruses (Figure 3.2). Since the 
polymerase chain reaction often produces non-specific amplification products 
(Saiki et al, 1988), it was necessary to confirm their specificity by restriction 
endonuclease digestion. Digestion of the amplification products with the four 
enzymes, Bgll, Hinfl, Smal and Aval produced the BHV-1.1 fragments 
predicted from the gl gene sequences (Figure 3.3). The three amplification
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Figure 3.1. Electrophoretic patterns of Bgin restriction
enzyme digests of 32P labelled DNA from BHV-1.1 
(lane 1), BHV-1.2 (lane 2), CapHV-2 (lane 3), 
CerHV-1 (lane 4), RanHV-1 (lane 5), HSV-1 strain 
17+ (lane 6) and EHV-1 (lane 7). The samples were 
run in adjacent wells of the same gel: the tracks have 
been separated to allow labelling of the fragments in 
individual wells.
in
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Figure 3.2. PCR amplification products of gl sequences for the 
five alphaherpesviruses analysed on a 2% agarose gel 
containing ethidium bromide. Amplified product 
from BHV-1.1 (lane 1), BHV-1.2 (lane 2), Molecular 
weight markers (M^ (lane 3), RanHV-1 (lane 4), 
CapHV-2 (lane 5), CerHV-1 (lane 6), Bovine viral 
diarrhoea virus (BVD) cDNA control (lane 7). The 
DNA bands were visualised by ultraviolet light.
1 2 3 4 5 6__ 7
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Figure 3.3. PCR specificity of the amplified products for the five 
alphaherpesviruses digested with restriction enzymes 
Bgll (A), Hinfl (B), Smal (C) and Aval (D) analysed 
by 10% SDS-PAGE and visualised by silver staining. 
Digested amplification products from BHV-1.1 (lane 
1), BHV-1.2 (lane 2), RanHV-1 (lane 3), CerHV-1 
(lane 4), CapHV-2 (lane 5) and Molecular weight 
markers (Mr).
1 2- ^  J 2 ^  3^ 4 5
I j Li ‘
M  S =  U J  U J  U irf 4344
4124
4110
—i 4 266
—* 4 202
1 2 Mr 3 4 5
1 2 M r  3 4  5
4468
4329 44684 331
4139 . -  4137
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products (panel B) for BHV-1.2, CerHV-1 and RanHV-1 contained the same 
fragments following digestion with Hinfl as were generated from the BHV-1.1 
fragment. Two additional bands were evident in CapHV-2 (panels A, B, track 
5 ): that above the 344 bp fragment (panel A and B) most probably represents 
undigested 468 bp DNA whilst that above the 124 bp fragment (panel A) and 
above the 266 bp fragment (panel B) is probably the minor product of 
amplification arrowed (Fig. 3.2, track 5). However, the sizes of the other two 
major bands (344bp and 124 bp) corresponded to those of BHV-1.1, BHV-1.2. 
CerHV-1 and RanHV-1 contained slightly different Bgll restriction sites from 
those of the other three (panel A), while BHV-1.1, BHV-1.2, RanHV-1, 
CerHV-1 and CapHV-2 contained an identical Hinfl site and BHV-1.1, 
BHV-1.2, CerHV-1 and CapHV-1 contained Smal (panel C) and Aval (panel 
D) restriction sites. The RanHV-1 amplification product did not contain Smal 
and Aval restriction sites (panels C and D, lanes 3). The results indicated that 
the five viruses could be placed into three groups: the first containing 
BHV-1.1, BHV-1.2 and CapHV-2, the second and third comprised RanHV-1 
and CerHV-1 respectively. Six other enzymes (Hpal, Hindm, Pstl, Ddel, 
BglH and Pvul) were used to try to discriminate between the three viruses in 
group one but none cut within the fragment.
3.3.4. Analysis of antigenic relationships by ELISA and SNT.
Initially, optimum conditions were established by checkerboard titrations 
using the five viral antigens ranging from a dilution of 1/10 to 1/3200, and 
conjugate dilutions from 1/100 to 1/102400. Optimal results with specific
8 6
binding were achieved with antigen dilutions of 1/100 for all viruses and the 
three conjugates at a dilution of 1/1500. Using the rabbit hyperimmune sera 
against each virus comparison of the homologous and heterologous reactions 
revealed considerable cross-reactivity (Fig. 3.4A-3.4E). The reaction of each 
antiserum was strongest against the virus used for immunisation of the rabbits 
with the exception of the two BHV-1 viruses which were very similar (Fig 
3.4B and 3.4C). The titre of each rabbit hyperimmune polyclonal serum with 
each virus in the ELISA and SNT are given in Table 3.1 A and 3.IB 
respectively. In two cases there was an indication of a one way reactivity with 
the heterologous viruses. Sera raised against RanHV-1 and CapHV-2 virus 
react strongly with lysates of cells infected with the two BHV-1 viruses in the 
ELISA, whereas sera raised against the 2 BHV-1 viruses reacted weakly with 
RanHV-1 and CapHV-2 in both the ELISA and SNT. As shown in Table 
3.1C the coefficients of antigenic similarity were calculated in order to 
compare the similarity of the five viruses to each other using the ELISA titres. 
The values obtained for each pair of viruses indicate that (1) the two bovine 
herpesviruses are most closely related, (2) the cervine and caprine 
herpesviruses appear to be more closely related to the two bovine 
herpesviruses than they were to each other and (3) the rangiferine virus 
appeared to be more closely related to the cervine virus than to the bovine or 
caprine viruses.
When convalescent field sera were used the cognate anti-species conjugate 
generally gave the best results, although there was cross-reactivity with the
86a
Figure 3.4A-E. Titration of rabbit homologous and heterologous 
polyclonal sera raised against five ruminant 
alphaherpesviruses against lysates of cells 
infected with each of the five viruses. Antigens: 
A- caprine herpesvirus-2 (CapHV-2) B- bovine 
herpesvirus-1.1 (BHV-1.1), C- bovine
herpesvirus-1.2 (BHV-1.2), D- cervine
herpesvirus (CerHV-1), and E- rangiferine 
herpesvirus-1 (RanHV-1). Results from the five 
sera from rabbits immunised with: BHV-1.1 (a), 
BHV-1.2, (o) CapHV-2 (v), CerHV-1 (a) and 
RanHV-1 (pf). Optical density values (OD492nm) 
represent the piositive viral antigen minus the 
respective negative control antigen. Each optical 
density value represents the average of two 
replicates.
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TABLE 3.1A Antibody titresa of rabbit homologous and heterologous polyclonal 
antisera with the five ruminant alphaherpesviruses
Polyclonal
Antisera
Raised
Antigens
against BHV-1.1 BHV-1.2 CapHV-2 CerHV-1 RanHV-1
BHV-1.1 102400 102400 3200 12800 800
BHV-1.2 204800 2M80Q 3200 25600 1600
CapHV-2 12800 51200 102400 6400 800
CerHV-1 102400 102400 3200 102400 25600
RanHV-1 25600 25600 1600 6400 25600
aELIS A titre expressed as the reciprocal of the highest serum dilution
giving an OD of ^ 0.1 
Homologous polyclonal antisera are underlined
TABLE 3.IB. Serum neutralisation antibody titres of rabbit homologous and
heterologous antisera with the five ruminant alphaherpesviruses
Polyclonal
Antisera
Raised
against BHV-1.1
Antigens 
BHV-1.2 CapHV-2 CerHV-1 RanHV-1
BHV-1.1 9£L 256 11 3 <2
BHV-1.2 64 360 8 6 2
CapHV-2 3 3 1024 11 8
CerHV-1 45 16 45 2048 32
RanHV-1 32 45 32 90 128.
TABLE 3.1C Antigenic relationships among 5 ruminant alphaherpesviruses
by ELISA (R values)
Virus BHV-1.1 BHV-1.2 CapHV-2 CerHV-1 RanHV-1
BHV-1.1 100
BHV-1.2 100 100
CapHV-2 6 9 100
CerHV-1 35 35 4 100
RanHV-1 9 9 2 25 100
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three anti-ruminant IgG conjugates and especially between the bovine and red 
deer conjugates which detected deer sera equally well (Table 3.2). The 
analysis of pairs of OD492 readings among the five viruses for each bovine and 
red deer field serum (Table 3.3a and 3.4a) indicate significant correlations 
between the OD492 values for all viruses (Table 3.3b and 3.4b) respectively. 
In each case the paired t-test revealed significant differences (P^O.OOl) 
between the OD492 of each pair of viruses except between those of the two 
BHV-1 viruses which were not significantly different (P>0.05).
Figure 3.5A to 3.5C and 3.5D to 3.5F show the results of viral antigen 
titrations against 3 bovine and 3 red deer field sera respectively (Table 3.5a 
and 3.5b). In each case it appears that the relative reactivities of the different 
sera with antigen are largely independent of the antigen concentration but 
reflect their antigenic similarity.
3.3.5. Analysis of viral antigens by Western blotting
The immune reactions of the viral antigens of all five viruses with both 
homologous and heterologous rabbit hyperimmune sera and convalescent 
antisera from cattle, goat, red deer and reindeer were analysed by Western 
blotting. Figure 3.6 shows the polypeptides which were recognized from cells 
infected with each of the five viruses by the polyclonal sera. The 
convalescent sera hardly recognised any proteins from any viral-infected cells. 
However several weak bands with apparent molecular weights of 200, 68-70, 
45 kDa in CapHV-2; 87-90, 68-74, 55, 50, 46, 42 kDa in CerHV-1 and 180,
87a
TABLE 33a ELISA reactivity of 40 field bovine sera against five ruminant 
alphaherpesviruses
Serum Sample OD492 produced against antigens
No. Identification Bovine viral
Number BHV-1.1 BHV-1.2 CapHV-2 CerHV-1 RanHV-1 diarrhoea virus
(BVD) (control)
1 Q3937 2.36 2.27
2 Q3911 2.38 2.31
3 Q3910/4 2.34 2.31
4 Q3910/3 2.30 2.25
5 Q3910/2 2.25 2.27
6 Q3910/1 2.28 2.13
7 Q3877 2.38 2.35
8 Q3865/2 2.39 2.38
9 Q3858/5 2.42 2.40
10 Q3842 2.42 2.38
11 Q3825/3 2.11 2.13
12 Q3825/1 1.37 1.35
13 Q3814/1 2.24 2.15
14 Q3811/6 0.94 1.04
15 Q3811/5 1.23 1.22
16 Q3811/4 1.39 1.38
17 Q3777/5 0.65 0.57
18 Q3777/4 2.00 1.98
19 Q3761/8 2.21 1.90
20 Q3761/7 2.12 2.05
21 Q3761/6 2.09 1.88
22 Q3761/5 1.85 2.13
23 Q3761/4 2.19 2.09
24 Q3761/3 1.92 2.26
25 Q3761/2 2.33 2.29
26 Q3761/1 2.29 2.29
27 Q3747 1.80 1.87
28 Q3746 1.85 1.76
29 Q3744 1.90 1.64
30 Q3741/2 1.13 1.25
31 Q3741/1 2.12 2.25
32 Q3740/14 1.16 1.17
33 Q3740/13 2.21 2.17
34 Q3740/12 0.74 0.84
35 Q3740/11 0.94 1.07
36 Q3740/10 1.58 1.45
37 Q3740/7 1.78 1.87
38 Q3740/6 2.30 2.19
39 Q3740/9 2.41 2.40
40 Q3740/8 2.35 2.23
0.38 0.81 0.50 0.00
0.52 1.50 0.60 0.00
0.51 1.47 1.19 0.00
0.46 0.74 0.49 0.00
0.41 0.60 0.36 0.01
0.34 0.61 0.61 0.01
0.68 1.06 0.90 0.00
0.37 0.96 0.50 0.02
0.27 0.64 0.57 0.00
0.67 1.33 0.87 0.00
0.32 0.80 0.54 0.00
0.17 0.37 0.26 0.02
0.48 0.82 0.50 0.01
0.12 0.25 0.12 0.00
0.11 0.34 0.17 0.01
0.10 0.34 0.08 0.01
0.05 0.15 0.09 0.01
0.32 0.66 0.43 0.02
0.62 1.31 0.80 0.00
0.40 0.83 0.54 0.02
0.50 1.01 0.76 0.02
0.56 1.19 0.92 0.00
0.40 1.12 0.72 0.00
0.47 1.11 0.85 0.02
0.52 0.88 0.68 0.00
0.69 1.06 0.70 0.00
0.16 0.65 0.42 0.00
0.23 0.56 0.46 0.00
0.12 0.53 0.33 0.01
0.12 0.28 0.17 0.01
0.37 0.79 0.74 0.01
0.07 0.31 0.15 0.01
0.29 0.63 0.41 0.02
0.08 0.20 0.06 0.01
0.08 0.32 0.09 0.01
0.15 0.39 0.25 0.00
0.30 0.66 0.43 0.00
0.59 1.21 0.95 0.00
0.64 1.40 1.09 0.00
0.38 0.82 0.66 0.00
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TABLE 33b. Correlation coefficients of OD readings of 40 field 
bovine sera as determined by ELISA with pairs of 
ruminant alphaherpesviruses.
Virus BHV-1.1 BHV-1.2 CapHV-2 CerHV-1 RanHV-1
BHV-1.1 1.000
BHV-1.2 0.972 1.000
CapHV-2 0.799 0.809 1.000
CerHV-1 0.779 0.788 0.902 1.000
RanHV-1 0.774 0.796 0.883 0.920 1.000
87c
TABLE 3.4a ELISA reactivity of 40 field red deer sera against five 
ruminant alphaherpesviruses.
Serum Sample OD492 produced against antigens
No. Identification Bovine Viral
Number BHV-1.1 BHV-1.2 CapHV-2 CerHV-1 RanHV-1 Diarrhoea Virus
(BVD) (control)
1 Q521 1.77 1.67 0.56 1.74 0.75 0.00
2 Q522 1.63 1.54 0.42 1.46 0.72 0.00
3 Q523 1.96 1.97 0.75 1.96 1.23 0.01
4 Q524 1.90 1.76 0.58 1.78 1.08 0.00
5 Q527 1.76 1.66 0.44 1.45 1.01 0.01
6 Q528 1.92 1.85 0.78 1.96 1.21 0.00
7 Q529 1.93 1.87 0.80 2.00 1.40 0.01
8 Q530 0.64 0.75 0.04 1.01 0.19 0.00
9 Q531 1.55 1.58 0.33 1.71 0.56 0.00
10 Q532 2.10 2.06 0.92 2.08 1.46 0.00
11 Q534 0.06 0.24 0.00 0.09 0.00 0.00
12 Q535 2.11 2.08 0.80 2.04 1.42 0.00
13 Q536 1.48 1.45 0.42 1.67 0.70 0.01
14 Q537 2.09 2.08 1.15 2.13 1.62 0.00
15 Q538 1.74 1.51 0.39 1.66 0.91 0.00
16 Q540 1.93 1.90 0.63 1.96 1.41 0.00
17 Q541 2.21 2.19 0.81 2.02 1.40 0.00
18 Q542 1.82 1.79 0.60 1.95 0.89 0.00
19 Q543 2.04 2.05 0.76 2.03 1.23 0.00
20 Q544 2.05 2.17 0.91 2.07 1.59 0.00
21 Q545 1.84 1.82 0.65 1.90 1.01 0.00
22 Q546 1.60 1.58 0.51 1.80 0.99 0.00
23 W547 1.64 1.40 0.33 1.64 0.72 0.00
24 Q548 1.86 1.83 0.45 1.82 0.87 0.00
25 Q549 1.68 1.68 0.75 1.61 1.10 0.00
26 Q550 1.77 1.69 0.84 1.81 1.32 0.00
27 Q551 1.85 1.74 0.63 1.94 0.82 0.00
28 Q553 1.73 1.77 0.79 1.98 1.31 0.00
29 Q554 1.18 1.11 0.31 1.36 0.68 0.01
30 Q555 1.70 1.59 0.45 1.82 0.94 0.00
31 Q556 2.34 2.32 0.95 2.27 1.47 0.00
32 Q557 1.86 1.69 0.37 1.84 0.62 0.00
33 Q558 2.19 2.12 0.94 2.16 1.44 0.00
34 Q559 0.91 0.90 0.12 1.28 0.17 0.00
35 Q560 2.25 2.20 0.80 2.21 1.39 0.00
36 Q561 1.56 1.55 0.35 1.68 0.84 0.00
37 Q562 1.95 1.97 0.76 1.92 1.39 0.00
38 Q563 2.06 1.97 0.80 1.93 1.47 0.00
39 Q552 0.05 0.19 0.03 0.15 0.00 0.00
40 Q564 2.03 2.06 0.58 2.17 1.01 0.00
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TABLE 3.4b. Correlation coefficients of OD readings of 40 field 
deer sera as determined by ELISA with pairs of 
ruminant alphaherpesviruses.
Virus BHV-1.1 BHV-1.2 CapHV-2 CerHV-1 RanHV-2
BHV-1.1 1.000
BHV-1.2 0.988 1.000
CapHV-2 0.842 0.871 1.000
CerHV-1 0.964 0.966 0.815 1.000
RanHV-1 0.877 0.898 0.951 0.837 1.000
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Figure 3.5A-F. Titration of ruminant alphaherpesvirus 
antigens: BHV-1.1 (a ) , BHV-1.2 (o), CapHV-1 (v  
), CerHV-1 and (a) RanHV-1 (p) against three 
different field bovine (A-C) and red deer (D-F) 
sera by ELISA. Optical density values 
(OD492nm) represent the positive viral antigen 
minus the respective negative control antigen. 
Each optical density value represents the 
average of two replicates.
Reciprocal of antigen 
dilution
Optical Density (OD«2)
©
O
ts)Wl
o
s
N)o
4k
©
o
00oo
oo
o
©
TA
BL
E 
3.
5a
. 
Ti
tra
tio
n 
of 
5 
ru
m
in
an
t 
al
ph
ah
er
pe
sv
iru
s 
an
tig
en
s 
ag
ain
st 
3 
bo
vin
e 
fie
ld 
ser
a 
(Q
39
10
, 
Q3
84
2,
 Q
38
65
) 
by 
EL
IS
A
87f
Q
O
C/3c
<v
•  pH
c
<
©o
WO
c3
CU
0^
X
4)c• pH
>o
sCS
■4—>• P<XX
C3
O
wo
cd
T3<D
3
cd
<5C/3
<uc• pH>o
8— <D.a>■a S(30 CoOh a mzi 
o < 2Uft! o Q
wox
00
CO
o
04
oo
CO
a
on
co
a
woSO
00
CO
o
ph
>  9ac00 ^  S3,
o
pH
O n
COo'
woX
oo
CO
a
04Tf
oo
04I>
X
(3 ao
pH
ON
CO
a
wo
X
oo
CO
a
04
oo
CO
a
04^HI
X>CQ
ON
CO
a
wo
X
oo
CO
O'
04■H-
oo
COa
O n
CO
O'
oo Oo» O nCOO npHWOwo X04 TfpH wo©
© ©* pHtH © © ©‘ ©
oo ©© oooo ©00 ©CO04© woX 04CO
© H^ pH pH 1—H©* ©
X
O n
0404 04© 8 COX ON O n 0004© l-H04* 04* © ©’ ©*
04X OONO O'wo rTON X 00pH O
© H^ pH© © ©‘ ©
ON04 ON04 00© ©© O' ©00 ooO n O'X
pH 04* 04* pHpH© ©
ooCOCO© woH^ O'© O nso ooON O'wo 04CO
pH04* 04* 04* pH © © ©
s 04CO00X 00wo 04 H^▼Hs s
© © © © © © © ©
04pH ©O n O'© ©© 04O' XCOO'pH O n©
© © pH © © © ©
04^H O nX oo© ©ON Tj-X ON O'© ©
© © © © © © ©
o-r- pHCOCOXCOON04 oooo oo© wo© 04* 04* 04* 04* pH pH©
wo04 COXCOwoCOTfCO04 CO00 04pHpH pH04* 04* 04* 04*
C"; O n04 XCOXCO04CO00pH04O; ©oo
r-H04* 04* 04* 04 04* 1
XO' s pHpHO npHpH04 TfX r '00 ©
© 04* 04* 04* 04* pH© ©
4-HCO©"3; O'ON 04ON ©04 © Xt"; H^©4-HpH pH pH04* 04* 1
woO; © woCOwo04 wop H wopH 00O'; CO©l-H04* 04* 04* 04* 04* rH pH
wo04 ©wo
o©
pH
©©04
©©Tf
©©oo
©©X 32
00
TA
BL
E 
3.
5b
. T
itr
ati
on
 
of 
5 
ru
m
in
an
t 
al
ph
ah
er
pe
sv
iru
s 
an
tig
en
s 
ag
ain
st 
3 r
ed 
de
er 
fie
ld 
ser
a 
(Q
52
1,
 Q
52
3,
 Q
52
4)
 b
y 
EL
IS
A
.
87g
<N
ON
cTo
C/3
C
<D
C
<
ooin
cd
<D*o
c
cd
X)
cdt-i
OVi
cd
TD
2
S3
3
cd
<D
C/3
l-i
8
Q
1 3  gf \  O
8 .SP g 
fe.C-3 
•B <  3W u _ ,  5o Q
CMlO
a
cn
CMin
a
CMin
a
CMin
a
cn  
CM 
„  «n
3 ° '
CMma
CMin
oCMi> 
f f i
CL.IO ed O'u
cn
CM
CM
I
>«
CMino'
CMin
a
cn
CMina
CMina
"d-
CMin
o
cn
CMina
CM«n
O'
oo •n■d- cn00 CM00 ©in inCM CM s
© d d d © © © ©
s r -oo vo"d; Os 00 r-cn d" 00©
d d © ©© ©
oo incn ©00 oo ininr-»VO s
© d © ©© © © ©
in
VO
CM
cn
00-d; cncn 0000 VO cnCM d-
© r—H © © ©©
in CMOs CM© 8
Ov f"
vO cn
CM* CM* i-H© ©
oo CM CMin invq t-Hcn VOr** cncn VO
T—1 1—H © © ©
oo CMCM incn CMcn ©CM CM VO© cn©
o o © © o © © ©
VOo 3 v or- O sr- v om C"CM vo© r-»©
o d © © © © © ©
oo ocn Oscn ood- OvCM in cn ©©
© d © © © © © ©
00
r-H
cnd; OvCM ©00 ©in CM in
© i—H T—H © © © ©
VOino00 ©© OsOs ©00 r- ooVO "dcn
d l-HCM* r-H H © ©
CM
cn
CM
CM
cn in CMOv CMVO ©cn CM
d © © © ©
ooo cn in CM VOOv 00in vOcn O s
d d r*H © © © ©
O s
CM
©
vq
CM oo
00
00
vq
Ov Ov
VO
CMd
d r-H T“H © ©
r-
cn
CM
CM
CM Ovd; 00o v CMVO cn ©CM
o l-H t-H © © © ©
o  oo  o  o  o  o  o  i n o o o o o ^ o c M  
c M i n * —i cm oo »—t e n
87h
Figure 3.6. Western blot of cattle (AT), goat (A2), red deer 
(A3), reindeer (A4) convalescent field sera and 
rabbit hyperimmune sera against BHV-1.1 (B^, 
BHV-1.2 (B2), CapHV-2 (B3), CerHV-1 (B4), 
RanHV-1 (B5) and normal rabbit sera (B6). Each 
serum was reacted with detergent extracts 
(NP-40) of BHV-1.1, BHV-1.2, CapHV-2, 
CerHV-1 and RanHV-1 infected cell antigens 
resolved by 10% SDS-PAGE under reducing 
conditions and transferred to the nitrocellulose 
strips shown on each of the five panels of 10 
strips. Mr are molecular weight markers in 
kilodaltons (kDa).
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90, 46 kDa in RanHV-1 were recognized by the anti-BHV-1 serum. The 
caprine convalescent serum weakly recognized polypeptides of 130 kDa in the 
two BHV-1 viruses, polypeptides 200 kDa, a 180 kDa doublet, 97 kDa, 43 
kDa and 38 kDa in CapHV-2, and hardly recognized any proteins in CerHV-1 
or RanHV-1 viruses. The cervine and reindeer convalescent sera weakly 
recognized polypeptides in BHV-1.1 and BHV-1.2 infected cells with 
molecular weights ranging from 130 kDa to 45 kDa. The CerHV-1 sera 
reacted weakly with polypeptides in cells infected with its homologous virus 
and RanHV-1 while the RanHV-1 sera showed a stronger reactivity with its 
homologous virus and with more proteins than will all heterologous viruses.
The rabbit hyperimmune sera were in general far more reactive than 
convalescent sera. A summary of the molecular weights of recognised 
polypeptides is presented in Table 3.6, but a few general points may be made. 
The two anti BHV-1 hyperimmune sera reacted with more BHV-1.1 than 
BHV-1.2 polypeptides. The spectrum of polypeptides from BHV-1.1 infected 
cells recognised by both anti-BHV-1.1 and BHV-1.2 sera was very similar as 
was the spectrum from BHV-1.2 infected cells recognised by both 
anti-BHV-1.1 and BHV-1.2 infected cells. Few BHV-1.1 and BHV-1.2 
polypeptides were recognized by the CapHV-2 and RanHV-1 rabbit 
hyperimmune sera. The CerHV-1 rabbit hyperimmune sera recognised more 
BHV-1.1 than BHV-1.2 polypeptides. In contrast, there were more CapHV-2 
and RanHV-1 polypeptides recognized by the two BHV-1 hyperimmune sera. 
Whereas RanHV-1 hyperimmune sera showed a poor recognition of CerHV-1
88a
TABLE 3.6. Summary of antigenic reactivity of ruminant alphaherpesvirus 
polypeptide antigens against their homologous rabbit 
hyperimmune sera as visualised by Western blotting 
(see Figure 3.6).
Virus Approximate molecular weights (kDa)
BHV-1.1 205,180, 130,116, 97-108, 87-90, 74-77, 64-66,55,45,43, 30,28
BHV-1.2 120,108, 87-90,74-77, 66-70, 65, 64, 63,55,46
CapHV-2 200,180, 130,108, 97, 90-66,55, 46,40, 33,28
CerHV-1 205,180, 130,120,108,100, 90-70, 65,55,46,42, 40, 33
RanHV-1 130,112, 97-108,74, 70-64,46
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polypeptides, more RanHV-1 polypeptides were recognized by the CerHV-1 
hyperimmune sera. Finally, there was marked and strong recognition of the 
RanHV-1 polypeptides by all the four heterologous hyperimmune sera.
3.4. Discussion
3.4.1. Restriction endonuclease profiles
The restriction endonuclease profiles with Bgin of the five ruminant 
alphaherpesviruses indicated that the viruses were different from each other. 
The reasons for the poor radiolabelling of the two BHV-1 viruses was not 
immediately apparent. Perhaps the virus titre was lower than expected. 
Harvesting of the viruses at different times after labelling would possibly have 
helped to improve the amount of radiolabelled DNA in these samples.
3.4.2. Analysis of viral DNA by PCR
Polymerase chain reaction (PCR) was used to amplify a 468 bp fragment of 
the five ruminant alphaherpesviruses using 22 bp oligomers from the BHV-1 
gl gene sequences (Whitbeck et al, 1988) as primers. A successful 
amplification was achieved after optimising the PCR reaction conditions. 
Particularly important were inclusion of glycerol in the PCR buffer and initial 
denaturation of the viral DNA’s at an elevated temperature of 96°C as 
suggested by Vilcek (1993) perhaps necessary because of a high G + C 
content. For several of the PCR reaction conditions, slight deviations from the 
optimal values can result in reduced or undetectable amplification (Saiki et al, 
1988). Restriction enzyme digestion was used to verify the specificity of the
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amplified fragments since PCR often produces non-specific amplification 
products that may cross-hybridize with the desired product or may 
coincidentally be of the same size as the expected fragment (Saiki et al, 
1988). The results indicated that the five alphaherpesviruses examined 
contained gl sequences that were amplified and that at least three different 
viruses were present. Additional enzymes were used in an attempt to 
discriminate between BHV-1.1, BHV-1.2 and CapHV-2 but none cut the 
amplified products. This was perhaps not surprising as it is probable that the 
PCR fragments for these three viruses contained sequences with similar 
restriction sites for many of the enzymes used, as the BHV-1 gl gene selected 
for amplification (the HSV gB gene homologue) is known to be highly 
conserved amongst the herpesviruses (Hammerschmidt et al, 1988; Borchers 
et al, 1991; Griffin, 1991). Although the PCR fragment analysis failed to 
unambigously establish the difference in the five viruses, together with the RE 
profiles of whole viral genomes, it provided evidence to indicate that all five 
viruses were different from each other.
3.4.3. Antigenic relationships by ELISA and SNT
The present study reveals evidence of a wide cross-reactivity as shown by 
both heterologous rabbit polyclonal and field sera on each of the five 
alphaherpesviruses. The results indicate antigenic similarity among these 
viruses. Indeed, ELISAs and SNT performed in these studies clearly show 
that a close serological relationship exists between the bovine, caprine, cervine 
and reindeer alphaherpesviruses. The results suggest that (1) the two bovine
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herpesviruses are most closely related, (2) the cervine and caprine viruses are 
serologically more related to the closely related BHV-1 viruses than they are 
to each other and (3) the rangiferine herpesvirus appeared to be more closely 
related to the cervine virus than to the bovine or caprine virus. Rimstad et al 
(1992), Nixon et al (1988) and Martin et al (1990) obtained serological 
results compatible with the present study. Furthermore, the results indicate 
that the rangiferine virus is more closely related to the cervine virus than to the 
caprine virus. The existence of the cross-reactivities among these viruses in 
the present data supports the previous views by Nettleton and others (1986) 
that the widespread evidence of antibodies to CerHV-1 in wild and farmed red 
deer in Britain (overall prevalence 29%) is likely to be due to infection with 
CerHV-1 rather than BHV-1. In addition, while most antigens displayed 
cross-reactivities between pairs of viruses, a number of one-way reactivities 
between heterologous viruses were also noted. The latter phenomenon was 
observed between the two BHV-1 viruses and the caprine virus and also 
between the BHV-1 viruses and the rangiferine virus (RanHV-1). One-way 
reactivity between BHV-1 and CapHV-2 was previously reported by others 
(Ackermann et al, 1986; Friedli and Metzler, 1987). Recently, Rimstad et al, 
(1992) reported a one-way reactivity between BHV-1 and RanHV-1. The 
results indicated that a weak one-way reactivity in one or other direction could 
not have been a function of the sensitivity of the test system used but rather a 
reflection of their antigenic similarities. Furthermore, it has been shown that 
at least some of the cross-reacting antibodies bind to the viral proteins VP4 
and gl (Ackermann et al, 1986; Metzler et al, 1985).
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Whether the one-way reactivities observed between species examined in 
this study were really due to epitopes of the same polypeptide merits further 
investigation, particularly with Western blotting and epitope mapping by 
competitive ELISAs with monoclonal antibodies.
3.4.4. Antigenic relationships by Western blotting
Analysis of rabbit polyclonal and host field sera for the five ruminant 
alphaherpesvirus antibodies in Western blots revealed a wide range of 
cross-reacting antibodies. While a marked strong reactivity of each polyclonal 
serum against the homologous virus was observable, there was also a marked 
variation of reactivity of each polyclonal serum against the heterologous virus. 
Whereas the two BHV-1 polyclonal sera recognized more of CapHV-2 and 
RanHV-1 proteins, far fewer of the two BHV-1 proteins were recognized by 
either CapHV-2 or RanHV-1 polyclonal sera. This result suggests a one-way 
reactivity which has also been reported by others (Ackerman et al, 1986; 
Friedli and Metzler, 1987; Rimstad et al, 1992). The cross-reacting 
antibodies were mainly directed against glycoproteins with molecular weights 
130 kDa, 95 kDa, 68-74 kDa, 55 kDa and 45 kDa (figure 3.6). The 130 kDa, 
74 kDa and 55 kDa proteins have been previously identified to be components 
of glycoprotein gl in BHV-1 (van Drunen et al 1986). These results support 
the recent findings of Engels et al (1992) and Koptopoulos (1992), that the 
cross-reacting antibodies were mainly induced by glycoprotein gl (HSV gB 
homologue), the major capsid protein and several non-structural proteins,
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whereas glycoproteins gin and gIV (HSV gC and gD homologues 
respectively) were found to induce virus-specific antibodies (Ackermann et 
al, 1986; Friedli and Metzler, 1987). In contrast, Collins et al (1993) recently 
showed glycoproteins gin and gIV to be responsible for the cross-reactivity 
between BHV-1.1 and BHV-1.3. The reactivities of cattle, goat, red deer and 
reindeer field sera with BHV-1, CapHV-2, CerHV-1 and RanHV-1 antigens in 
the Western blots confirms the viral origins of these antigens. As glycoprotein 
gl is known to be the most conserved within the whole herpesvirus group 
(Hammerschmidt et al, 1988) cross-reacting antibodies were to be expected. 
HSV gC homologues have been shown to exhibit the most virus- and 
strain-specific properties (Ben-Porat et al, 1986; Friedli and Metzler 1987; 
Allen and Coogle, 1988).
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CHAPTER 4 
PRODUCTION AND CHARACTERISATION OF MONOCLONAL 
ANTIBODIES AGAINST CERVINE HERPESVIRUS TYPE 1
4.1. Introduction
Antibodies have been used widely in the laboratory diagnosis of a wide 
range of diseases caused by viruses as well as in detailed investigations of 
virus structure. However, serological assays have always had problems of 
interpretation, reproducibility and standardisation, resulting partly from the 
unavoidable heterogeneity of the antibodies in the test. Since Kohler and 
Milstein (1975) introduced the hybridoma technology for generating 
monoclonal antibodies (Mab), which overcomes these limitations, both the 
application and usefulness of immunoassays has greatly expanded. This 
technology has also significantly improved the quality and reliability of 
serological assays. It has also made identification and analysis of viral 
proteins easier.
The general procedure and practice which has now become established is 
the use of a myeloma cell line, which grows in culture but is deficient in the 
enzyme hypoxanthine phosphoribosyl transferase (HGPRT), as a fusion 
partner with spleen cells of previously immunised animals. After fusion, cells 
are grown in a selective culture medium supplemented with hypoxanthine, 
aminopterin and thymidine (HAT). In this medium the main pathway of
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cellular DNA synthesis is blocked by aminopterin, while in addition, the 
alternative or "salvage" pathway cannot be carried out in the myeloma cells 
because of their deficiency in HGPRT. Thus only the hybrids between the 
myeloma and spleen cells survive in the HAT medium where the spleen cells 
supply functional HGPRT enzyme and the myeloma cells supply the ability to 
grow in tissue culture. The hybrid cell lines or hybridomas grow continuously 
in culture. These hybridomas are thereafter screened for their secretion of 
specific antibody. Several workers have produced Mabs against BHV-1 
(Collins et al, 1984; Metzler et al, 1985; Chang et al, 1986; Fitzpatrick et al, 
1990b; Shen et al, 1991; Baranowski et al, 1993.). There is no description of 
production of Mabs against the other ruminant alphaherpesviruses.
This chapter describes the production and characterisation of monoclonal 
antibodies against one of the five ruminant alphaherpesviruses namely 
CerHV-1.
4.2. Materials and Methods
The materials and methods for the production of monoclonal antibodies 
against CerHV-1 are described in detail in Chapter 2 (section 2.5).
4.2.1. Serum Neutralisation Test (SNT)
Microneutralisation tests were carried out as described in Chapter 2 to 
determine the neutralising activity of each Mab against cervine herpesvirus-1 
(CerHV-1).
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4.2.2. SDS-PAGE and Western blotting
SDS-PAGE of each of the five alphaherpesviruses and Western blotting of 
all Mabs to determine their protein specificities were carried out as previously 
described in Chapter 2.
4.2.3. Indirect Fluorescent Antibody Test (IFAT) for CerHV-1 Mabs.
Embryonic bovine tracheal cells (EBTr) at 2 x 105 cells per ml were grown 
in E’199’ medium on coverslips in 10 ml tubes and incubated at 37°C until 
monolayered. The tubes and coverslips were washed twice in warm Hanks 
balanced salt solution. Duplicate tubes were either mock-infected or infected 
each with 0.2 ml (m.o.i. of 10) of CerHV-1, and incubated at 37°C for 1 hour. 
One ml of E’199’ medium containing 2% foetal bovine serum (FBS), 100 
IU/ml penicillin, 100 ug/ml streptomycin and 1 mM glutamine were added 
and incubated at 37°C for 4, 8, 12, 16, 20 and 24 hours (for a time course 
appearance of proteins recognised by the Mabs). All coverslips were washed 
twice in warm PBS and placed on labelled blotting paper to air dry. The 
coverslips were then fixed in neat cold acetone for 10 minutes and 0.1 ml of 
each Mab at a previously determined appropriate dilution was added to each 
coverslip and incubated at 37°C for 30 minutes in a moist atmosphere. All 
coverslips were washed three times in warm PBS for 10 minutes using fresh 
PBS each time. Coverslips were allowed to air dry and 0.1 ml of sheep 
anti-mouse IgG conjugated to fluorescein isothiocyanate (FITC) at a 
predetermined dilution was added and incubated at 37°C for 30 minutes in a
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moist atmosphere. Coverslips were washed three times in warm PBS for 10 
minutes, allowed to air dry and then mounted on slides using phosphate 
buffered glycerol (pH 8.2) before being examined under a Leitz Ortholux 2 
ultraviolet microscope.
4.3. RESULTS
4.3.1. Characterisation of hybridomas
The screening ELISA method was simple, sensitive and capable of testing 
more than two hundred hybridoma cell culture supernatant samples at a time. 
Out of the five fusions performed, only the first and last were successful. The 
second, third and fourth fusions failed to produce any positive hybridomas 
possibly due to a toxic batch of PEG being used. A total of 515 wells 
containing HAT resistant hybridomas were obtained from the two successful 
fusions from which 32 wells were shown to contain hybridomas producing 
anti-CerHV-1 specific antibody (Table 4.1). Of these 32 hybridomas selected 
for analysis, 14 clones were propagated successfully with the remainder 
growing poorly or being lost due to overgrowth with non-secreting 
hybridomas during subcloning. The 14 hybridomas were successfully 
subcloned three times by the limiting dilution method using initially RPMI 
1640 medium with 20% MTM as a growth-supporting factor. The 
hybridomas were weaned off MTM in the second subcloning. MTM was also 
not used during their expansion in 25 cm2 flasks. Both the duration of 
production and amount of ascitic fluid in mice injected with the hybrid cells 
appeared to be a growth characteristic of each individual clone. Abdominal
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TABLE 4.1. A summary of five fusions and hybridomas produced.
Fusion
number
No. of 
myeloma 
cells used
No. of
immunised 
spleen cells 
used
No. of 
wells
withHAT-
resistant
hybridomas
No. of 
positive 
hybridomas 
established
No. of 
monoclonal 
antibodies 
obtained3
1 1.90xl07 1.01x10s 351 18 6
2 2.80xl07 2.92x10s 0 0 0
3 2.40X106 2.38xl07 0 0 0
4 2.50xl07 2.56xl08 12 0 0
5 2.05xl07 2.05xl08 164 14 8
aCloned three times by limiting dilution
TABLE 4.2. Immunoglobulin isotype of antibodies secreted by hybridomas
aIsotype
Mab designation IgGl IgG2a IgG2b
2G8 +
4D7 +
4F10 +
4G8 +
6C10 +
8B11 +
1G7 +
2C3 +
3B6 +
3C6 +
3D9 +
3E5 +
5C2 +
6E9 +
aAll are K light chains
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swelling developed between 2-3 weeks after i/p inoculation. All of the 14 
selected Mabs were of the IgG class with K light chains. Three of the 6 Mabs 
obtained in the first fusion were IgGl (4G8, 6C10 and 8B11), 1 IgG2a (2G8) 
and 2 IgG2b (4D7 and 4F10). All of the 8 Mabs from the second successful 
fusion were of the IgG2a isotype (Table 4.2). The 14 Mabs were titrated in 
parallel in an ELISA to construct binding affinity curves, where all of them 
were observed to have good binding affinities. However the three IgGl Mabs 
(4G8, 6C10 and 8B11) showed higher and similar ELISA binding affinities 
(Figure 4.1 and Table 4.3).
4.3.2. Quantification and conjugation of Mabs to HRP
Although ascites can be used directly in tests or assays without any 
purification, it was decided to purify Mabs for conjugation to HRP as a 
standard reagent for further experimental work to avoid possible 
complications caused by unknown reactivities of other, non Ig, 
HRP-conjugated ascitic proteins. The immunoglobulin content of ascitic fluid 
from 9 Mabs which had each produced 2-4 mis of ascites per mouse were 
quantified (Table 4.4) and conjugated to HRP.
4.3.3. Protein specificities of the monoclonal antibodies in Western blots.
The protein specificities of the Mabs were determined by Western blotting. 
The resolved CerHV-1 proteins on the nitrocellulose strips were probed with 
each of the Mabs present in the appropriately diluted ascitic fluid. A notable 
variation in the reactivity of the 14 Mabs with polypeptides from
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Figure 4.1. Binding affinity curves of the 14 CerHV-1 Mabs 
(4G8, 8B11, 6C10, 4D7, 1G7, 4F10, 3E5, 2G8, 
2C3, 5C2, 6E9, 3C6, 3B6 and 3D9) (ascites) 
against homologous virus in an indirect ELISA.
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TABLE 4.4. Purification of ascitic fluid containing some of the 
monoclonal antibodies showing the amount of 
immunoglobulin recovered per ml of ascitic fluid
Mab designation Istotype Amount of immunoglobulin 
per ml of ascites
1G7 IgG2a 3.40 mg
3B6 IgG2a 1.42 mg
3C6 IgG2a 1.08 mg
3D9 IgG2a 3.92 mg
4D7 IgG2b 6.48 mg
4F10 IgG2b 5.90 mg
4G8 IgGl 3.53 mg
6C10 IgGl 2.23 mg
8B11 IgGl 3.34 mg
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CerHV-1-infected cell extracts under reducing conditions (Figure 4.2) was 
observed. Of these 14 Mabs, 4 Mabs (1G7 -lane 1,2C3 - lane 2, 3B6 - lane 4, 
3D9 - lane 6) reacted with the 64kDa polypeptide while 3 Mabs (3E5 - lane 7, 
5C2 - lane 11, 6D9 - lane 13) reacted with both the 64 kDa polypeptide and 
diffusely with a 68-70kDa polypeptide. Mab 2G8 (lane 3) reacted with a 
64-69 kDa polypeptide. Mab 4F10 (lane 9) showed a diffuse reaction with a 
68-70 kDa polypeptide. Mab 3C6 (lane 5) reacted with the 64 kDa 
polypeptide and also appeared to react faintly with one of 74kDa. The 
remaining 4 Mabs (4D7 - lane 8, 4G8 - lane 10, 6C10 - lane 12 and 8B11 - 
lane 14) reacted with the 74kDa polypeptide and a diffuse 68-70 kDa band. 
Mouse anti-CerHV-1 polyclonal serum which was included as a control in the 
Western blots reacted weakly with 130kDa, 74kDa and 64 kDa polypeptides 
of the same size as those recognised by the CerHV-1 Mabs. None of the 
Mabs or the mouse anti-CerHV-1 polyclonal serum recognized any bands in 
extracts of mock-infected cells.
4.3.4. Reactivity of Mabs in SNT and ELISA.
The Mabs were also characterised in terms of their reactivity in SNT and 
ELISA. The Mabs which were directed against the 64 kDa, 64-69 kDa, 68-70 
proteins showed no neutralising activity against CerHV-1, whereas the four 
Mabs which were directed against the 74 kDa and 68-70 kDa had similar 
neutralising activity with titres ^1:256. The Mabs showed varying optical 
density (OD492) values in the ELISA where two Mabs (2C3, and 5C2) had the 
lowest OD492 values of ^ 0.1 to 0.19, eight Mabs (1G7, 3C6, 3D9, 3E5, 4F10,
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Figure 4.2. Western blot of CerHV-1 Mabs with a detergent extract of 
CerHV-1 infected cells electrophoresed through a 10% SDS- 
polyacrylamide gel under reducing conditions and 
transferred to nitrocellulose. Mabs tested were 1G7, 2C3, 
2G8, 3B6,3C6,3D9, 3E5,4D7,4F10,4G8,5C2,6C10,6E9 
and 8B11 (lanes 1 to 14) and mouse anti-CerHV-1 serum 
(Poly). Mr are molecular weight markers.
I<4205
4 6 6
429
1 0 0
4G8, 6C10 and 8B11) had OD492 values of ^ 0.3 and the remaining four Mabs 
(2G8, 3B6, 6E9 and 4D7) had intermediate OD492 values of ^0.2 to 0.29 
(Table 4.5).
4.3.5. Immunofluorescence staining of Mabs in IFAT.
EBTr cells grown on coverslips and infected with CerHV-1 at a moi of 0.1 
pfu/cell were fixed at 20h or at 0, 6,12,18 and 24h post infection for the time 
course experiment. The cultures on the coverslips fixed at 20h post infection 
were probed with all 14 Mabs. The coverslips were fixed at 20h post infection 
so as to provide some uninfected cells among the infected cell to act as 
negative controls. For the time course experiment, eight selected Mabs 
representing the two Mab groups were used to probe the fixed cultures to 
study both their patterns of IF staining and time course appearance of the 
proteins recognized by these Mabs.
The results obtained in these tests are summarised in Tables 4.6 and 4.7 
and the typical IF appearance is shown in a single photograph in Fig. 4.3. 
The bulk of photographs for the IF staining were not obtained because of an 
unrecognised fault in the camera. Mabs which reacted with the 64 kDa 
protein showed predominantly a weak diffuse fluorescence which was 
distributed on the surface of infected cells. Only 4F10 showed in addition a 
diffuse cytoplasmic fluorescence, while no fluorescence was observed with 
Mab 2G8. The Mabs which recognized the 74 kDa and 68-70 kDa proteins 
had a more intense fluorescence distributed diffusely both on the surface of
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TABLE 4.5. Monoclonal antibodies to CerHV-1; neutralising activity reactivity 
in an ELISA test and Western blots
Mab
designation
Isotypea SNT15 ELISA testc Polypeptide 
specificity 
in Western blots 
(kDa)
1G7 IgG2a <2 +++ 64
2C3 IgG2a 8 + 64
3B6 IgG2a <2 ++ 64
3C6 IgG2a <2 +++ 64, 74
3D9 IgG2a <2 +++ 64
3E5 IgG2a 8 +++ 64, 68-70
5C2 IgG2a <2 + 64, 68-70
6E9 IgG2a <2 ++ 64, 68-70
2G8 IgG2a 8 ++ 64-69
4F10 IgG2b <2 +++ 68-70
4D7 IgG2b >256 ++ 68-70,74
4G8 IgGl 256 +++ 68-70,74
6C10 IgGl 256 +++ 68-70,74
8B11 IgGl 256 H—1—h 68-70,74
aAll are K light chains
bTitres expressed as the reciprocal of the highest serum dilution 
resulting in a 50% reduction of plaques relative to a virus 
control
cOD492 +>0.1; ++>0.2; +++ >0.3
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TABLE 4.6. Immunofluorescence staining of acetone-fixed CerHV-1 
infected cells using 14 Mabs
Protein Mab IF in fixed CerHV-1 infected cells
specificity
(kDa) Intensity Distribution Pattern
1G7 + S D
2C3 + S D
2G8 - - -
64 kDa 3B6 + s D
3C6 + s D
3D9 + s D
3E5 + s D
4F10 ++ s,c D
5C2 + s D
6E9 + s D
74 kDa 4D7 ++ S,C D
4G8 ++ s,c D
6C10 ++ s,c D
8B11 ++ s,c D
+ is a subjective indication of the degree of fluorescence intensity 
S - surface 
C - cytoplasm 
D - diffuse
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TABLE 4.7. Time course appearance of the 64kDa and 74kDa proteins 
as shown by the IF staining of CerHV-1 infected cells 
with 8 selected Mabs.
Protein 64 kDa 74 kDa Poly-
Mab clonal
1G7 3B6 3D9 3E5 4D7 4G8 6C10 8B11
Time
(hrs)
0 . . . .  . . . .
4 . . . .  . . . .
8 . . . .  . . . .  +
12 . . . .  _ _ _ + + +
16 + + +  + + + +  ++ +++ 
20 ++ + + +  + + + + + + +  + + ++ +++
24 +++ +++ +++ ++ + ++ + +++ + + + + + +  +++
Note + is a subjective indication of the degree of fluorescence
lOOd
Figure 4.3. Typical immunofluorescent staining pattern of the CerHV-1 
Mabs (4F10, 4D7, 4G8, 6C10, 8B11) in an indirect 
immunofluorescent test (IFAT) at 20h post infection. 
Infected cells appear fluorescent among a dark background 
of non-infected cells.
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infected cells and within the cytoplasm (Table 4.6).
The appearance of the two proteins in the time course experiment was 
shown to be from 12hr for the 74 kDa and 68-70 kDa proteins and 16 hrs for 
the 64 kDa, 64-69, 68-70 kDa proteins. There was an indication of an 
increase in amount of these proteins with time as shown by the increased 
intensity in fluorescence (Table 4.7).
4.4. DISCUSSION
4.4.1. Production of Mabs
The low proportion of successful fusions (2 out of 6) which were obtained 
in this study highlights the inherent problems associated with monoclonal 
antibody production. Tedder, Yao and Anderson (1982) and others emphasise 
how small variations in the technique, such as the use of different batches of 
PEG and/or the use of feeder cell layers, can enhance or decrease the number 
of antibody positive clones. Of 32 positive hybridomas only 14 were 
successfully cloned three times. Several clones (1G7, 2C3, 2G8, 5C2) grew 
very slowly and yielded less ascitic fluid with lower immunoglobulin content 
per ml as compared to the rest which grew faster yielding more ascitic fluid. 
These differences appeared to be a growth characteristic of each individual 
clone.
4.4.2. Isotypes
Isotype determination of the Mabs was important because it affected their
1 0 2
behaviour and choice of reagents in subsequent experiments. Knowledge of 
their isotypes was particularly relevant when choosing the detection systems 
for Western blotting and during purification of Mabs from ascitic fluids.
All 14 clones were identified as single isotypes lending support for the 
adequacy and efficiency of the subcloning which was carried out and their 
stability.
4.4.3. Protein specificity and reactivity of Mabs in ELISA and IFAT.
Mabs produced by four hybridomas (4D7, 4G8, 6C10 and 8B11) had 
similar high neutralising titres (Table 4.5) and binding characteristics (Figure 
4.1 and Table 4.3). Three of them were of the IgGl and one was of the IgG2b 
isotype. The IgG2b Mab had a higher neutralisation titre than those of the 
IgGl isotype. The lack of neutralising capability of the other Mabs could 
have been due to the stringent conditions of 100 TCID50 of the virus used. 
Mabs representing all isotypes of IgG which had complement-requiring or 
enhanced neutralising activities have been reported against other 
alphaherpesviruses (Collins et al, 1984; Highlander et al, 1987; Horimoto et 
al, 1990; Okazaki et al, 1986; Shen et al, 1991).
Of the ruminant alphaherpesvirus structural proteins, data from BHV-1 
studies have shown four major glycoproteins to be present on the virus 
envelope and plasma membrane of BHV-1 infected cells (van Drunen 
Littel-van den Hurk et al, 1984; Collins et al, Marshall et al, 1986; Hughes et
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al, 1988; Baranowski et al, 1993). These are: gl, a 130kDa disulphide-linked 
74/55kDa heterodimer; gn, a 108kDa glycoprotein; gin a 180kDa/91kDa 
dimeric glycoprotein and gIV, a 140kDa/71kDa dimeric glycoprotein. It has 
been shown further that gl, gin and gIV all stimulate the production of 
neutralising antibodies in mice, rabbits and cattle and they all serve as targets 
for antibody-dependent complement-mediated lysis of virus-infected cells 
(Collins et al, 1984; van Drunen Littel-van den Hurk et al, 1984; van Drunen 
Littel-van den Hurk and Babiuk, 1985; Marshall et al, 1986; Okazaki et al, 
1986; Trepanier et al, 1986; Israel et al, 1988; van Drunen Littel-van den 
Hurk et al, 1990). These glycoproteins are homologues of the HSV 
glycoproteins gB, gC and gD respectively. Glycoproteins gl and gIV have 
also been shown to be the primary targets for neutralising and protective 
antibodies (Babiuk et al, 1987). Four Mabs (1G7,2C3, 3B6, 3D9) recognized 
a cell-associated glycoprotein of 64kDa perhaps similar to that reported earlier 
for BHV-1 by Metzler et al (1985). The reactivity of Mab 3E5, 5C2, 6E9 
with the 64 kDa and a 68-70 kDa band was quite apparent as was the 
reactivity of 4F10 to the diffuse 68-70 kDa protein band. The reactivity of 
one Mab to more than one protein has also been observed by other workers 
(Collins et al 1984). Whether the multiple glycoproteins recognized by these 
Mabs were related was not investigated. The multiple reactivity is unlikely to 
be due to antibodies or two or more specificities since the hybridoma cell lines 
had been cloned. The IF staining patterns produced by the Mabs and their 
protein specificities bear similarities to those shown elsewhere for BHV-1 
(Shen et al, 1991). The four Mabs for the 74kDa and 68-70 kDa proteins gave
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an even diffuse distribution on the cell surface and cytoplasm, whereas there 
was an almost exclusively diffuse surface staining with the 64kDa Mabs.
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CHAPTER 5
THE USE OF MONOCLONAL ANTIBODIES IN THE ANALYSIS OF 
RUMINANT ALPHAHERPESVIRUS ANTIGENS
5.1. Introduction
There is an increasing awareness of the difficulties experienced in 
distinguishing the ruminant alphaherpesviruses due to their close serological 
relationships. The viruses are related structurally and antigenically; infection 
with one virus induces to varying extents, antibodies reactive with other 
viruses in this group (Pastoret et al, 1988). The five viruses cannot easily be 
differentiated by tests which rely on the detection of antibody using polyclonal 
sera. However, monoclonal antibodies directed against the virus specific 
antigens like BHV-1.1, gHI or gIV (Friedli and Metzler, 1987; Collins et al, 
1993) have enabled differentiation of BHV-1.1 from BHV-1.3 or SHV-1.
To facilitate the differential diagnosis of the five ruminant 
alphaherpesvirus antigens or infections the reactivity of the panel of Mabs 
produced in the present study against each of the five viruses was investigated. 
The information about their reactivity was then used to select Mabs with the 
potential for differentiating these viruses from each other. Several Mabs were 
selected to investigate whether the two CerHV-1 proteins, with molecular 
weights of 64kDa and 74kDa, to determine if these proteins were glycosylated
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and to see if they were homologues of known BHV-1 proteins.
5.2. Materials and Methods
5.2.1. Cells and viruses
The five viruses (Table 2.1, Chapter 2) were grown in a semi- continuous 
cell line of embryonic trachea cells (EBTr) as described in Chapter 2.
5.2.2. Antibodies
All 14 Mabs were used to determine their reactivity to the 5 ruminant 
alphaherpesviruses by ELISA. Three Mabs directed against the 64kDa (3B6, 
3C6, 4F10) and the 4 Mabs against the 74kDa protein (4D7, 4G8, 6C10, 
8B11) were selected to try to define epitopes on the two proteins and to 
identify analogous/homologous proteins in BHV-1.1. A bovine viral 
diarrhoea (BVD) Mab VPM22 was included as a control.
5.2.3. ELISA with Mabs against the five viruses
The ELISA procedures described in Chapter 2 with some minor 
modifications were used to determine the reactivity of each Mab with each of 
the five alphaherpesviruses as described below. Briefly, infected and 
non-infected cell lysates of each alphaherpesvirus (Table 2.1, Chapter 2) were 
used as the viral and control antigens respectively for coating a 96-well 
polyvinyl plate (Cooke M l29A Dynatech Labs) overnight at 4°C. Wells in 
column one were used as a blank in each plate. A two-fold dilution of each
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Mab (ascitic fluid) was done in rows for each plate and incubated for 2 hours 
at room temperature in a humid chamber. Appropriately diluted sheep 
anti-mouse IgG conjugated to HRP was added to all wells except those in 
column one, and incubated for lhr at room temperature. Orthophenylene 
diamine (OPD) (Sigma) in citrate buffer, pH 5.0 was added as substrate. The 
reaction was stopped by addition of 2.5M H2S04 and the optical density was 
read at 492nm.
5.2.4. Radioimmunoprecipitation of CerHV-1 and BHV-1.1 antigens.
Radiolabelled antigens were prepared and the radioimmunoprecipitation 
procedure was performed as described in Chapter 2. [3H]-
glucosamine-labelled CerHV-1 and BHV-1.1 antigens were each 
immunoprecipitated with Mabs 3B6, 3C6 and 4F10 (for 64kDa) and Mabs 
4D7, 4G8, 6C10, 8B11 (for 74kDa). The immune complexes were analysed 
by SDS-PAGE and autoradiography as described previously.
5.2.5. Competitive binding assay (CBA)
A modified enzyme-linked immunosorbent assay (ELISA) described 
previously (Lyaku et al, 1990) was carried out for two groups of Mabs; 3B6, 
3C6 and 4F10 (specific for 64kDa) and 4D7, 4G8, 6C10 and 8B11 (specific 
for 74kDa). Bovine viral diarrhoea (BVD) Mab VPM22 was used as a 
control. From a starting dilution of 1:100, lOOul of serial two-fold dilutions of 
each Mab were added to columns of wells of a flat-bottomed microelisa plate
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coated with CerHV-1 viral antigen at a dilution of 1:100 (determined 
previously by checkerboard titration) and incubated at 37°C for 1 hour. After 
three washings with PBST-20, 100 ul of horseradish peroxidase 
(HRP)-labeUed Mab at a predetermined dilution of 1:100 which gave optimum 
OD492 was added to each well containing the competing Mab. The conjugated 
Mab was also added to control wells without the competing Mab. After 
another three washes with PBST-20, lOOul of OPD as substrate solution 
containing lOul of 30% H20 2 was added to all wells and incubated at 37°C for 
20 minutes in the dark. The reaction was stopped with 2.5M H2S04 solution 
and the OD492 was determined. The amount of competitive binding inhibition 
was estimated from the OD492 in the presence or absence of unlabelled 
competing Mabs.
5.3. Results
5.3.1. Reactivity of the Mabs against the five alphaherpesviruses
The reactivity of each Mab with the five ruminant alphaherpesviruses is 
shown in Table 5.1. The Mabs show a wide range of serological reactivity 
indicating their potential for the differentiation of these viruses. Particularly 
noteworthy are two Mabs (3D9 and 3E5) which cross-reacted with all five 
ruminant alphaherpesviruses; two Mabs (4D7 and 8B11) reacted exclusively 
with CerHV-1; 3 Mabs (2G8, 4F10 and 4G8) reacted with all viruses except 
BHV-1.1 and one Mab (6E9) which reacted with all viruses except RanHV-1. 
Caution must be exercised in the interpretation of this table as although 4
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TABLE 5.1. ELISA reactivity patterns of the 14 Mabs with the 
ruminant alphaherpesviruses in the ELISA
Ruminant alphaherpesvirus antigens
Mab
designation Isotype BHV-1.1 BHV-1.2 CapHV-2 RanHV-1 CerHV-1
3D9 IgG2a ++ + + + +++
3E5 IgG2a ++ +++ + + +++
2G8 IgG2a - + + + ++
4F10 IgG2b - + + ++ +++
4G8 IgGl - + ++ ++ +++
3C6 IgG2a + - ++ + +++
2C3 IgG2a ++ - - ++ +
3B6 IgG2a + - - ++ +
6E9 IgG2a ++ + + - ++
1G7 IgG2a +++ + - - +++
5C2 IgG2a + - - - +
6C10 IgGl + - - - +++
4D7 IgG2b - - - - ++
8B11 IgGl - - - - +++
- negative result OD492 <0.1 
OD492 + ^0.1, ++ 0.2, +++ 0.3
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categories of reactivity have been defined (+++, ++, + and -) adjacent 
categories, might not be significantly different i.e. +++ might not be different 
from ++.
5.3.2. Comparison of antigenically related proteins of CerHV-1 and 
BHV-1.1
The two groups of selected Mabs which reacted against the 64kDa (3B6, 
3C6, and 3D9, 4F10) and 74kDa protein (4D7, 4G8, 6C10, 8B11) in the 
Western blotting experiments both showed comparable immunoprecipitation 
patterns with the two viruses (Figure 5.1). The four Mabs (4D7, 4G8, 6C10, 
8B11) precipitated two glycoproteins with molecular weights of 74kDa and 
55kDa in both viruses. A 130kDa glycoprotein was also faintly precipitated 
from CerHV-1 infected cells by three (4G8, 6C10, 8B11) of the four Mabs 
directed against the 74 kDa glycoprotein. The four Mabs specific for the 
64kDa protein precipitated two glycoproteins with molecular weights of 
150kDa and 45kDa.
5.3.3. Competitive binding assays (CBA)
Initially, checkerboard titrations were performed to determine the optimal 
conditions for competitive ELISA’s where maximal dilutions of both 
CerHV-1 antigen and HRP-conjugated Mabs which gave OD492 readings of 
about 1.0 in the absence of competitor Mabs. The optimum dilutions were 
established to be 1:100 for CerHV-1 antigen, 1:50 for 3B6, 3C6, 4F10 and
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Figure 5.1. Autoradiograph of immunoprecipitation of [3H] 
glucosamine labelled BHV-1.1 (left) and 
CerHV-1 (right) viral proteins with CerHV-1 
monoclonal antibodies: 4D7 (lane 1), 4G8 (lane 
2), 6C10 (lane 3), 8B11 (lane 4) 3B6 (lane 5), 
3C6 (lane 6), 3D9 (lane 7), 4F10 (lane 8). Lane 
9 and 10 are BHV-1.1 and CerHV-1 mock 
infected cell lysates immunoprecipitated with a 
mixture of all the eight Mabs such that the 
concentration of each was the same as when 
used individually. The track labelled Mr shows 
molecular weight marker positions.
BHV-1-1 CerHV-1 Mr
2 3  4 5 6 7 8 1  2 3 4 5 6 7 8 9  10 kDa
4 1 5 0
4 1 3 0  
4 74
4 5 5  
4 4 5
1 1 0
4G8, 1:100 for 6C10 and 1:400 for 8B11 HRP-conjugated Mabs. Mabs 
directed against the same protein were tested in two-way competition 
inhibition assays. Competition assays with HRP-conjugated Mabs directed 
against the 64kDa glycoprotein are shown in Table 5.2 and Figure 5.2. Two 
Mabs (3B6 and 3C6) showed similar reciprocal competitive inhibition 
reactions and thus may be assigned to one overlapping epitope on the 64 kDa 
protein. Mab 4F10 reacted differently with the two competitor Mabs (3B6 
and 3C6) showing only partial inhibition. However a similar reciprocal 
competition inhibition was observed when 4F10 was used as the competitor 
Mab.
Competition assays for the 74kDa glycoprotein are shown in Table 5.3 and 
Figure 5.3. Unlike the experiments with the Mabs against the 64kDa 
glycoprotein, there was no clear evidence for competitive inhibition between 
any of the Mabs against the 74kDa glycoprotein. The main problem was the 
absence of self-competition. Most likely this was due to Mab 4D7 being 
insufficiently concentrated while Mab’s 4G8, 6C10 and 8B11 were not diluted 
enough. Unfortunately, there was insufficient time to optimise the antibody 
dilutions for the anti-74kDa glycoprotein antibodies.
5.4. Discussion
5.4.1. Reactivity of the Mabs against the five viruses in the ELISA
The ability of monoclonal antibodies (Mabs) to detect minor antigenic
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TABLE 5.2. Competitive binding assay of Mabs directed against a CerHV-1 
64kDa glycoprotein.
Conjugatecl^abs
Competitor
Mabs
Dilution
of Competitor 
Mab
3B6 3C6 4F10 VPM22
(BVDM
100 0.18 0.10 0.40 0.00
200 0.18 0.12 0.42 0.00
3B6 400 0.19 0.12 0.57 0.01
800 0.21 0.18 0.60 0.02
1600 0.24 0.26 0.64 0.01
3200 0.15 0.23 0.72 0.01
6400 0.25 0.32 0.80 0.03
12800 0.29 0.38 0.84 0.02
* 0.81 0.84 0.67 0.01
100 0.18 0.08 0.42 0.02
200 0.20 0.08 0.46 0.02
400 0.20 0.13 0.56 0.01
3C6 800 0.24 0.15 0.61 0.01
1600 0.19 0.26 0.64 0.02
3200 0.24 0.26 0.71 0.02
6400 0.26 0.40 0.80 0.00
12800 0.33 0.47 0.80 0.00
* 0.85 0.84 0.62 0.01
100 0.10 0.02 0.04 0.01
200 0.12 0.05 0.05 0.01
400 0.12 0.05 0.06 0.01
4F10 800 0.16 0.07 0.08 0.01
1600 0.22 0.15 0.15 0.03
3200 0.23 0.19 0.18 0.03
6400 0.30 0.29 0.20 0.01
12800 0.35 0.42 0.30 0.01
* 0.79 0.81 0.68 0.01
Note *OD492 of conjugated Mabs in the absence of competitor Mabs.
110b
Figure 5.2. Competitive binding assays (CBA) for 
64kDa protein. Competitor Mabs 3B6 
(above), 3C6 (middle) and 4F10 (below) 
with conjugated Mabs 3B6 (•), 3C6 (■) 
and 4F10W-
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TABLE 5.3. Competitive binding assay of monoclonal antibodies 
directed against a CerHV-1 74kDa glycoprotein
Competitor
Mabs
Dilution of 
Competitor 
Mab 4D7
ConjugatedpMabs 
4G8 6C10 8B11 VPM22 
(BVD Mab)
100 1.06 0.65 0.92 0.65 0.00
200 1.05 0.66 1.01 0.77 0.00
400 1.05 0.69 1.10 0.85 0.00
4D7 800 1.11 0.71 1.17 0.98 0.01
1600 1.16 0.76 1.13 0.98 0.00
3200 1.19 0.74 1.14 1.00 0.01
6400 1.34 0.69 1.16 0.96 0.01
12800 1.39 0.81 1.27 1.02 0.01
* 1.31 1.14 2.12 1.78 0.01
100 0.52 0.51 0.56 0.37 0.03
200 0.55 0.42 0.57 0.39 0.01
400 0.57 0.49 0.56 0.42 0.03
4G8 800 0.69 0.48 0.59 0.46 0.02
1600 0.83 0.46 0.65 0.43 0.02
3200 0.90 0.47 0.60 0.43 0.03
6400 0.76 0.47 0.54 0.46 0.03
12800 0.90 0.55 0.55 0.49 0.02
* 1.50 1.14 2.28 1.94 0.03
100 0.64 0.60 0.55 0.36 0.00
200 0.66 0.60 0.67 0.49 0.01
400 0.76 0.57 0.75 0.55 0.01
6C10 800 0.81 0.57 0.75 0.58 0.01
1600 1.01 0.60 0.73 0.56 0.01
3200 1.13 0.58 0.76 0.52 0.01
6400 1.10 0.57 0.76 0.54 0.01
12800 0.87 0.63 0.74 0.56 0.00
* 1.30 1.11 2.34 1.99 0.00
100 0.76 0.67 0.89 0.57 0.01
200 0.84 0.67 1.03 0.73 0.02
400 0.91 0.66 0.99 0.68 0.02
8B11 800 0.95 0.75 1.01 0.77 0.02
1600 1.10 0.69 0.96 0.79 0.02
3200 1.37 0.68 1.03 0.77 0.03
6400 1.22 0.76 1.03 0.76 0.01
12800 1.77 0.78 1.04 0.84 0.01
* 1.52 1.08 2.10 1.80 0.01
Note *OD492 of conjugated Mabs in the absence of competitor Mabs
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Figure 5.3. Competitive binding assays (CBA) for 74kDa 
protein. Competitor Mabs 4D7 (above), 4G8 
(2nd middle) 6C10 (3rd middle) and 8B11 
(below) with conjugate Mabs 4D7 (•), 4G8 (■) 
6 0 0 ^ )  and 8B11(*).
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differences has facilitated the differentiation of serologically closely related 
viruses or even variants of the same strain of virus (Prabhakar et al, 1982). 
The different reactivities of the Mabs developed in this study support this view 
(Table 5.1). Two Mabs (3D9 and 3E5) cross-reacted with all five ruminant 
alphaherpesviruses, confirming their close antigenic relationship reported 
previously by others (Nixon et al, 1988; Martin et al, 1990) and more 
recently during the course of this study by Rimstad et al (1992). These Mabs 
could be used to establish the common viral protein antigens which form the 
basis of their close serological relationship. Two Mabs (4D7 and 8B11) 
reacted exclusively with CerHV-1 and could be used to differentiate this virus 
from the other four viruses. While on one hand a group of 3 Mabs (2G8, 
4F10, and 4G8) failed to react with BHV-1.1,5 other Mabs (2C3, 3CB6, 3C6, 
5C2 and 6C10) did not react with BHV-1.2. The differential reactivity of 
these eight Mabs supports the existence of antigenic differences between the 
BHV-1.1 and BHV-1.2 isolates. This is in agreement with others (Metzler et 
al, 1985; 1986) who showed that the two BHV-1 types could be differentiated 
from each other by the discriminating reactivity of one of their Mabs or by 
differences in the mobilities of virus induced-polypeptides in 
SDS-polyacrylamide gels. Recently, Collins et al, (1993) demonstrated that 
Mabs directed against gin of BHV-1.1 could be used to discriminate BHV-1.1 
from BHV-1.3.
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5.4.2. Radioimmunoprecipitation of CerHV-1 and BHV-1.1 antigens
The four Mabs 4D7, 4G8, 6C10 and 8B11 all immunoprecipitate 74kDa 
and 55 kDa glycoproteins from both BHV-1.1 and CerHV-1 infected cells. 
The two glycoproteins i.e. 74kDa and 55kDa have been previously identified 
to be the uncleaved components of the 130kDa heterodimer glycoprotein in 
BHV-1 (Misra et al, 1981) which is gl according to the nomenclature 
proposed by van Drunen Littel van den Hurk et al (1984). This glycoprotein 
has been identified to be a homologue of gB in HSV (Whitbeck et al, 1988). 
According to Ludwig (1983) and Ludwig and Gregersen (1986), a similar 
glycoprotein of 74kDa was shown to be responsible for the 
cross-neutralization between CapHV-2 and BHV-1. These studies identify for 
the first time the CerHV-1 gB homologue.
Three Mabs (4G8, 6C10 and 8B11) additionally precipitated a 130 kDa 
glycoprotein in CerHV-1. Mab 4D7 however failed to precipitate this protein 
in CerHV-1. All four Mabs failed to precipitate a similar glycoprotein in 
BHV-1.1. It is likely that the 130kDa, 74kDa and 55 kDa glycoproteins are 
related and that processing occurs at a different rate in CerHV-1 infected cells 
than in BHV-1.1 infected cells. The nature of the precursor-product 
relationship has not been examined but one possible scheme would involve 
cleavage of the 130 kDa glycoprotein to yield the 74kDa glycoprotein which 
in turn is cleaved to yield the 55kDa glycoprotein. The reactive epitope would 
like within the 55 kDa glycoprotein. An alternative explanation would be that
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the 74kDa glycoprotein physically associates with other (130kDa and 55kDa) 
glycoproteins. The observation that only the 74kDa glycoprotein is seen on 
western blots supports this latter view. The observation that Mab 4D7 does 
not precipitate the 130kDa glycoprotein suggests it might recognise a different 
epitope on the 74kDa glycoprotein from that seen by Mabs 4G8, 6C10 and 
8B11.
The Mabs (3B6, 3C6, 3D0 and 4F10) reactive with the 64kDa 
glycoprotein by Western blotting immunoprecipitated two proteins with 
molecular weights of 150kDa and 45kDa. The failure of these antibodies to 
imunoprecipitate a 64kDa glycoprotein is not clear but perhaps it might be a 
stable end product with the 150kDa and 45kDa glycoproteins being precursor 
forms. There is a precedent for such a scheme in BHV-1 where a 64kDa 
glycoprotein was shown to have precursor 148kDa and 42kDa proteins 
(Friedli and Metzler, 1987). This possibility could be tested with pulse-chase 
experiments.
5.4.3. Analysis of epitopes on the 64kDa and 74kDa glycoproteins
Competition between a Mab and a Mab conjugate in CBA indicates that 
the epitopes that are recognized by the two Mabs overlap or are adjacent on 
the antigen (Stone and Nowinsky, 1980), especially for reciprocally 
competing Mabs. Non-reciprocal competition may occur due to the affinity 
and avidity of the two Mabs differing greatly; where the binding of one Mab
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induces a change in the conformation that alters the binding site of the other 
Mab. The binding of one Mab may sterically hinder the binding of the other 
Mab; or the conjugating of one Mab to peroxidase may alter the ability of the 
other Mab to bind. The results for the 64kDa glycoprotein showed reciprocal 
competition suggesting that Mabs (4F10, 3C6 and 3B6) identified a single or 
overlapping epitope(s). Although the reactivities of these three Mabs show 
three different patterns with the five viruses (Table 5.1) this does not imply 
that the Mabs identify different epitopes since the degree of reactivity with the 
BHV-1.1, BHV-1.2, CapHV-2 and RanHV-1 differ by only one category for 
any particular virus which might not be significantly different (Section 5.3.1).
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CHAPTER 6 
GENERAL DISCUSSION
The major aim of the work described in this thesis was to compare the 
serological relationships among the five ruminant alphaherpesviruses. The five 
viruses used in this study were shown to be different from each other by the 
restriction endonuclease profiles as described in Chapter 3. Antigenic 
relationships were analysed by the use of polyclonal sera and monoclonal 
antibodies as described in Chapters 3, 4 and 5 respectively. This chapter brings 
together findings obtained from this study and those of others to discuss the 
following: First, the basis of the close serological relationships which exist among 
these viruses as determined by the viral proteins recognised by both polyclonal 
sera and monoclonal antibodies. Second, the implications of these serological 
relationships for epidemiological data, diagnostic tests and development of 
vaccines. Third, the use of monoclonal antibodies as tools in developing sensitive 
and reliable diagnostic tests which are capable of differentiating infections caused 
by these ruminant alphaherpesviruses. Fourth, the importance of understanding 
the genetic structure, composition and the possible evolutionary relationships 
which exist among these viruses which could be used to form a clear and 
objective herpesvirus classification.
6.1. Serological relationships and their implication for epidemiological data 
and diagnostic tests.
The existence of close serological relationships among the five ruminant
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alphaherpesviruses was established by ELISA, SNT and Western blotting 
(Chapter 3). Until recently there have been few studies on the serological 
relationships among these viruses. Nixon et al, (1988) and Martin et al (1990) 
reported the serological relationships between BHV-1, CapHV-2 and CerHV-1. 
While work on this thesis was proceeding Rimstad et al (1992) published a 
report containing preliminary findings on the serological relationships between 
BHV-1, CapHV-2 and RanHV-1. The present study reports for the first time an 
extensive comparison and analysis of the antigenic relationships among this group 
of five ruminant alphaherpesviruses. The evidence in this study supports and 
confirms all the findings in the above mentioned reports, namely that: 1) the two 
BHV-1 viruses are the most closely related, 2) CerHV-1, CapHV-2 and RanHV-1 
are more closely related to the two BHV-1 viruses than they are to each other, 3) 
the CerHV-1 is more related to the BHV-1 viruses than to CapHV-2 or RanHV-1, 
and 4) RanHV-1 is more related to CerHV-1 than to the two BHV-1 and 
CapHV-2 viruses (see Figure 6.1.). The extent and degree of serological 
cross-reactivities reported in the present work, supports the view that ruminants 
other than cattle can indeed be seropositive to a virus antigenically related to but 
distinct from BHV-1. The data presented here supports the view that antibodies 
to CerHV-1 in wild and farmed red deer in Britain (overall prevalence 29%) is 
likely to be due to infection with CerHV-1 rather than BHV-1.
The available evidence suggests that alphaherpesvirus infections in both wild 
and domestic ruminants occur only in their natural hosts and do not cross stably 
into other species (Brake and Studdert, 1985; Pastoret et al, 1988). However,
Figure 6.1. A schematic diagram of antigenic relationships 
among the five ruminant alphaherpesviruses.
CapHV-l BHV-II BHV-1-2 CerHV-1 RanHVI
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experimental latent infections of a species different from that of the natural host 
have been demonstrated, for example, BHV-1 infections in domestic goats (Pirak 
et al, 1983); and red deer (Reid et al, 1986). The close serological relationship 
observed in this study among these viruses precludes the use of polyclonal 
antibodies in distinguishing, for example, CerHV-1 from BHV-1 infection in red 
deer.
These findings highlight the potential of misinterpretation of both diagnostic 
tests and epidemiological data. As pointed out earlier by Nixon and others 
(1988), the best results for diagnostic serology is likely to be achieved by using an 
appropriate virus isolate. Considerations should also be given in the development 
and use of appropriate test protocols to avoid possible misinterpretation of results 
where tests are being done for the purposes of national or international disease 
control or animal certification. Thus, if the objective is to control the spread of 
CerHV-1 in red deer or CapHV-2 in goats, it should be mandatory to use cognate 
antigen for diagnosis.
6.2. Prospects for the use of monoclonal antibodies in the development of 
reliable differential diagnostic tests.
The work reported in this thesis has shown clearly the potential of monoclonal 
antibodies for differentiation of the serologically closely related ruminant 
alphaherpesviruses (Chapter 4 and 5). The Mabs showed a wide range of 
reactivity, with two Mabs (4D7 and 8B11) being specific for CerHV-1. A group 
of 3 Mabs (2G8,4F10, and 4G8) failed to react with BHV-1.1 while 5 other Mabs
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(2C3, 3B6, 3C6, 5C2 and 6C10) did not react with BHV-1.2. Two Mabs (3D9 
and 3E5) reacted with all the five ruminant alphaherpesviruses. Therefore the use 
of such Mabs could facilitate the differentiation of these alphaherpesviruses. The 
Mabs 4D7 and 8B11 (Table 5.1) which reacted exclusively with CerHV-1 could 
potentially be used to develop a test which could differentiate CerHV-1 from the 
other four serologically related alphaherpesviruses although this potential has yet 
to be realised. Kit and others (1992) have described a blocking ELISA for 
distinguishing BHV-1.1 infected animals from those vaccinated with a 
gene-deleted marker vaccine. For their ELISA, undiluted test sera were used to 
block the binding of an anti-IBR virus gDI monoclonal antibody HRP-conjugate 
to glU antigen. A similar sensitive anti-pseudorabies virus glycoprotein gin 
blocking ELISA for distinguishing between pseudorabies-infected and vaccinated 
pigs has also been reported (Kit et al, 1990). It can therefore be argued that 
monoclonal antibodies directed against virus specific antigens like gin and glV 
(Ben-Porat et al, 1986; Friedli and Metzler, 1987; Allen and Coogle, 1988) could 
be more advantageous and reliable for developing differential diagnostic tests for 
the ruminant alphaherpesviruses (van Drunen Littel-van den Hurk et al, 1990). 
An alternative approach could be the use of anti-idiotypes (antibodies to specific 
Mabs) as "network" antigens (Kholer et al, 1989) in direct ELIS As. The 
potential of using anti-idiotypes lies in their ability to biologically mimic the 
epitope(s) by their bearing the internal image of a particular antigen (against 
which the Mab(s) are directed). Recently anti-idiotypes capable of inducing 
neutralising antibodies to BHV-1 glV and gl have been developed (Srikumaran et 
al, 1990; Hariharan et al, 1991). Their work not only promises a new avenue of
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using anti-idiotypes as antigens in diagnostic tests, but also as potential 
immunogens against these viruses.
Another approach would be synthetic peptides mimicking defined epitopes. 
In particular, synthetic peptides can be used as specific antigens in diagnostic 
ELISA test systems for the detection of antibody in sera (Gnann et al, 1987; 
Marsden et al, 1992). As pointed out by Norrby and others (1987) and Gnann 
and coworkers (1987), one of the major advantages of peptide tests has been 
shown to be an easy and fast distinction between virus subtype infections e.g. 
diagnosis of human immunodeficiency virus HIV-l/HIV-2 infections. 
Oligopeptides represent mostly sequential epitopes of limited size. Thus, their 
use in diagnostic test systems require methods for the definition of those 
dominant antigenic sites that are recognised by the immune response and 
accessible to antibody binding. In this case, identification and characterisation of 
antigenic sites is a pre-requisite for the successful use of a peptide as antigen for 
antibody detection in sera. The smallest epitopes for antibody recognition have 
been described as four to six amino acids (Tang et al, 1988); generally peptides 
of about 12-20 amino acids are used. As recently reported by Marsden et al 
(1992), branched peptides which consist of a small two-fold bifurcating, 
polylysine core onto which the peptide of interest is synthesised are capable of 
detecting lower amounts of antibodies than could be detected with monomeric 
peptides. The physical aspects of branched peptides which might be important 
for the observed increase in sensitivity include the following. First, they might 
bind more readily to the microtitre wells than monomeric peptides. Second,
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multivalent binding between antibody and branched peptide would result in a 
considerable increase in stability, compared to simple monovalent binding of 
monomeric peptides (Tam and Zavala, 1989). Third, to be immunoreactive 
monomeric peptides have to both bind to the plastic well and remain available for 
binding to the antibody, whereas one or more arms of a branched peptide could 
bind to the plastic and leave the others free to bind to the antibody. It is possible 
that in binding to the plastic, physical constraints are imposed on a monomeric 
peptide to prevent it from interacting freely with the antibody. The large savings 
potentially available when using branched peptides for peptide-based 
serodiagnostic kits and their greater sensitivity leads to the suggestion that they 
might become the reagents of choice.
6.3. Identification and characterisation of antigens and implications for 
vaccine development.
Identification and characterisation of the envelope glycoproteins of the 
ruminant alphaherpesviruses is required to understand their relative 
immunological significance in the naturally-infected natural hosts. This is a 
necessary pre-requisite to the development of new effective vaccines for these 
important pathogens particularly BHV-1 (Lupton and Reed, 1990). It has 
been shown that herpesvirus glycoproteins play important roles in 
pathogenicity, particularly in adsorption, penetration, and in the mediation of 
cell-to-cell spread of virus (Cai et al, 1988; Ligas and Johnson, 1988). These 
glycoproteins are known to be among the targets for the host’s humoral and 
cell mediated immune responses (reviewed by Spear, 1990, 1993a). In the
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present study, ELISA, SNT and Western blotting indicated that the five 
viruses possess many shared as well as unique antigenic determinants. These 
findings support previous reports on the existence of the wide serological 
relationships among the ruminant alphaherpesviruses (Ludwig, 1983; Buddie 
et al, 1990; Engels et al, 1992). As for all investigated herpesviruses, it could 
be shown that only a few glycoproteins are of importance for the immune 
response of the host against virions and infected cells. To date, three major 
BHV-1 envelope glycoproteins namely gl, gLQ and glV have been shown to 
be involved in virus neutralisation (van Drunen Littel-van den Hurk and 
Babiuk 1986b; Marshall et al, 1988). In addition, genes for these three 
glycoproteins have been identified and sequenced (Zamb, 1987) and the gene 
products were found to induce high levels of antibody in cattle which could 
neutralise virus and participate in antibody-dependent cell cytotoxicity of 
BHV-1 infected cells (Collins, et al 1993). Animals immunised with these 
glycoproteins were fully protected from disease (Babiuk et al, 1987). Israel et 
al (1992) have recently shown that an intranasal vaccination with BHV-1 gl, 
expressed from recombinant baculovirus-infected insect cells, can induce 
protective antibodies in the nasal secretion of cattle.
Since control of BHV-1 is based largely on vaccination, and the safety of 
the commonly used live attenuated vaccines is continuously being questioned 
due to latency and consequent reactivation (Pastoret et al, 1980; Whetstone et 
al, 1989) development of subunit vaccines consisting of any one or a 
combination of these immunodominant glycoproteins could be considered as a
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viable alternative.
6.4. Genetic structure, composition, possible evolutionary relationships and 
herpesvirus classification.
The taxonomy of ruminant alphaherpesviruses as for the whole family 
herpesviridae is based on their antigenic properties and the restriction enzyme 
analysis of their genomes. Initially the classification of herpesviruses into 
subfamilies was based on simple measurements or observations e.g. 
cytopathology or growth time that could be readily determined in the majority of 
laboratories. Most herpesviruses assigned to the three subfamilies would have 
been assigned now to the same subfamilies on the basis of the wider range of 
more objective criteria currently available. Indeed with a few exceptions, the 
criteria proposed in 1981 yielded a scheme of relationships which mirrored that 
since determined by DNA sequence homology, gene organisation and 
composition. However, with the ever accumulating information based on the 
herpesvirus genomes, the exceptions are considered to be highly significant in 
that they indicate the criteria used to align viruses to the three subfamilies to have 
been unsatisfactory for some viruses.
The key exceptions are the gallid herpesvirus 1 (GHV-1, Marek’s disease 
herpesvirus) and herpesvirus of turkeys classified in 1981 as members of 
Gammaherpesvirinae, the human herpesvirus-6 (HHV-6) which was not known at 
that time and the fish herpesvirus, channel catfish virus. The classification of 
GHV-1 and the herpesvirus of turkeys as a members of the Gammaherpesvirinae
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reflected the observation that the virus caused tumour-like growths in chickens, 
the tumours were of lymphoid type and the viral genomes were present and 
expressed in cells contained in those tumours. Current data indicate that their 
genome arrangement resembles that of the Alphaherpesvirinae rather than that of 
Gammaherpesvirinae (Buckmaster et al, 1988). The complete genome sequence 
of the fish herpesvirus, channel catfish virus (CCV) shows no clear relationship 
whatever with the viruses of the three herpesvirus subfamilies thus Davison 
(1992) proposed that it should be assigned to a separate taxonomic group. 
Recently the ICTV proposed several objective criteria for the classification of 
herpesvirus subfamilies (Roizman et al, 1992). These criteria include (i) 
conservation of genes and gene clusters (e.g. DNA polymerase, glycoproteins B, 
C and H, the major single-stranded DNA binding protein, major capsid protein); 
(ii) the arrangement of gene clusters relative to each other; (iii) the arrangement of 
the terminal sequences involved in packaging of the viral genome; and (iv) the 
presence and distribution of nucleotides that are subject to methylation (Davison 
and Taylor, 1986; Deiss et al, 1986). The imaginative application of the 
polymerase chain reaction (PCR) will enhance and readily speed up the 
realisation of the aforementioned objective criteria for the comparative analysis 
and classification of the herpesviruses. As the results in this thesis have 
indicated; it is possible to amplify a small section of heterologous 
alphaherpesvirus DNA by using synthetic primers selected from known gene 
sequences of one of the closely related herpesviruses.
The objectives of herpesvirus taxonomy should be firstly to provide a
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quantitative measure of the relatedness of the different herpesviruses to each other 
from which one can infer an evolutionary tree. Secondly, it should serve the 
utilitarian function of assisting those involved in the isolation of new viruses to 
predict biologic properties in the same fashion that biochemical and morphologic 
properties identify bacteria.
The major aims of this study were firstly to compare and analyse the 
serological relationships among the five ruminant alphaherpesviruses. The 
results in this present study show the existence of close serological 
relationships among these viruses (Lyaku et al, 1992a). Secondly, the 
potential for distinction and differentiation of these five viruses was suggested 
by the reactivity of a panel of the 14 Mabs (Lyaku et al 1992b). The 
information obtained in this thesis shows the potential ability of Mabs in 
differentiating closely related viruses. Further work is however required to 
unravel the nature of the relationships which exist among these viruses, to 
exploit for diagnostic purposes the Mabs described and to produce more Mabs 
for developing sensitive and reliable differential diagnostic tests.
6.5. Future work
The information provided by findings in this thesis opens several 
avenues for future work. Firstly, the two Mabs (4D7 and 8B11) directed 
against gl and specific for CerHV-1 should be further investigated to see if 
they can form the basis of a discriminatory Mab capture based ELISA. The 
two Mabs (4D7 and 8B11) could also be used for affinity purification of gl
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which could in turn be used to raise more Mabs for both physical and 
functional epitope mapping of this glycoprotein. Secondly, the genes 
responsible for the expression of CerHV-1 gl, gin and glV might be 
identified by PCR and nucleotide sequencing of the viral DNA. The 
nucleotide sequences of these genes could then be used to specify 
overlapping synthetic peptides which could be synthesised and used for the 
screening of sera to serodiagnostic tests capable of distinguishing the five 
ruminant alphaherpesviruses. Recombinant glycoprotein gin antigens could 
also be produced by cloning the respective fragment containing gin gene into 
a suitable expression system (eg Baculovirus). The possibility of using such 
antigens in the development of diagnostic tests could also be explored. This 
approach has already been used for the serological distinction of vaccinated 
from wild type infections in SHV-1 and BHV-1.1 (Van Oirschot et al, 1988, 
1990; Kit et al, 1992). As well as this approach, data from HSV (Lee et al 
1985, 1986) and recently from EHV-4 (Crabb et aly 1992) strongly indicate 
that fine discriminatory serological tests can be developed using glycoprotein 
G to detect HSV-1 or HSV-2 and EHV-1 or EHV-4 type-specific antibodies 
respectively. This was only possible after the accumulation of detailed 
knowledge of the molecular biology of HSV and EHV. Further detailed 
analysis of the ruminant alphaherpesviruses will be necessary before such 
elegant discriminatory tests can be developed.
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